0001080602-12-000022.txt : 20120711 0001080602-12-000022.hdr.sgml : 20120711 20120710190834 ACCESSION NUMBER: 0001080602-12-000022 CONFORMED SUBMISSION TYPE: 10-Q/A PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20111130 FILED AS OF DATE: 20120711 DATE AS OF CHANGE: 20120710 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Allezoe Medical Holdings Inc CENTRAL INDEX KEY: 0001080602 STANDARD INDUSTRIAL CLASSIFICATION: METAL MINING [1000] IRS NUMBER: 980413066 STATE OF INCORPORATION: DE FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: 10-Q/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33090 FILM NUMBER: 12956754 BUSINESS ADDRESS: STREET 1: 1800 NW CORPORATE BOULEVARD STREET 2: SUITE 201 CITY: BOCA RATON STATE: FL ZIP: 33431 BUSINESS PHONE: 321-452-9091 MAIL ADDRESS: STREET 1: 1800 NW CORPORATE BOULEVARD STREET 2: SUITE 201 CITY: BOCA RATON STATE: FL ZIP: 33431 FORMER COMPANY: FORMER CONFORMED NAME: STANFORD MANAGEMENT LTD DATE OF NAME CHANGE: 19990225 10-Q/A 1 f10qa11302011.htm FORM 10-Q/A Converted by EDGARwiz

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549


FORM 10-Q/A


(Mark One)


[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

       OF 1934

For the Quarterly Period Ended November 30, 2011

or

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

     OF 1934

For the Transition Period From ____ To______


Commission file number: 001-33090


ALLEZOE MEDICAL HOLDINGS, INC.

( Exact Name of Registrant as Specified in its Charter)


Delaware

98-0413066

(State or other jurisdiction of incorporation or organization)

(IRS Employer Identification No.)


1800 NW Corporate Boulevard, Suite 201, Boca Raton, FL

33431

(Address of principal executive offices)

(Zip Code)


(321)-452-9091

(Registrants Telephone Number, Including Area Code )


Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [X] No [ ]


Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).

Yes [X] No [ ]


Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):


Large accelerated filer

                            [   ]

Accelerated filer

                                          [   ]

Non-accelerated filer

                            [   ]

Smaller reporting company                                          [X]

(Do not check if a smaller reporting company)



Indicate by check mark whether registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [ ] No [ X]


As of January 17, 2012, there were 182,236,685 shares of Common Stock ($0.001 par value) outstanding.






EXPLANATORY NOTE


The Company is filing this amended Form 10-Q/A in order to restate its financial statements as a result of the rescission of a February 18, 2011 transaction in which the Company acquired all of the outstanding shares of Organ Transport Systems, Inc. (OTS). As disclosed in the financial statements and other sections of this document, the Companys previously reported financial results have been restated to present financial statements of the Company as if the OTS transaction never occurred.



TABLE OF CONTENTS




Page Number




PART I.

FINANCIAL INFORMATION





ITEM 1.

Financial Statements (unaudited)

1





Balance Sheets as of November 30, 2011 and August 31, 2011

2





Statements of Operations for the three months ended November 30, 2011 and 2010 and for the period from September 24, 1998 (Date of Inception) to November 30, 2011

3


Statements of Stockholders Equity (Deficit) for the period from September 24, 1998 (Date of Inception) to November 30, 2011

4-5

-

Statements of Cash Flows for the three months ended November 30, 2011 and 2010 and for the period from September 24, 1998 (Date of Inception) to November 30, 2011

6


Notes to the Financial Statements.

7




ITEM 2.

Managements Discussion and Analysis of Financial Condition and Results of Operations

26




ITEM 3.

Quantitative and Qualitative Disclosure about Market Risk

31




ITEM 4.

Controls and Procedures

32




PART II.

OTHER INFORMATION

33




ITEM 1.

Legal Proceedings

33




ITEM 1A.

Risk Factors

33




ITEM 2.

Unregistered Sales of Equity Securities and Use of Proceeds

33




ITEM 3.

Defaults Upon Senior Securities

34




ITEM 4.

(Removed and Reserved)

34

ITEM 5.

Other Information

34




ITEM 6.

Exhibits

34





SIGNATURES

34









PART 1 FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS


The accompanying balance sheets of Allezoe Medical Holdings, Inc. (a development stage company) (the "Company) at November 30, 2011 (with comparative figures as at August 31, 2011); and the  statements of operations for the three months ended November 30, 2011 and 2010, and for the period from September 24, 1998 (date of inception) to November 30, 2011; the  statements of stockholders equity (deficit) for the period from September 24, 1998 (date of inception) to November 30, 2011; and the  statements of cash flows for the three months ended November 30, 2011 and 2010 and for the period from September 24, 1998 (date of inception) to November 30, 2011 have been prepared by the Companys management in conformity with accounting principles generally accepted in the United States of America.


On February 18, 2011, the Company acquired all of the outstanding shares of Organ Transport Systems, Inc. (OTS), a Nevada corporation, and simultaneously disposed of the assets relating to its former activities in mining exploration, along with all related liabilities. Consequently, OTS was considered to be the surviving entity, with the Company intending to include only the financial results of OTS in its financial statements. In March, 2012, however, the Company determined that the development costs and time to development for the OTS technology were significantly greater than originally expected and, as a result, determined to return OTS to Healthcare of Today, Inc., from which it had been originally acquired. As a result, the February 18, 2011 transaction with OTS was rescinded and OTS is no longer a part of the Companys corporate group. The Company will focus on the HPV detection and treatment technology as well as on the technology currently being developed by BioCube, Inc. for the disinfection of healthcare facilities. The historical financial results presented in this Report have been restated to present those solely of the Company.


In the opinion of management, all adjustments considered necessary for a fair presentation of the  results of operations and financial position have been included and all such adjustments are of a normal recurring nature.


Operating results for the three months ended November 30, 2011 are not necessarily indicative of the results that can be expected for the year ending August 31, 2012.















1


Allezoe Medical Holdings, Inc.

(A Development Stage Company)

BALANCE SHEETS






November 30, 2011 (Restated and unaudited)


August 31, 2011 (Restated)








ASSETS

CURRENT ASSETS





 Cash


 $                   135,615


 $               21,972


 Prepaid expenses

                  1,000


            1,000



 Total current assets

             136,615


           22,972

 Deferred loan costs, net of accumulated amortization of $1,075 and $800

               4,425


       4,700

 Loan receivable

          1,884,150


      257,653

 Advances to related parties

                5,000


            5,000



 Total assets

 $                2,030,190


 $             290,325

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES





 Accounts payable and accrued expenses

 $                     28,101


 $                 7,045


 Notes payable - net of debt discount of $142,917 and $128,422

            232,583


           64,578


 Accrued interest

            173,355


            9,964



 Total current liabilities

              434,039


             81,587

LONG-TERM LIABILITIES





 Long-term notes payable

1,447,126


                      -



 Total liabilities

1,881,165


         81,587

STOCKHOLDERS' EQUITY (DEFICIT)





Common stock, $0.001 par value; 500,000,000






shares authorized. 95,069,482 and 61,825,039 shares






issued and outstanding

             95,070


             61,825


Additional paid in capital

             5,821,711


      4,665,738


Deferred equity

          (1,680,000)


      (1,680,000)


Deficit accumulated during the development stage

         (4,087,756)


   (2,838,825)



Total stockholders' equity (deficit)

               149,025


        208,738



Total liabilities and stockholders' equity

 $                2,030,190


 $             290,325


The accompanying notes are an integral part of these financial statements.



2


Allezoe Medical Holdings, Inc.

(A Development Stage Company)

STATEMENTS OF OPERATIONS

For the Periods from September 24, 1998 (Date of Inception), to November 30, 2011



Three Months Ended

Cumulative from Inception to November 30, 2011 (Restated)



November 30, 2011 (Restated)

November 30, 2010 (Restated)







REVENUES

 $                             -   

 $                                -   

 $                                 -   






GENERAL AND ADMINISTRATIVE EXPENSES





Payroll and payroll taxes

             491,978

                                   -   

                2,545,045


Professional fees

              510,543

                 4,950

                 790,201


Travel and entertainment

                    925

                                   -   

                     4,035


Insurance

                        -   

                                   -   

                     48,559


Office expense

                      -   

                      268

                     1,209


Telephone and internet

                      -   

                                   -   

                   6,353


General and administrative

                      492

                       75

                281,357


Dues and subscriptions

                         -   

                                   -   

                         55


Repairs and maintenance

                       -   

                                   -   

                     4,202







Loss from operations

            (1,003,938)

               (5,293)

        (3,681,016)






OTHER INCOME (EXPENSE)





Finance cost

                      -   

                                   -   

                   (133,494)


Interest, net

      (244,993)

                                   -   

                (273,246)







Net loss

 $            (1,248,931)

 $                      (5,293)

 $               (4,087,756)






Net loss per share (basic and diluted)

 $                     (0.02)

 $                        (0.00)







Weighted average number of shares outstanding during the period-basis and diluted

       67,112,080

         52,170,000



The accompanying notes are an integral part of these financial statements.



3


Allezoe Medical Holdings, Inc.

(A Development Stage Company)

STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)

For the Periods from September 24, 1998 (Date of Inception), to November 30, 2011













Deficit







Accumulated

Total




Additional


During the

Stockholders'


Common Stock

Paid In


Development

Equity


Shares

Par Value

Capital

Deferred Equity

Stage

(Deficit)








Balance - September 24, 1998 (inception)

                    -

 $           -   

 $                    -   

 $                      -   

 $                    -   

 $                   -   

Common stock issued for cash

47,170,000

    47,170

     (41,720)

                -   

               -   

        5,450

Contributions-noncash expenses

           -

        -

      138,600

                 -   

            -   

  138,600

Common stock issued for cash

    5,000,000

    5,000

      45,000

                  -   

               -   

    50,000

Net loss for the period from September 24, 1998(inception) to August 31, 2009

                 -   

             -   

                -   

                   -   

     (340,716)

     (340,716)

Balance - August 31, 2009 (restated)

 52,170,000

   52,170

 141,880

                   -

    (340,716)

      (146,666)

Contributions-noncash expenses

                    -

     -

     12,600

                  -

                -   

    12,600

Net loss for the year ended August 31, 2010

             -   

     -   

             -   

                -   

   (22,365)

(22,365)

Balance - August 31, 2010 (restated)

52,170,000

52,170

154,480

-

       (363,081)

       (156,431)

Common stock issued for services, $0.42 per share

    5,000,000

    5,000

     2,095,000

     (1,680,000)

               -

          420,000

Common stock issued for services, $0.42 per share

  3,000,000

3,000

1,257,000

                  -

             -

1,260,000

Converted notes payable to common stock, $0.36per share

 927,666

    928

      458,454

                 -

            -

    459,382

Converted notes payable to common stock, $0.36per share

      556,600

 557

     275,072

                 -

              -

  275,629

Common stock issued for services, $0.724 per share

     77,624

  77

        56,122

               -

              -

    56,199

Common stock issued for services, $0.724 per share

     46,574

   47

     33,672

                  -

              -

 33,719

Common stock issued for services, $0.724 per share

       46,575

   46

     33,673

                 -

              -

       33,719

Issuance of notes payable-beneficial conversion feature

             -    

       -

  145,833

                 -

             -

   145,833

Additional capital contributed

                -

        -

      156,432

                 -

              -

    156,432

Net loss for the year ended August 31, 2011

              -

      -

               -

                      -

    (2,475,744)

   (2,475,744)

Balance - August 31, 2011 (restated)

   61,825,039

 $ 61,825

 $     4,665,738

 $     (1,680,000)

 $   (2,838,825)

 $       208,738


The accompanying notes are an integral part of these financial statements.



4


Converted notes payable to common stock, $0.01875 per share

       2,666,667

     2,667

                       47,333

                                   -   

                                -   

                        50,000

Converted notes payable to common stock, $0.01035 per share

                 4,830,918

                 4,831

                       45,169

                                   -   

                                -   

                        50,000

Converted notes payable to common stock, $0.00675 per share

                 8,888,888

                 8,889

                       51,111

                                   -   

                                -   

                        60,000

Common stock issued for services, $0.57 per share

                    391,304

                    391

                     222,652

                                   -   

                                -   

                      223,043

Common stock issued for services, $0.057 per share

                 4,000,000

                 4,000

                     224,000

                                   -   

                                -   

                      228,000

Common stock issued at $0.57 per share

         234,782

  235

   133,591

                   -   

                 -   

        133,826

Common stock issued at $0.057 per share

    2,400,000

    2,400

        134,400

                    -   

            -   

        136,800

Common stock issued at $0.0098 per share

      9,831,884

9,832

       86,521

                    -   

                -   

         96,353

Issuance of notes payable-reissuance

                  -   

            -   

      154,074

                   -   

                -   

          154,074

Issuance of notes payable-beneficial conversion feature

-

-

                       57,122

-

-

                        57,122

Net loss for the period ended November 30, 2011

                             -   

                       -   

                               -   

                                   -   

                  (1,248,931)

                  (1,248,931)

Balance - November 30, 2011 (restated)

    95,069,482

 $ 95,070

 $      5,821,711

 $     (1,680,000)

$(4,087,756)

 $       149,025



The accompanying notes are an integral part of these financial statements.



5





Allezoe Medical Holdings, Inc.

(A Development Stage Company)

 STATEMENTS OF CASH FLOWS

For the Periods from September 24, 1998 (Date of Inception), to November 30, 2011





Three Months Ended November 30,

For the Period from September 24, 1998 (Inception) to November 30, 2011





2011       (restated)

2010    (restated)









CASH FLOWS FROM OPERATING ACTIVITIES





Net loss

 $         (1,248,931)

 $          (5,293)

 $                 (4,087,756)


Adjustments to reconcile net loss to net






cash used by operations:






Capital contributions-noncash expenses

                     -

                -

               151,200



Stock based compensation expense

818,022

                -

            2,898,176



Amortization of deferred loan costs

             275

               -

                  1,075



Amortization of debt discount

          42,628

                -

                193,533


Changes in certain operating assets and liabilities:






Interest accrued on notes payable

        163,391

                 -

               173,355



Increase in prepaid expenses

                            -

               -

                 (1,000)



Loans receivable

          (179,371)

                -

            (437,024)



Increase (decrease) in accounts payable







and accrued expenses

           21,056

(56,209)

                 28,101

Net cash used by operating activities

      (382,930)

   (61,502)

                (1,080,340)

CASH FLOWS FROM FINANCING ACTIVITIES





Additional capital contributed

                           -

                -

                 156,432


Proceeds from issuance of common stock

                   -

                -

                 55,450


Proceeds from notes payable

                496,573

                 -

                 1,009,073


Related party advances

                      -

      61,503

               (5,000)

Net cash provided by financing activities

               496,573

     61,503

             1,215,955

Net increase (decrease) in cash

            113,643

              1

            135,615

Cash and equivalents, beginning of period

          21,972

  1,015

                             -

Cash and equivalents, end of period

 $              135,615

 $               1,016

 $                      135,615

Supplemental cash flow information:





Cash paid for interest

 $                          -

 $                       -

 $                          4,500


Cash paid for income taxes

 $                          -

 $                       -

 $                                  -


Significant non-cash investing and financing activities






Notes payable converted to common stock

 $              160,000

 $                       -

 $                      618,495



Assignment of notes payable - officer debentures

 $           1,408,579

 $                       -

 $                   1,408,579


The accompanying notes are an integral part of these financial statements.


6





ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 1.           ORGANIZATION


Allezoe Medical Holdings, Inc., formerly Stanford Management, Ltd. (the Company), was incorporated under the laws of the State of Delaware on September 24, 1998 with the authorized common stock of 25,000,000 shares at $0.001 par value.  On March 9, 2007, at the Annual General Meeting of Stockholders a Resolution was approved increasing the authorized share capital to 500,000,000 common shares with a par value of $0.001 per share.


The Company was organized for the purpose of acquiring and developing mineral properties.  On February 18, 2011, all of the mineral properties and related development and exploration activities were disposed of as part of a series of transactions resulting in the Company moving into the medical technology industry.


On February 18, 2011, the Company acquired all of the outstanding shares of Organ Transport Systems, Inc. (OTS), a Nevada corporation, and simultaneously disposed of the assets relating to its former activities in mining exploration, along with all related liabilities. Consequently, OTS was considered to be the surviving entity, with the Company intending to include only the financial results of OTS in its financial statements. In March, 2012, however, the Company determined that the development costs and time to development for the OTS technology were significantly greater than originally expected and, as a result, determined to return OTS to Healthcare of Today, Inc., from which it had been originally acquired. As a result, the February 18, 2011 transaction with OTS was rescinded and OTS is no longer a part of the Companys corporate group. The Company will focus on the HPV detection and treatment technology as well as on the technology currently being developed by BioCube, Inc. for the disinfection of healthcare facilities. The historical financial results presented in this Report have been restated to present those solely of the Company.


Nature of Operations


The Company has recently formed a wholly-owned subsidiary, SureScreen Medical, Inc., through which we have entered into a licensing agreement with AVM Corp. for the licensing of proprietary, patent pending technology that would enable healthcare providers to "see and treat" Human Papillomavirus (HPV), the most common sexually transmitted infection and a cause of cervical cancer, In addition to offering easy, affordable, and on-the-spot HPV diagnosis, the technology offers an important alternative to the HPV vaccine.


NOTE 2.           SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES


Basis of Presentation of Interim Period Financial Statements


The accompanying unaudited financial statements of the Company at November 30, 2011 and 2010 have been prepared on the accrual basis of accounting in accordance with generally accepted accounting principles (GAAP) for interim financial statements, instructions to Form 10-Q, and Regulation S-X.


In managements opinion, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation to make the Companys financial statements not misleading have been included. The results of operations for the periods ended November 30, 2011 and 2010 presented are not necessarily indicative of the results to be expected for the full year.


7






ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 2.           SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)


Development Stage


The Company's financial statements are presented as those of a development stage enterprise. Activities during the development stage include company formation, equity issued for patents and technology, and fixed assets and further implementation of the business plan. The Company has not generated any revenues since inception.


Risks and Uncertainties


The Company operates in an industry that is subject to rapid technological change. The Company's operations will be subject to significant risk and uncertainties including financial, operational, technological, regulatory and other risks associated with a development stage company, including the potential risk of business failure.


Use of Estimates


The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. A significant estimate as of November 30, 2011 and August 31, 2011, respectively included a 100% valuation allowance for deferred tax assets arising from net operating losses incurred since inception.


Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ materially from estimates.


Cash and Equivalents


The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents.  The Company had no cash equivalents at November 30, 2011 and August 31, 2011, respectively.

 

The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.  There were no balances that exceeded the federally insured limit at November 30, 2011 and August 31, 2011, respectively.


8





ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 2.           SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)


Earnings per Share


In accordance with Financial Accounting Standards Board FASB Accounting Standards Codification ASC Topic 260, Earnings per Share,  basic earnings (loss) per share (EPS) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method (by using the average stock price for the period to determine the number of shares assumed to be purchased from the exercise of stock options or warrants), and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive. The computation of basic and diluted loss per share for the period from September 24, 1998 (inception) to November 30, 2011, is equivalent since the Company has had continuing losses. The Company also has no common stock equivalents.


Accounting for Stock-Based Compensation


The Company adopted the provisions of FASB ASC 718-20, Stock Compensation Awards Classified as Equity, which require companies to expense the estimated fair value of employee stock options and similar awards based on the fair value of the award on the date of grant. The cost is recognized over the period during which an employee is required to provide service in exchange for the award, usually the vesting period. The Companys stock-based compensation plans and assumptions used in determining stock-based compensation expense common stock are computed using the treasury stock method which assumes that the increase in the number of shares is reduced by the number of shares which could have been repurchased by the Company with the proceeds from the exercise of the options and warrants (which were assumed to have been made at the average market price of the common shares during the reporting period). Diluted loss per common share is the same as basic loss per share as the effect of potentially dilutive securities are anti-dilutive.


Non-Employee Stock Based Compensation


Share-based payment awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable.


Income Taxes


The Company accounts for income taxes in accordance with FASB ASC 740, Income Taxes. Under the asset and liability method of ASC 740, deferred tax assets and liabilities are recognized for the future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. A valuation allowance is recorded and deducted from deferred tax assets when the deferred tax assets are not expected to be realized based on currently available evidence. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that includes the enactment date.


Management has analyzed its various federal and state filing positions and believes that its income tax filing positions and deductions are well documented and supported. Additionally, management believes that no accruals for tax liabilities are necessary. Therefore, no reserves for uncertain income tax positions have been recorded.


9





ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 2.           SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)


Concentrations of Credit Risk


The Company maintains its cash in a bank deposit account in a bank which participates in the Federal Deposit Insurance Corporation (FDIC) Program. As of November 30, 2011 and August 31, 2011, the Company had no balances in excess of federally insured limits.


Fair Value of Financial Instruments


The carrying amounts of the Companys short-term financial instruments, including accounts payable and accrued liabilities, approximate fair value due to the relatively short period to maturity for these instruments.


Fair Value of Measurements


The Company follows accounting guidance relating to fair value measurements. This guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:


Level 1  quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date.


Level 2  inputs other than quoted prices included within Level 1 that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.


Level 3  unobservable inputs for the asset or liability only used when there is little, if any, market activity for the asset or liability at the measurement date.


At November 30, 2011, the Company has no instruments that require additional disclosure.


The asset or liabilitys fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the unobservable inputs.


Recurring Fair Value Measurements


In accordance with accounting principles generally accepted in the United States of America, certain assets and liabilities are required to be recorded at fair value on a recurring basis.






10






ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 2.           SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (continued)


Going Concern


As reflected in the accompanying financial statements, the Company has not yet emerged from the development stage, has a net loss of $1,248,931 and net cash used in operations of $382,930 for the quarter ended November 30, 2011; and negative working capital of $297,424 and an accumulated deficit of $4,087,756 at November 30, 2011.


The accompanying financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.  The Company is a development stage company and has suffered recurring losses and has no established source of revenue.  Its ability to continue as a going concern is dependent upon achieving profitable operations and generating positive cash flows.


There can be no assurances that the Company will be able to achieve profitable operations or obtain additional funding.  These factors create substantial doubt about the Companys ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of the uncertainty.


Management intends to raise financing through private or public equity financing or other means and interests that it deems necessary to provide the Company with the ability to continue in existence.


Recent Accounting Pronouncements


In September 2011, the FASB issued an amendment to Topic 350, IntangiblesGoodwill and Other, which simplifies how entities test goodwill for impairment. Previous guidance under Topic 350 required an entity to test goodwill for impairment using a two-step process on at least an annual basis. First, the fair value of a reporting unit was calculated and compared to its carrying amount, including goodwill. Second, if the fair value of a reporting unit was less than its carrying amount, the amount of impairment loss, if any, was required to be measured. Under the amendments in this update, an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads the entity to determine that it is more likely than not that its fair value is less than its carrying amount. If after assessing the totality of events or circumstances, an entity determines that it is not more likely than not that the fair value of the reporting unit is less than its carrying amount, then the two-step impairment test is unnecessary. If the entity concludes otherwise, then it is required to test goodwill for impairment under the two-step process as described under paragraphs 350-20-35-4 and 350-20-35-9 under Topic 350. The amendments are effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011 and early adoption is permitted. The Company is currently evaluating whether early adoption is necessary.


The Company continually assesses any new accounting pronouncements to determine their applicability to the Company. Where it is determined that a new accounting pronouncement affects the Companys financial reporting, the Company undertakes a study to determine the consequence of the change to its financial statements and assures that there are proper controls in place to ascertain that the Companys financials properly reflect the change.


11






ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 3.  RESTATEMENT OF THE FINANCIAL STATEMENTS


The Company is restating its previously issued financial statements as of and for the three months ended November 30, 2011 to reflect the rescission of its subsidiary Organ Transport Systems, Inc. (OTS) in March 2012. The rescission of OTS resulted in the removal of all OTS transactions from the Companys previously reported financial statements as of and for the three months ended November 30, 2011 and 2010.


The effect of the restatements on our balance sheet as of November 30, 2011 is as follows:




As previously Reported

Adjustments

Restated

ASSETS

CURRENT ASSETS





 Cash

 $            152,693

 $               (17,078)

 $             135,615


 Prepaid expenses

                 12,396

              (11,396)

             1,000



 Total current assets

            165,089

            (28,474)

      136,615

 Property, plant and equipment net

         1,792

              (1,792)

                -   

 Deferred loan costs, net

              4,425

                      -   

          4,425

 Patents

       372,201

        (372,201)

                  -   

 Loans receivable

                  -   

    1,884,150

    1,884,150

 Advances to related parties

                  -   

           5,000

             5,000



 Total assets

 $            543,507

 $            1,486,683

 $          2,030,190

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES





 Accounts payable and accrued expenses

 $            630,356

 $             (602,255)

 $               28,101


 Accrued salaries

       467,996

           (467,996)

               -   


 Notes payable - net of debt discount

      2,001,646

          (1,769,063)

      232,583


 Accrued interest

        302,674

          (129,319)

          173,355



 Total current liabilities

  3,402,672

           (2,968,633)

       434,039

 Long-term notes payable

           691,806

755,320

  1,447,126



 Total liabilities

     4,094,478

      (2,213,313)

      1,881,165

STOCKHOLDERS' EQUITY (DEFICIT)





Common stock, $0.001 par value; 500,000,000






shares authorized. 95,069,482 shares






issued and outstanding

           173,325

               (78,255)

          95,070


Additional paid in capital

       27,324,277

     (21,502,566)

       5,821,711


Deferred equity

      (1,680,000)

                     -   

  (1,680,000)


Deficit accumulated during the development stage

    (29,368,573)

     25,280,817

   (4,087,756)



Total stockholders' equity (deficit)

     (3,550,971)

       3,699,996

           149,025



Total liabilities and stockholders' equity

 $            543,507

 $            1,486,683

 $          2,030,190


12






ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 3.  RESTATEMENT OF THE FINANCIAL STATEMENTS (continued)


The effect of the restatements on our balance sheet as of August 31, 2011 is as follows:




As previously Reported

Adjustments

Restated

ASSETS

CURRENT ASSETS





 Cash

 $          38,320

 $         (16,348)

 $        21,972


 Prepaid expenses

      12,396

         (11,396)

        1,000



 Total current assets

         50,716

      (27,744)

     22,972

 Property, plant and equipment, net

2,558

(2,558)

            -   

 Deferred loan costs, net

4,700

            -   

4,700

 Patents

    363,561

       (363,561)

 -

 Loan receivable

            -

           257,653

257,653

 Advances to related parties

            -

               5,000

5,000



 Total assets

 $        421,535

 $         (131,210)

 $      290,325

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES





 Accounts payable and accrued expenses

 $        585,240

 $        (578,195)

 $          7,045


 Accrued salaries

          393,821

          (393,821)

                -   


 Notes payable - net of debt discount

    1,827,868

   (1,763,290)

      64,578


 Accrued interest

    216,389

        (206,425)

          9,964



 Total current liabilities

 3,023,318

(2,941,731)

     81,587

 Long-term notes payable, net of debt discount

      499,072

       (499,072)

                 -   



 Total liabilities

    3,522,390

 (3,440,803)

           81,587

STOCKHOLDERS' EQUITY (DEFICIT)





Common stock, $0.001 par value; 500,000,000






shares authorized. 61,825,039 issued and outstanding

 140,080

        (78,255)

        61,825


Additional paid in capital

   26,535,284

(21,869,546)   

    4,665,738


Deferred equity

     (1,680,000)

                  -   

    (1,680,000)


Deficit accumulated during the development stage

  (28,096,219)

     25,257,394

 (2,838,825)



Total stockholders' equity (deficit)

     (3,100,855)

       3,309,593

   208,738



Total liabilities and stockholders' equity

 $        421,535

 $         (131,210)

 $      290,325


13







ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

(UNAUDITED)


NOTE 3.  RESTATEMENT OF THE FINANCIAL STATEMENTS (continued)


The effect of the restatements on our statement of operations for the three months ended November 30, 2011 is as follows:



As previously Reported

Adjustments

Restated






REVENUES

 $                    -   

 $                    -   

 $                   -   

GENERAL AND ADMINISTRATIVE EXPENSES





Payroll and payroll taxes

           286,535

       205,443

        491,978


Research and development

            12,168

          (12,168)

                      -


Professional fees

           518,123

             (7,580)

      510,543


Travel and entertainment

              1,393

           (468)

          925


Rent

           7,052

     (7,052)

                     -


Insurance

               2,184

    (2,184)

                     -


Office expense

        607

              (607)

                  -


Telephone and internet

                375

               (375)

              -


General and administrative

        1,384

         (892)

           492


Depreciation and amortization expense

            766

       (766)

                  -


Loss from operations

        (830,587)

        (173,351)

    (1,003,938)

OTHER INCOME (EXPENSE)





Finance cost

                    -   

                  -   

              -   


Interest, net

       (441,767)

     196,774

 (244,993)


Net loss

 $   (1,272,354)

 $          23,423

 $  (1,248,931)

Net loss per share (basic and diluted)

 $            (0.01)

N/A

 $           (0.02)

Weighted average number of shares outstanding during the period-basic and diluted

   136,507,915

N/A

                         67,112,080


14







ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

(UNAUDITED)


NOTE 3.  RESTATEMENT OF THE FINANCIAL STATEMENTS (continued)


The effect of the restatements on our statement of operations for the three months ended November 30, 2010 is as follows:



As previously Reported

Adjustments

Restated






REVENUES

 $                     -   

 $                   -   

 $                  -   

GENERAL AND ADMINISTRATIVE EXPENSES





Payroll and payroll taxes

             186,778

(186,778)

                     -   


Professional fees

               25,430

        (20,480)

         4,950


Advisor fees

             225,000

        (225,000)

                     -   


Rent

               17,064

       (17,064)

                     -   


Office expense

                    417

          (149)

        268


Telephone and internet

              791

        (791)

                     -   


General and administrative

                  951

           (876)

             75


Depreciation and amortization expense

                  950

          (950)

                    -   


Loss from operations

      (457,381)

       452,088

   (5,293)

OTHER INCOME (EXPENSE)





Finance cost

                        -   

                      -   

                     -   


Interest, net

            (9,403)

        9,403

                     -   


Net loss

 $       (466,784)

 $       461,491

 $        (5,293)

Net loss per share (basic and diluted)

 $             (0.01)

N/A

 $          (0.00)

Weighted average number of shares outstanding during the period-basic and diluted

     52,170,000

N/A

   52,170,000


15






ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

(UNAUDITED)


NOTE 3.  RESTATEMENT OF THE FINANCIAL STATEMENTS (continued)


The effect of the restatements on our statement of cash flows for the three months ended November 30, 2011 is as follows:





As previously Reported

Adjustments

Restated

CASH FLOWS FROM OPERATING ACTIVITIES





Net loss

 $        (1,272,354)

 $          23,423

 $  (1,248,931)


Adjustments to reconcile net loss to net






cash used by operations:






Depreciation expense

                  766

      (766)

                  -



Stock based compensation expense

            451,043

      366,979

           818,022



Amortization of deferred loan costs

                         -

            275

                275



Amortization of debt discount

          209,256

    (166,628)

        42,628



Interest accrued on notes payable

          86,561

      76,830

    163,391



Increase in prepaid expenses

                     -

              -

           -



Increase in accounts payable


   

   




and accrued expenses

      45,116

 (24,060)

   21,056



Loans receivable

                     -

(179,371)

 (179,371)



Increase in accrued salaries

          74,175

    (74,175)

             -

Net cash used by operating activities

          (405,437)

  22,507

       (382,930)

CASH FLOWS FROM INVESTING ACTIVITIES





Purchase of property and equipment

                     -

                 -

                  -


Investment in patents

               (8,640)

          8,640

                -

Net cash used by investing activities

             (8,640)

         8,640

                 -

CASH FLOWS FROM FINANCING ACTIVITIES





Proceeds from issuance of common stock

                            -

                    -

                    -


Proceeds from notes payable

           528,450

     (31,877)

       496,573


Payments of notes payable

                        -

                 -

                 -

Net cash provided by financing activities

           528,450

     (31,877)

      496,573

Net increase (decrease) in cash

        114,373

         (730)

        113,643

Cash and equivalents, beginning of period

             38,320

    (16,348)

           21,972

Cash and equivalents, end of period

 $             152,693

 $       (17,078)

 $        135,615

Supplemental cash flow information:





Cash paid for interest

 $                         -

 $                    -

 $                    -


Cash paid for income taxes

 $                         -

 $                    -

 $                    -


Significant non-cash investing and financing activities






Notes payable - officer debentures

 $                         -

 $     1,408,579

 $     1,408,579



Notes payable converted to common stock

 $             160,000

 $                    -

 $        160,000



Common Stock issued at par

 $               12,467

 $       (12,467)

 $                    -


16





ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

(UNAUDITED)


NOTE 3.  RESTATEMENT OF THE FINANCIAL STATEMENTS (continued)


The effect of the restatements on our statement of cash flows for the three months ended November 30, 2010 is as follows:





As previously Reported

Adjustments

Restated








CASH FLOWS FROM OPERATING ACTIVITIES





Net loss

 $           (466,784)

 $            461,491

 $           (5,293)


Adjustments to reconcile net loss to net






cash used by operations:






Depreciation expense

                    950

          (950)

                      -



Amortization of debt discount

           33,130

     (33,130)

                     -



Increase in accounts payable


   

   




and accrued expenses

           243,326

   (299,535)

      (56,209)



Increase in accrued salaries

          169,333

  (169,333)

                     -

Net cash used by operating activities

  (20,045)

      (41,457)

            (61,502)

CASH FLOWS FROM INVESTING ACTIVITIES





Investment in patents

    (22,945)

       22,945

               -

Net cash used by investing activities

           (22,945)

       22,945

                -

CASH FLOWS FROM FINANCING ACTIVITIES





Proceeds from notes payable

             30,001

           (30,001)

                     -


Related party advances

                      -

       61,503

          61,503

Net cash provided by financing activities

               30,001

        31,502

                  61,503

Net increase (decrease) in cash

             (12,989)

         12,990

                   1

Cash and equivalents, beginning of period

           17,647

      (16,632)

              1,015

Cash and equivalents, end of period

 $                 4,658

 $             (3,642)

 $             1,016



17





ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

(UNAUDITED)


NOTE 3.  RESTATEMENT OF THE FINANCIAL STATEMENTS (continued)


The effect of the restatements on our statement of statement of stockholders equity (deficit) for the three months ended November 30, 2010 is as follows:







Accumulated

Total




Additional


During the

Stockholders'


Common Stock

Paid In


Development

Equity


Shares

Par Value

Capital

Deferred Equity

Stage

(Deficit)








Balance - September 24, 1998 (inception)

                    -

 $           -   

 $                    -   

 $                      -   

 $                    -   

 $                   -   

Common stock issued for cash

47,170,000

    47,170

     (41,720)

                -   

               -   

        5,450

Contributions-noncash expenses

           -

        -

      138,600

                 -   

            -   

  138,600

Common stock issued for cash

    5,000,000

    5,000

      45,000

                  -   

               -   

    50,000

Net loss for the period from September 24, 1998(inception) to August 31, 2009

                 -   

             -   

                -   

                   -   

     (340,716)

     (340,716)

Balance - August 31, 2009 (restated)

 52,170,000

   52,170

 141,880

                   -

    (340,716)

      (146,666)

Contributions-noncash expenses

                    -

     -

     12,600

                  -

                -   

    12,600

Net loss for the year ended August 31, 2010

             -   

     -   

             -   

                -   

   (22,365)

(22,365)

Balance - August 31, 2010 (restated)

52,170,000

52,170

154,480

-

       (363,081)

       (156,431)

Common stock issued for services, $0.42 per share

    5,000,000

    5,000

     2,095,000

     (1,680,000)

               -

          420,000

Common stock issued for services, $0.42 per share

  3,000,000

3,000

1,257,000

                  -

             -

1,260,000

Converted notes payable to common stock, $0.36per share

 927,666

    928

      458,454

                 -

            -

    459,382

Converted notes payable to common stock, $0.36per share

      556,600

 557

     275,072

                 -

              -

  275,629

Common stock issued for services, $0.724 per share

     77,624

  77

        56,122

               -

              -

    56,199

Common stock issued for services, $0.724 per share

     46,574

   47

     33,672

                  -

              -

 33,719

Common stock issued for services, $0.724 per share

       46,575

   46

     33,673

                 -

              -

       33,719

Issuance of notes payable-beneficial conversion feature

             -    

       -

  145,833

                 -

             -

   145,833

Additional capital contributed

                -

        -

      156,432

                 -

              -

    156,432

Net loss for the year ended August 31, 2011

              -

      -

               -

                      -

    (2,475,744)

   (2,475,744)

Balance - August 31, 2011 (restated)

   61,825,039

 $ 61,825

 $     4,665,738

 $     (1,680,000)

 $   (2,838,825)

 $       208,738



18


Converted notes payable to common stock, $0.01875 per share

       2,666,667

     2,667

                       47,333

                                   -   

                                -   

                        50,000

Converted notes payable to common stock, $0.01035 per share

                 4,830,918

                 4,831

                       45,169

                                   -   

                                -   

                        50,000

Converted notes payable to common stock, $0.00675 per share

                 8,888,888

                 8,889

                       51,111

                                   -   

                                -   

                        60,000

Common stock issued for services, $0.57 per share

                    391,304

                    391

                     222,652

                                   -   

                                -   

                      223,043

Common stock issued for services, $0.057 per share

                 4,000,000

                 4,000

                     224,000

                                   -   

                                -   

                      228,000

Common stock issued at $0.57 per share

         234,782

  235

   133,591

                   -   

                 -   

        133,826

Common stock issued at $0.057 per share

    2,400,000

    2,400

        134,400

                    -   

            -   

        136,800

Common stock issued at $0.0098 per share

      9,831,884

9,832

       86,521

                    -   

                -   

         96,353

Issuance of notes payable-reissuance

                  -   

            -   

      154,074

                   -   

                -   

          154,074

Issuance of notes payable-beneficial conversion feature

-

-

                       57,122

-

-

                        57,122

Net loss for the period ended November 30, 2011

                             -   

                       -   

                               -   

                                   -   

                  (1,248,931)

                  (1,248,931)

Balance - November 30, 2011 (restated)

    95,069,482

 $ 95,070

 $      5,821,711

 $     (1,680,000)

$(4,087,756)

 $       149,025


19








ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

(UNAUDITED)


NOTE 4. INCOME TAXES


The Company accounts for income taxes in accordance with accounting standards for Accounting for Income Taxes which require the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and tax credit carry-forwards. Additionally, the standards require the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets.


The following is a schedule of deferred tax assets as of November 30, 2011, and August 31, 2011:




November 30, 2011


August 31, 2011

Net operating loss


 $             4,087,756


 $                  2,475,744

Future tax benefit at 34%                      


1,389,837


841,753

Less: Valuation allowance


   (1,389,837)


(841,753)

Net deferred tax asset


 $                           --


 $                               --


The valuation allowance changed by approximately $548,084 during the three months ended November 30, 2011.

 

Under Sections 382 and 269 (the shell corporation rule) of the Internal Revenue Code, following an ownership change, special limitations (Section 382 Limitations) apply to the use by a corporation of its net operating loss, or NOL, carry-forwards arising before the ownership change and various other carry-forwards of tax attributes (referred to collectively as the Applicable Tax Attributes). The Company had NOL carry-forwards due to historical losses of Stanford of approximately $368,374 at November 30, 2011.


The Company has adopted the provisions of FASB ASC 740-10-25. As a result of its implementation, the Company performed a comprehensive review of its uncertain tax positions in accordance with recognition and measurement standards established by FASB ASC 740-10-25. In this regard, an uncertain tax position represents the Companys expected treatment of a tax position taken in a prepared and filed tax return, or expected to be taken in a tax return, that has not been reflected in measuring income tax expense for financial reporting purposes. The Company does not expect any reasonably possible material changes to the estimated amount of liability associated with uncertain tax positions through November 30, 2011. The Companys continuing policy is to recognize accrued interest and penalties related to income tax matters in income tax expense.



20







ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

(UNAUDITED)


Note 5. SIGNIFICANT TRANSACTIONS WITH RELATED PARTIES


Healthcare of Today, Inc. (HOTI) provides financial, accounting, legal, administrative and similar services to the Company at a monthly fixed fee of $10,000, commencing March 1, 2011.


NOTE 6.

CAPITAL STOCK


The Company is authorized to issue 500,000,000 shares of common stock, par value $0.001 per share.


On September 2, 2011, the Company issued 391,304 shares of common stock for services rendered under consulting agreements.


On October 13, 2011, the Company issued 4,000,000, shares of common stock for services rendered under consulting agreements.


On November 8, 2011, the Company converted $50,000 of notes into 2,666,667 shares of common stock.


On November 17, 2011, the Company converted $50,000 of notes into 4,830,918 shares of common stock.


On November 29, 2011, the Company converted $60,000 of notes into 8,888,888 shares of common stock.


The Company issued an additional 12,466,666 shares to Healthcare of Today, Inc., pursuant to the original OTS acquisition agreement and closing whereby in the event that additional common shares were issued to other parties, then additional common shares would also be issued to Healthcare of Today, Inc. so that its resulting ownership percentage of the then outstanding common shares would remain at 60 percent. Though the Company agreed to return its stock in OTS to Healthcare of Today, Inc. in exchange for the return of the 78,255,000 shares of stock previously issued to Healthcare of Today, Inc., pursuant to the agreement to rescind the acquisition of OTS, the additional 12,466,666 shares that were issued were not returned and are considered to be issued and outstanding as of November 30, 2011. These shares have been recorded at fair market value and are included in payroll related expenses on the statement of operations and stock based compensation on the statement of cash flows for the three months ended November 30, 2011.



21






ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 6.

CAPITAL STOCK (continued)


As a result of these transactions, there were 95,069,482 common shares outstanding at November 30, 2011.


NOTE 7.  NOTES PAYABLE


The following is a summary of notes payable at November 30, 2011 and August 31, 2011:

Description

November 30, 2011


August 31, 2011

Asher Enterprises, Inc.




Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature April 11, 2012 and is convertible 180 days after issuance into shares of the Companys common stock at a price discounted from average trading price. $53,000 Note less discount of $21,326 for conversion.

            31,674


            17,083

Asher Enterprises, Inc.




Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature May 18, 2012 and is convertible 180 days after issuance into shares of the Companys common stock at a price discounted from average trading price. $40,000 Note less discount of $21,703 for conversion.

            18,297


            6,680

Asher Enterprises, Inc.




Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature July 5, 2012 and is convertible 180 days after issuance into shares of the Companys common stock at a price discounted from average trading price.

          32,500


-

Magna Group




Convertible notes payable to The Magna Group. The notes accrue interest at 12% per annum and mature November 4, 2012 and are convertible into shares of Allezoe common stock at a price discounted from the average trading price. $150,000 in Notes less discount of $57,122 for conversion.

92,878


-





22






ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 7.  NOTES PAYABLE (continued)

Convertible debentures




Convertible notes payable to related parties officers by OTS. The notes accrue interest at 12% per annum, mature December 15, 2012, and are convertible one year after issuance into shares of Company common stock at a price discounted from average trading price. No beneficial conversion recorded as note transferred back to OTS. See Note 8.

       1,447,126


       -

Crystal Falls Investments, LLC.




Convertible notes payable to Crystal Falls. The notes accrue interest at 9% per annum and mature January 31, 2012 and are convertible into shares of Allezoe common stock at a price discounted from the average trading price. $100,000 Note less discount of $42,765 for conversion.

          57,235


          40,815

Total

       1,679,710


       64,578

Less: current portion

232,584


64,578

Long-term debt

 $       1,447,126


 $                 -


Notes payable consist of borrowings under convertible debenture arrangements. In July 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $53,000 with interest payable at 8% per annum with a maturity date of January 31, 2012. The indebtedness including interest is convertible into common stock at 58% of the average lowest three (3) trading prices during the ten (10) trading day period ending on the latest complete trading day prior to conversion. In August 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $40,000 with interest payable at 8% per annum with a maturity date of January 31, 2012. The indebtedness including interest is convertible into common stock at 58% of the average lowest three (3) trading prices during the ten (10) trading day period ending on the latest complete trading day prior to conversion. In July 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $100,000 with interest payable at 9% per annum with a maturity date of January 31, 2012. The indebtedness including interest is convertible into common stock at $.29 per share. In October 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $32,500 with interest payable at 8% per annum with a maturity date of July 4, 2012. The indebtedness including interest is convertible into common stock at 58% of the average lowest three (3) trading prices during the ten (10) trading day period ending on the latest complete trading day prior to conversion. In November 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $50,000 with interest payable at 12% per annum with a maturity date of November 4, 2012. The indebtedness including interest is convertible into common stock at 50% of the average lowest price during the ten (10) trading day period ending on the latest complete trading day prior to conversion.


In November 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $260,000 with interest payable at 12% per annum with a maturity date of November 4, 2012. The indebtedness including interest is convertible into common stock at 75% of the average lowest price during the three (3) trading day period ending on the latest complete trading day prior to conversion. This was an assignment of part of the convertible notes payable to related parties officers by OTS where $261,453 was assigned to a creditor for $260,000. In November 2011, the Company converted $160,000 of the note into 16,386,473 shares of common stock. The Company accounted for the borrowings under these arrangements in accordance with ASC 470-20 Debt with Conversions and Other Options. The fair value of the beneficial conversion feature is calculated using the intrinsic value method at the time of issuance or commitment date. The company records a debt discount for the calculated value, which is amortized over the debt term.


23





ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 8.  SUBSEQUENT EVENTS


In December, 2011, the Company issued 18,247,619 common shares on conversion of $101,000 in loan principal (see Note 7) and 36,231,884 common shares for $250,000 in consulting fees. HOTI was issued 32,687,701, common shares for stock based compensation.


In December, 2011, the Company entered into an Acquisition Agreement (the "Acquisition Agreement") with Élan Health Services, Inc. (the "Seller"), pursuant to which it will acquire BioCube, Inc., a Nevada corporation (BioCube), which will then become our wholly-owned subsidiary as filed in ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT of the 8-K dated January 5, 2012.


Effective March 19, 2012, the Company, Healthcare of Today, Inc. and Élan Health Services, Inc. agreed to rescind the acquisition of Organ Transport Systems, Inc. (OTS) from Healthcare of Today, Inc. by the Company, which closed in February, 2011.  Under the terms of the rescission, the Company agreed to return its stock in OTS to Healthcare of Today, Inc. in exchange for the return of the 78,255,000 shares of stock issued to Healthcare of Today.  However, since Healthcare of Today, Inc. had previously transferred all of the shares of the Company received in the earlier transaction to third parties, of which 48,037,610 were transferred to Élan Health Services, Inc. for the assumption of debt, it was agreed that Élan Health Services would return the 48,037,610 shares held by it immediately, and then would credit the balance of 30,217,390 common shares against the planned acquisition of BioCube, Inc. by the Company from Élan Health. The market value of the shares to be received as a credit at March 19, 2012 was $0.0155 per share, or a total of $468,370, which has been recorded as Loan Receivable on the balance sheet in March 2012.  The net effect of the rescission transaction has been to return OTS as a subsidiary of Healthcare of Today, Inc., to remove OTS as a subsidiary of the Company.  The table below summarizes the effect of the rescission transaction in March 2012:



Shares

Price

Value

Acquisition of OTS-February 18, 2011

78,255,000

 $ 0.5500

N/A

Allezoe Shares Returned by Élan in March 2012

(48,037,610)

 $ 0.0155

$ (744,583)

Stock still due to Allezoe on BioCube closing

(30,217,390)

 $ 0.0155

 $ (468,370)




24






ALLEZOE MEDICAL HOLDINGS, INC.

(A Development Stage Company)

NOTES TO FINANCIAL STATEMENTS

November 30, 2011

 (UNAUDITED)


NOTE 8.  SUBSEQUENT EVENTS (continued)


The separate receivable recorded by the Company totaling $1,884,150 at November 30, 2011 represents amounts actually paid by the Company to or for OTS, primarily for salaries due to OTS officers and employees of $437,024 and for assumption of notes payable to OTS officers of $1,447,126. The loan receivable of $1,884,150 at November 30, 2011 is offset by a corresponding note payable to officers of OTS of $1,447,126 at November 30, 2011 (See Note 7) would total $437,024.  As part of the later rescission transaction with Healthcare of Today, Inc., the latter also guaranteed payment of the amounts then due the Company by OTS, which had then increased to a total of $469,827 (exclusive of notes) from the $257,653 due at August 31, 2011. This receivable was non-interest bearing and repayment by OTS was guaranteed by a security interest in all equity interests of OTS held by Healthcare of Today, Inc. as a result of the rescission.  In June 2012, OTS paid $235,000 to the Company in settlement of the full amount then due of $469,827 as of the date of the rescission, in addition to the assumption by OTS of the notes from the Company.


























25






ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIONS AND RESULTS OF OPERATIONS


FORWARD-LOOKING INFORMATION


To the extent that the information presented in this Quarterly Report on Form 10-Q/A for the quarter ended November 30, 2011 discusses financial projections, information or expectations about our products, services, or markets, or otherwise makes statements about future events or statements regarding the intent, belief or current expectations of Allezoe Medical Holdings, Inc. and its subsidiary (collectively the Company), its directors or its officers with respect to, among other things, future events and financial trends affecting the Company, such statements are forward-looking. We are making these forward-looking statements in reliance on the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Although we believe that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. Forward-looking statements are typically identified by the words believes, expects, anticipates, and similar expressions. In addition, any statements that refer to expectations or other characterizations of future events or circumstances are forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and that matters referred to in such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. We undertake no obligation to publicly update or revise these forward-looking statements because of new information, future events or otherwise, except as required by law.


OVERVIEW


The Company was incorporated under the laws of the State of Delaware on September 24, 1998 with authorized common stock of 25,000,000 shares at $0.001 par value. On March 9, 2007, at the Annual General Meeting of Stockholders a Resolution was approved increasing the authorized share capital to 500,000,000 common shares with a par value of $0.001 per share.


The Company was organized for the purpose of acquiring and developing mineral properties. On February 18, 2011, all of the mineral properties and related development and exploration activities were disposed of as part of a series of transactions resulting in the Company moving into the medical technology industry.


On February 18, 2011, the Company acquired all of the outstanding shares of Organ Transport Systems, Inc. (OTS), a Nevada corporation, and simultaneously disposed of the assets relating to its former activities in mining exploration, along with all related liabilities. Consequently, OTS was considered to be the surviving entity, with the Company intending to include only the financial results of OTS in its financial statements. In March, 2012, however, the Company determined that the development costs and time to development for the OTS technology were significantly greater than originally expected and, as a result, determined to return OTS to Healthcare of Today, Inc., from which it had been originally acquired. As a result, the February 18, 2011 transaction with OTS was rescinded and OTS is no longer a part of the Companys corporate group. The Company will focus on the HPV detection and treatment technology as well as on the technology currently being developed by BioCube, Inc. for the disinfection of healthcare facilities. The historical financial results presented in this Report have been restated to rescind the February 18, 2011 OTS transaction and to present financial statements of the Company as if the transaction never occurred.

26





The Business


Allezoe Medical Holdings, Inc. (the Company or ALZM) is a development stage company. The Company was organized under the laws of the State of Delaware as Stanford Management Ltd., on September 24, 1998.  We formed our Company for the purpose of acquiring and developing mineral properties. On February 18, 2011, all of the mineral properties and related development and exploration activities were disposed of as part of a series of transactions resulting in the Company moving into the medical device industry.



Current Business of Allezoe


We are a development stage company in the business of medical technology development and marketing.  Our business is, and will be, operated through subsidiary corporations.

We have recently formed a wholly-owned subsidiary, SureScreen Medical, Inc., through which we have entered into a licensing agreement with AVM Corp. for the licensing of proprietary, patent pending technology that would enable healthcare providers to "see and treat" Human Papillomavirus (HPV), the most common sexually transmitted infection and a cause of cervical cancer, In addition to offering easy, affordable, and on-the-spot HPV diagnosis, the technology offers an important alternative to the HPV vaccine.

Currently HPV infects 233 million women worldwide; one woman dies every 2 hours from cervical cancer. Many experts advocate for HPV vaccination, but unexplained deaths in some patients has caused alarm. The Centers for Disease Control and Prevention (CDC) has examined 35 deaths that occurred among young people who received the vaccine. While no causation has been established, many patients and parents are avoiding the vaccine option.

Prominent figures, most recently two U.S. Presidential candidates, have taken firm (and opposing) public stances, further highlighting the ongoing controversy about the HPV vaccine. For other reasons, including the vaccine's cost and the inconvenience of it being administered over a number of visits, many patients don't actually complete the series. Last year only 32 percent of teenage girls nationwide received all three shots needed to prevent HPV infection.  While popular, HPV vaccines do not treat existing HPV infections or HPV-associated diseases. Nor does the vaccine completely protect from all strains of HPV. Merck's Gardisil® vaccine prevents 70% of virally-caused cervical cancer but may only have limited effect against the other strains. The technology, equipment, and procedures SureScreen has announced are comprehensive in that a light-based exam identifies cells damaged by all known strains of HPV -- with 98% accuracy, in a single visit, and at low cost.  For those who receive the vaccine, our new technology serves as a natural complement, screening for HPV-related damage that occurred in the window before the vaccine was administered. SureScreen will see the technology, developed by Aequorea Vision Medical, through regulatory approvals and clearances, to be followed by a broad market release.

We are a development stage enterprise as defined in FASB Accounting Standards Codification (ASC) Topic 915-10, Development Stage Enterprises (formerly Statement of Financial Accounting Standards, No. 7, Accounting and Reporting by Development Stage Enterprises), with a limited operating history.



27






Liquidity and Capital Resources


We have historically met our capital requirements through either private placement of equity or private borrowings. Our cash balance increased $113,643 from $21,972 at August 31, 2011 to $135,615 at November 30, 2011. On February 24, 2011, we borrowed $25,000 from Orchid Island Capital, LLC and issued a convertible debenture in that amount due in August 2011 at 9 percent interest. The debenture is convertible into shares of our common stock at a price discounted 30 percent from the ten day average market price at the time of conversion.


Additionally, we received loan proceeds of $300,000 in March of 2011 from Crystal Falls Investments, LLC, an unrelated third party, and issued three identical convertible debentures for $100,000 each dated as of March 30, 2011 due September 30, 2011 at 9 percent interest. The notes are all convertible into common stock at a price equal to 80 percent of the five lowest volume weighted average prices for our common stock for the ten trading days prior to the notice of conversion.  On July 9, 2011, Crystal Falls Investments, LLC issued a notice of conversion of the principal amount of all three notes, with the accrued interest of $7,323 paid through the issue of a new convertible promissory note in that amount at July 9, 2011, due January 8, 2012, on the same terms as the converted notes.


We received loan proceeds of $260,000 in November of 2011 from Magna Group, LLC, an unrelated third party, due November 4, 2012 at 12 percent interest. The note is convertible into common stock at a price equal to 75 percent of the lowest trading price for our common stock for the three trading days prior to the notice of conversion.  In November, 2011, Magna Group, LLC issued three notices of conversion totaling $160,000. We accrued interest of $1,660 on this note as of November 30, 2011.


We received loan proceeds of $50,000 in November of 2011 from Hanover Holdings, LLC, an unrelated third party, due November 4, 2012 at 12 percent interest. The note is convertible into common stock at a price equal to 50 percent of the lowest trading price for our common stock for the ten trading days prior to the notice of conversion.  We accrued interest of $444 on this note as of November 30, 2011.


We received loan proceeds of $32,500 in November of 2011 from Asher Enterprises, LLC, an unrelated third party, due July 5, 2012 at 8 percent interest. The note is convertible into common stock at a price equal to 58 percent of the three lowest trading prices for our common stock for the ten trading days prior to the notice of conversion. We accrued interest of $406 on this note as of November 30, 2011.


In our opinion, available funds will satisfy our capital requirements for the next several months while we are in the process of negotiating additional funding to implement our FDA clearance process and bring the Life Cradle® to market. We expect to do so in 2012. There can be no assurance that we will be successful in raising additional funds to meet our capital needs.


28







Recurring Fair Value Measurements


In accordance with accounting principles generally accepted in the United States of America, certain assets and liabilities are required to be recorded at fair value on a recurring basis.


Off-Balance Sheet Arrangements


None


Current Economic Environment


The U.S. economy is currently in a recession, which could be long-term. Consumer confidence continued to deteriorate and unemployment figures continued to increase during 2011. However, in recent months, certain economic indicators have shown modest improvements. The generally deteriorating economic situation, together with the limited availability of debt and equity capital, including bank financing, will likely have a disproportionate impact on all micro-cap companies. As a result, we may not be able to execute our business plan due to our inability to raise sufficient capital and/or be able to develop a customer base for our planned products.


Contractual obligations


Currently, we have no employment agreements or other contractual undertakings with any of our officers, directors or employees, other than promissory notes issued in payment of accrued salaries.


The following is a summary of notes payable at November 30, 2011 and August 31, 2011:

Description

November 30, 2011


August 31, 2011

Asher Enterprises, Inc.




Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature April 11, 2012 and is convertible 180 days after issuance into shares of the Companys common stock at a price discounted from average trading price. $53,000 Note less discount of $21,326 for conversion.

            31,674


            17,083

Asher Enterprises, Inc.




Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature May 18, 2012 and is convertible 180 days after issuance into shares of the Companys common stock at a price discounted from average trading price. $40,000 Note less discount of $21,703 for conversion.

            18,297


            6,680

Asher Enterprises, Inc.




Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature July 5, 2012 and is convertible 180 days after issuance into shares of the Companys common stock at a price discounted from average trading price.

          32,500


-

Magna Group




Convertible notes payable to The Magna Group. The notes accrue interest at 12% per annum and mature November 4, 2012 and are convertible into shares of Allezoe common stock at a price discounted from the average trading price. $150,000 in Notes less discount of $57,122 for conversion.

92,878


-


29

Convertible debentures




Convertible notes payable to related parties officers by OTS. The notes accrue interest at 12% per annum, mature December 15, 2012, and are convertible one year after issuance into shares of Company common stock at a price discounted from average trading price. No beneficial conversion recorded as note transferred back to OTS.

1,447,126


       -

Crystal Falls Investments, LLC.




Convertible notes payable to Crystal Falls. The notes accrue interest at 9% per annum and mature January 31, 2012 and are convertible into shares of Allezoe common stock at a price discounted from the average trading price. $100,000 Note less discount of $42,765 for conversion.

          57,235


          40,815

Total

       1,679,710


       64,578

Less: current portion

232,584


64,578

Long-term debt

 $       1,447,126


 $                 -


We now maintain our corporate offices in space made available at no charge by our Chief Executive Officer, located in Boca Raton, Florida.


Results of Operations


For the quarters ended November 30, 2011 and 2010, the Company had no revenues.  Since inception, the Company has yet to earn revenues and has incurred cumulative net losses of $4,087,756.  For the quarters ended November 30, 2011 and 2010, the Company had net losses of $1,248,931 and $5,293, respectively.  Our activities have been attributed primarily to start up and business development.

 

For the quarters ended November 30, 2011 and 2010, we incurred operating expenses of $1,003,938 and $5,293, respectively.


30




ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK


Market Information


There are no common shares subject to outstanding options, warrants or securities convertible into common equity of our Company at November 30, 2011.


There are no shares that have been offered pursuant to an employee benefit plan or dividend reinvestment plan as of November 30, 2011. Our shares are traded on the OTCBB under the symbol ALZM. Although the OTCBB does not have any listing requirements per se, to be eligible for quotation on the OTCBB, we must remain current in our filings with the SEC; being as a minimum Forms 10-Q and 10-K. Securities already quoted on the OTCBB that become delinquent in their required filings will be removed following a 30 or 60 day grace period if they do not make their filing during that time.


In the future our common stock trading price might be volatile with wide fluctuations. Things that could cause wide fluctuations in our trading price of our stock could be due to one of the following or a combination of several of them:


variations in our operations results, either quarterly or annually;



trading patterns and share prices in other medical technology companies which our shareholders consider similar to ours; and



other events which we have no control over.


In addition, the stock market in general, and the market prices for thinly traded companies in particular, have experienced extreme volatility that often has been unrelated to the operating performance of such companies. These wide fluctuations may adversely affect the trading price of our shares regardless of our future performance. In the past, following periods of volatility in the market price of a security, securities class action litigation has often been instituted against such company. Such litigation, if instituted, whether successful or not, could result in substantial costs and a diversion of managements attention and resources, which would have a material adverse effect on our business, results of operations and financial conditions.


Trends

 

We are in the development stage and have not generated any revenue. We are unaware of any known trends, events or uncertainties that have had, or are reasonably likely to have, a material impact on our business or income, either in the long term or short term, as more fully described under Risk Factors in our current report on Form 8-K filed with the SEC on February 28, 2011.


31






ITEM 4. CONTROLS AND PROCEDURES


(a)

Evaluation of disclosure controls and procedures


It is managements responsibility for establishing and maintaining adequate internal control over financial reporting. Under the supervision and with the participation of our management, we have evaluated the effectiveness of our disclosure controls and procedures as required by the Exchange Act Rule 13a-15(d) as of November 30, 2011 (the Evaluation Date). Based on the evaluation by management, they have concluded these disclosure controls and procedures were not effective as of the Evaluation Date as a result of material weaknesses in internal control over financial reporting as more fully discussed below.


Under Rule 13a-15(e)/15d-15(e); Regulation S-K, Item 307, the SEC states that disclosure controls and procedures have the following characteristics:


designed to ensure disclosure of information that is required to be disclosed in the reports that we file or submit under the Exchange Act;


recorded, processed, summarized and reported with the time period required by the SECs rules and forms; and


accumulated and communicated to management to allow them to make timely decisions about the required disclosures.


As of November 30, 2011, our management assessed the effectiveness of our internal control over financial reporting based on the criteria for effective internal control over financial reporting established in Internal ControlIntegrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) and SEC guidance on conducting such assessments.


Management concluded, during the three months ended November 30, 2011, internal controls and procedures were not effective to detect the inappropriate application of US GAAP rules. Management realized there are deficiencies in the design or operation of our internal control that adversely affected our internal controls which management considers to be material weaknesses.


Material Weaknesses


Management assessed the effectiveness of our internal control over financial reporting as of the Evaluation Date and identified the following material weaknesses:


As of November 30, 2011, we did not have an audit committee which complies with the requirements of an audit committee since it did not have an independent financial expert on the committee. Even though we have a Code of Ethics it does not emphasize fraud and methods to avoid it.   On July 6, 2011, we adopted an Audit Committee Charter and appointed an Audit Committee of independent directors, and also amended our Code of Ethics to include fraud issues and methods to avoid it. Due to our small size, a whistleblower policy is not necessary.

Due to a significant number and magnitude of out-of-period adjustments identified during the quarter-end closing process, management has concluded that the controls over the quarter-end financial reporting process were not operating effectively. A material weakness in the quarter-end financial reporting process could result in our not being able to meet our regulatory filing deadlines and, if not remedied, has the potential to cause a material misstatement or to miss a filing deadline in the future. Management override of existing controls is possible given the small size of the organization and lack of personnel.


32


There is no system in place to review and monitor internal control over financial reporting. This is due to our maintaining an insufficient complement of personnel to carry out ongoing monitoring responsibilities and ensure effective internal control over financial reporting.


(a)

Changes in control over financial reporting


There were no changes in our internal controls over financial reporting during the three months ended November 30, 2011 that have materially affected, or are reasonably likely to material affect, our internal control over financial reporting.


PART II OTHER INFORMATION


ITEM 1. LEGAL PROCEEDINGS


There are no legal proceedings to which we are a party or to which we are subject, nor, to the best of our knowledge, are any material legal proceedings contemplated.


ITEM 1A RISK FACTORS




The list of risk factors contained in our Annual Report on Form 10-K for the year ended August 31, 2011, under Part 1 ITEM 1A, Risk Factors, are incorporated by reference.


ITEM 2. UNREGISTERED SALE OF EQUITY SECURITIES AND USE OF PROCEEDS





In September, 2011, we issued a total of 391,304 common shares to Centurion Private Equity, LLC for consulting expenses at $0.057 per share and also issued 234,782 common shares to Healthcare of Today, Inc. to maintain its 60 percent voting control, as agreed in the acquisition of Organ Transport Systems, Inc. Though the acquisition of Organ Transport Systems, Inc. was rescinded, the additional shares that were issued and outstanding as of November 30, 2011.


In October, 2011, we issued a total of 4,000,000 common shares to Centurion Private Equity, LLC for consulting expenses at $0.057 per share and also issued 2,400,000 common shares to Healthcare of Today, Inc. to maintain its 60 percent voting control, as agreed in the acquisition of Organ Transport Systems, Inc. Though the acquisition of Organ Transport Systems, Inc. was rescinded, the additional shares that were issued and outstanding as of November 30, 2011.



In November, 2011, we issued a total of 16,388,473 common shares to Magna Group, LLC on three conversions totaling $160,000 in principal amount of loans, at a price equal to $0.01875, $0.01035, and $0.00675 per share, representing 75 percent of the low price for the shares during a three day trading period, and also issued 9,831,884 common shares to Healthcare of Today, Inc. as stock based compensation. Though the acquisition of Organ Transport Systems, Inc. was rescinded, the additional shares that were issued and outstanding as of November 30, 2011.




33






In December, 2011, we issued a total of 18,247,619 common shares to Magna Group, LLC on two conversions totaling $101,000 in principal amount of loans, at a price equal to $0.0042 and $.0075 per share, representing 75 percent of the low price for the shares during a three day trading period, and also issued 10,948,570 common shares to Healthcare of Today, Inc. as stock based compensation.


In December, 2011, we issued a total of 36,231,884 common shares to Centurion Private Equity, LLC for consulting expenses at $0.0069 per share and also issued 21,739,130 common shares to Healthcare of Today, Inc. as stock based compensation.


As a result of the issue of these shares, we now have a total of 182,236,685 common shares issued and outstanding as of January 17, 2012.


ITEM 3. DEFAULTS UPON SENIOR SECURITIES


None


ITEM 4. (Removed and Reserved)


ITEM 5. OTHER INFORMATION


None.



ITEM 6. EXHIBITS


31.1

Certification of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley Act.

31.2

Certification of Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act.

32.1

Certification of Chief Executive Officer Pursuant to Section 906 of the Sarbanes-Oxley Act.

32.2

Certification of Principal Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act.


SIGNATURES


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


ALLEZOE MEDICAL HOLDINGS, INC.

(Registrant)


/s/MICHAEL GELMON

Michael Gelmon

Chief Executive Officer


/s/JOHN BURKE

John Burke

Principal Accounting Officer


Dated: July 10, 2012



34





EX-31 2 exhibit311.htm PRINCIPAL EXECUTIVE OFFICER CERTIFICATION Converted by EDGARwiz

Exhibit 31.1

PRINCIPAL EXECUTIVE OFFICER CERTIFICATION


I, Michael Gelmon, certify that:


(1) 

I have reviewed this quarterly report on Form 10-Q/A of Allezoe Medical Holdings, Inc.


(2) 

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

 

(3) 

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

 

(4) 

The issuers other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and we have:


 

(a) 

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b) 

Evaluated the effectiveness of the issuers disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon based such evaluation; and

 

 

 

 

(c) 

Disclosed in this report any change in the issuers internal control over financial reporting that occurred during the small business issuers most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the small business issuers internal control over financial reporting;

 

(5) 

The issuers other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuers auditors and the audit committee of the issuers board of directors (or persons performing the equivalent function):


 

(a) 

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuers ability to record, process, summarize and report financial information; and


 

(b) 

Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuers internal controls over financial reporting.


Dated: July 10, 2012

By:

/s/ Michael Gelmon

 

 

 

Michael Gelmon

Chief Executive Officer

 

 





EX-31 3 exhibit312.htm PRINCIPAL ACCOUNTING OFFICER CERTIFICATION Converted by EDGARwiz

Exhibit 31.2

PRINCIPAL ACCOUNTING OFFICER CERTIFICATION


I, John Burke, certify that:


(1) 

I have reviewed this quarterly report on Form 10-Q/A of Allezoe Medical Holdings, Inc.


(2) 

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 

 

(3) 

Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the small business issuer as of, and for, the periods presented in this report;

 

(4) 

The issuers other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the small business issuer and we have:


 

(a) 

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the small business issuer, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

 

 

 

(b) 

Evaluated the effectiveness of the issuers disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based upon based such evaluation; and

 

 

 

 

(c) 

Disclosed in this report any change in the issuers internal control over financial reporting that occurred during the small business issuers most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the small business issuers internal control over financial reporting;

 

(5) 

The issuers other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the small business issuers auditors and the audit committee of the issuers board of directors (or persons performing the equivalent function):


 

(a) 

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the small business issuers ability to record, process, summarize and report financial information; and


 

(b) 

Any fraud, whether or not material, that involves management or other employees who have a significant role in the small business issuers internal controls over financial reporting.


Dated: July 10, 2012

By:

/s/ John Burke

 

 

 

John Burke

Consulting Principal Accounting Officer

 

 





EX-32 4 exhibit32.htm CERTIFICATION Converted by EDGARwiz

Exhibit 32

CERTIFICATION

 

Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, 18 U.S.C. Section 1350, each of the undersigned officers of Allezoe Medical Holdings, Inc., (the Company), does hereby certify, to each such officers knowledge, that:  


(1)    The quarterly report on form 10-Q/A of the Company for the quarter ended November 30, 2011 (the Report) fully complies with the requirements of section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

 

(2)    The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.


Dated: July 10, 2012

By:

/s/ Michael Gelmon

 

 

Michael Gelmon

Chief Executive Officer

Dated: July 10, 2012

By:

/s/ John Burke

 

 

John Burke

Consulting Principal Accounting Officer

 


A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.




EX-101.INS 5 alzm.ob-20111130.xml XBRL INSTANCE DOCUMENT 10-Q 2011-11-30 false Allezoe Medical Holdings Inc 0001080602 --08-31 95069482 Smaller Reporting Company No No No 2012 Q1 135615 21972 1000 1000 136615 22972 4425 4700 1884150 257653 5000 5000 1893575 267353 2030190 290325 28101 7045 232583 64578 173355 9964 434039 81587 1447126 0 1881165 81587 95070 61825 5821709 4665738 -1680000 -1680000 -4087754 -2838825 149025 208738 2030190 290325 0 0 0 491978 0 2545045 510543 4950 790201 925 0 4035 0 0 48559 0 268 1209 0 0 6353 492 75 281357 0 0 55 0 0 4202 1003938 5293 3681016 -1003938 -5293 -3681016 0 0 -133494 -244993 0 -273246 -1248931 -5293 -4087756 0 0 0 -1248931 -5293 -4087754 -0.02 -0.00 67112080 52170000 47170 0 0 0 47170 47170000 -41720 0 0 47128280 5000 45000 0 0 50000 5000000 0 0 0 5000000 0 12600 0 0 12600 0 0 0 0 0 0 138600 0 0 138600 0 0 0 -363081 -363081 52170000 0 0 0 52170000 52170 154480 0 -363081 -156431 8170 3475467 -1680000 0 1803637 8170773 0 0 0 8170773 0 302265 0 0 302265 0 0 0 -2475744 -2475744 61825039 0 0 0 61825039 61825 4665738 -1680000 -2838825 4391 446652 0 0 451043 4391304 0 0 0 4391304 0 211196 0 0 211196 0 0 0 -1248931 -1248931 95069482 0 0 0 95069482 95070 5821711 -1680000 -4087756 0 0 151200 818022 0 2898174 275 0 1075 42628 0 193533 163391 0 173355 0 0 -1000 0 21056 -56210 28101 -382930 -61503 -1080340 0 0 156432 0 0 55450 496573 0 1009073 0 61503 -5000 496573 61503 1215955 113643 0 135615 21972 1016 0 135615 1016 0 0 4500 1568579 0 1867074 0 0 0 0.001 0.001 500000000 500000000 95069482 61825039 -179371 0 -437024 <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Allezoe Medical Holdings, Inc., formerly Stanford Management, Ltd. (the &#147;Company&#148;), was incorporated under the laws of the State of Delaware on September 24, 1998 with the authorized common stock of 25,000,000 shares at $0.001 par value.&nbsp;&nbsp;On March 9, 2007, at the Annual General Meeting of Stockholders a Resolution was approved increasing the authorized share capital to 500,000,000 common shares with a par value of $0.001 per share.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company was organized for the purpose of acquiring and developing mineral properties.&nbsp;&nbsp;On February 18, 2011, all of the mineral properties and related development and exploration activities were disposed of as part of a series of transactions resulting in the Company moving into the medical technology industry.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On February 18, 2011, the Company acquired all of the outstanding shares of Organ Transport Systems, Inc. (&#147;OTS&#148;), a Nevada corporation, and simultaneously disposed of the assets relating to its former activities in mining exploration, along with all related liabilities. Consequently, OTS was considered to be the surviving entity, with the Company intending to include only the financial results of OTS in its financial statements. In March, 2012, however, the Company determined that the development costs and time to development for the OTS technology were significantly greater than originally expected and, as a result, determined to return OTS to Healthcare of Today, Inc., from which it had been originally acquired. As a result, the February 18, 2011 transaction with OTS was rescinded and OTS is no longer a part of the Company&#146;s corporate group. The Company will focus on the HPV detection and treatment technology as well as on the technology currently being developed by BioCube, Inc. for the disinfection of healthcare facilities. The historical financial results presented in this Report have been restated to present those solely of the Company. </font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Nature of Operations</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company has recently formed a wholly-owned subsidiary, SureScreen Medical, Inc., through which we have entered into a licensing agreement with AVM Corp. for the licensing of proprietary, patent pending technology that would enable healthcare providers to "see and treat" Human Papillomavirus (HPV), the most common sexually transmitted infection and a cause of cervical cancer, In addition to offering easy, affordable, and on-the-spot HPV diagnosis, the technology offers an important alternative to the HPV vaccine. </font></p> <!--egx--><p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Basis of Presentation of Interim Period Financial Statements</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The accompanying unaudited financial statements of the Company at November 30, 2011 and 2010 have been prepared on the accrual basis of accounting in accordance with generally accepted accounting principles (&#145;GAAP&#146;) for interim financial statements, instructions to Form 10-Q, and Regulation S-X.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">In management&#146;s opinion, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation to make the Company&#146;s financial statements not misleading have been included. The results of operations for the periods ended November 30, 2011 and 2010 presented are not necessarily indicative of the results to be expected for the full year.</font></p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Development Stage</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company's financial statements are presented as those of a development stage enterprise. Activities during the development stage include company formation, equity issued for patents and technology, and fixed assets and further implementation of the business plan. The Company has not generated any revenues since inception.</font></p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Concentrations of Credit Risk</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company maintains its cash in a bank deposit account in a bank which participates in the Federal Deposit Insurance Corporation (FDIC) Program. As of November 30, 2011 and August 31, 2011, the Company had no balances in excess of federally insured limits.</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Use of Estimates</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of&nbsp;revenues and expenses during the reporting period. A significant estimate as of November 30, 2011 and August 31, 2011, respectively included a 100% valuation allowance for deferred tax assets arising from net operating losses incurred since inception.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ materially from estimates.</font></p> <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Cash and Equivalents</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents.&nbsp;&nbsp;The Company had no cash equivalents at November 30, 2011 and August 31, 2011, respectively.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp; </font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.&nbsp;&nbsp;There were no balances that exceeded the federally insured limit at November 30, 2011 and August 31, 2011, respectively. </font></p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Earnings per Share </font></b></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">In accordance with Financial Accounting Standards Board &#147;FASB&#148; Accounting Standards Codification &#147;ASC&#148; Topic 260, <i>&#147;Earnings per Share,&#148;&nbsp;&nbsp;</i>basic earnings (loss) per share (&#147;EPS&#148;) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method (by using the average stock price for the period to determine the number of shares assumed to be purchased from the exercise of stock options or warrants), and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive. The computation of basic and diluted loss per share for the period from September 24, 1998 (inception) to November 30, 2011, is equivalent since the Company has had continuing losses. The Company also has no common stock equivalents.</font></p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Accounting for Stock-Based Compensation</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company adopted the provisions of FASB ASC 718-20, Stock Compensation &#150; Awards Classified as Equity, which require companies to expense the estimated fair value of employee stock options and similar awards based on the fair value of the award on the date of grant. The cost is recognized over the period during which an employee is required to provide service in exchange for the award, usually the vesting period. The Company&#146;s stock-based compensation plans and assumptions used in determining stock-based compensation expense common stock are computed using the treasury stock method which assumes that the increase in the number of shares is reduced by the number of shares which could have been repurchased by the Company with the proceeds from the exercise of the options and warrants (which were assumed to have been made at the average market price of the common shares during the reporting period). Diluted loss per common share is the same as basic loss per share as the effect of potentially dilutive securities are anti-dilutive. </font></p> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">&nbsp;</font></b></p> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Non-Employee Stock Based Compensation </font></b><font style="FONT-SIZE:10pt"></font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Share-based payment awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable.</font></p> <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company accounts for income taxes in accordance with accounting standards for Accounting for Income Taxes which require the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and tax credit carry-forwards. Additionally, the standards require the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets.</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The following is a schedule of deferred tax assets as of November 30, 2011, and August 31, 2011:</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <table style="MARGIN:auto auto auto 41.4pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid"> <td width="204" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:153pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="60" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:45pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="132" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:99pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">November 30, 2011</font></p></td> <td width="36" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:27pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="138" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:103.5pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">August 31, 2011</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid"> <td width="204" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:153pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">Net operating loss </font></p></td> <td width="60" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:45pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="132" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:99pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,087,756</font></p></td> <td width="36" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:27pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="138" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:103.5pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <div style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:medium none; PADDING-BOTTOM:1pt; PADDING-LEFT:0in; PADDING-RIGHT:0in; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:medium none; PADDING-TOP:1pt"> <p style="BORDER-BOTTOM:medium none; TEXT-ALIGN:right; BORDER-LEFT:medium none; PADDING-BOTTOM:0in; MARGIN:0in 0in 0pt; PADDING-LEFT:0in; PADDING-RIGHT:0in; BORDER-TOP:medium none; BORDER-RIGHT:medium none; PADDING-TOP:0in" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2,475,744</font></p></div></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid"> <td width="204" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:153pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">Future tax benefit at 34%&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </font></p></td> <td width="60" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:45pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="132" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:99pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">1,389,837</font></p></td> <td width="36" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:27pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="138" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:103.5pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">841,753</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid"> <td width="204" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:153pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">Less: Valuation allowance</font></p></td> <td width="60" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:45pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="132" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:99pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;&nbsp; (1,389,837)</font></p></td> <td width="36" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:27pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="138" style="BORDER-BOTTOM:black 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:103.5pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">(841,753)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid"> <td width="204" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:153pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">Net deferred tax asset</font></p></td> <td width="60" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:45pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="132" style="BORDER-BOTTOM:windowtext 1.5pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:99pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;--</font></p></td> <td width="36" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:27pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;</font></p></td> <td width="138" style="BORDER-BOTTOM:windowtext 1.5pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:103.5pt; PADDING-RIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="top"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-FAMILY:'Times New Roman','serif'; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; --</font></p></td></tr></table> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The valuation allowance changed by approximately $548,084 during the three months ended November 30, 2011.</font></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Under Sections 382 and 269 (the &#145;shell corporation&#146; rule) of the Internal Revenue Code, following an &#147;ownership change,&#148; special limitations (&#147;Section 382 Limitations&#148;) apply to the use by a corporation of its net operating loss, or NOL, carry-forwards arising before the ownership change and various other carry-forwards of tax attributes (referred to collectively as the &#145;Applicable Tax Attributes&#146;). The Company had NOL carry-forwards due to historical losses of Stanford of approximately $368,374 at November 30, 2011.</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company has adopted the provisions of FASB ASC 740-10-25. As a result of its implementation, the Company performed a comprehensive review of its uncertain tax positions in accordance with recognition and measurement standards established by FASB ASC 740-10-25. In this regard, an uncertain tax position represents the Company&#146;s expected treatment of a tax position taken in a prepared and filed tax return, or expected to be taken in a tax return, that has not been reflected in measuring income tax expense for financial reporting purposes. The Company does not expect any reasonably possible material changes to the estimated amount of liability associated with uncertain tax positions through November 30, 2011. The Company&#146;s continuing policy is to recognize accrued interest and penalties related to income tax matters in income tax expense.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <!--egx--><p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Fair Value of Financial Instruments</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The carrying amounts of the Company&#146;s short-term financial instruments, including accounts payable and accrued liabilities, approximate fair value due to the relatively short period to maturity for these instruments.</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Fair Value of Measurements</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company follows accounting guidance relating to fair value measurements. This guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><u><font style="FONT-SIZE:10pt">Level 1</font></u><font style="FONT-SIZE:10pt">&nbsp;</font><font style="FONT-SIZE:10pt">&#150; quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><u><font style="FONT-SIZE:10pt">Level 2</font></u><font style="FONT-SIZE:10pt">&nbsp;</font><font style="FONT-SIZE:10pt">&#150; inputs other than quoted prices included within Level 1 that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><u><font style="FONT-SIZE:10pt"><font style="TEXT-DECORATION:none">&nbsp;</font></font></u></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><u><font style="FONT-SIZE:10pt">Level 3</font></u><font style="FONT-SIZE:10pt">&nbsp;</font><font style="FONT-SIZE:10pt">&#150; unobservable inputs for the asset or liability only used when there is little, if any, market activity for the asset or liability at the measurement date.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">At November 30, 2011, the Company has no instruments that require additional disclosure. </font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The asset or liability&#146;s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the unobservable inputs<i>.</i></font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Recurring Fair Value Measurements</font></b></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">&nbsp;</font></b></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">In accordance with accounting principles generally accepted in the United States of America, certain assets and liabilities are required to be recorded at fair value on a recurring basis. </font></p> <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Going Concern</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">As reflected in the accompanying financial statements, the Company has not yet emerged from the development stage, has a net loss of $1,248,931 and net cash used in operations of $382,930 for the quarter ended November 30, 2011; and negative working capital of $297,424 and an accumulated deficit of $4,087,756 at November 30, 2011.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The accompanying financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.&nbsp;&nbsp;The Company is a development stage company and has suffered recurring losses and has no established source of revenue.&nbsp;&nbsp;Its ability to continue as a going concern is dependent upon achieving profitable operations and generating positive cash flows.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">There can be no assurances that the Company will be able to achieve profitable operations or obtain additional funding.&nbsp;&nbsp;These factors create substantial doubt about the Company&#146;s ability to continue as a going concern.&nbsp;&nbsp;The financial statements do not include any adjustments that might result from the outcome of the uncertainty.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Management intends to raise financing through private or public equity financing or other means and interests that it deems necessary to provide the Company with the ability to continue in existence. </font></p> <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Recent Accounting Pronouncements</font></b><font style="FONT-SIZE:10pt"></font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">In September 2011, the FASB issued an amendment to Topic 350, Intangibles&#151;Goodwill and Other, which simplifies how entities test goodwill for impairment. Previous guidance under Topic 350 required an entity to test goodwill for impairment using a two-step process on at least an annual basis. First, the fair value of a reporting unit was calculated and compared to its carrying amount, including goodwill. Second, if the fair value of a reporting unit was less than its carrying amount, the amount of impairment loss, if any, was required to be measured. Under the amendments in this update, an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads the entity to determine that it is more likely than not that its fair value is less than its carrying amount. If after assessing the totality of events or circumstances, an entity determines that it is not more likely than not that the fair value of the reporting unit is less than its carrying amount, then the two-step impairment test is unnecessary. If the entity concludes otherwise, then it is required to test goodwill for impairment under the two-step process as described under paragraphs 350-20-35-4 and 350-20-35-9 under Topic 350. The amendments are effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011 and early adoption is permitted. The Company is currently evaluating whether early adoption is necessary.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company continually assesses any new accounting pronouncements to determine their applicability to the Company. Where it is determined that a new accounting pronouncement affects the Company&#146;s financial reporting, the Company undertakes a study to determine the consequence of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company&#146;s financials properly reflect the change. </font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">NOTE 3.&nbsp;&nbsp;RESTATEMENT OF THE FINANCIAL STATEMENTS</font></b></p> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">&nbsp;</font></b></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company is restating its previously issued financial statements as of and for the three months ended November 30, 2011 to reflect the rescission of its subsidiary Organ Transport Systems, Inc. (&#147;OTS&#148;) in March 2012. The rescission of OTS resulted in the removal of all OTS transactions from the Company&#146;s previously reported financial statements as of and for the three months ended November 30, 2011 and 2010.</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The effect of the restatements on our balance sheet as of November 30, 2011 is as follows:</font></p> <div align="center"> <table width="673" style="MARGIN:auto auto auto 4.7pt; WIDTH:504.8pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:30.15pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:30.15pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:30.15pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="285" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:214.1pt; PADDING-RIGHT:5.4pt; HEIGHT:30.15pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:30.15pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">As previously Reported</font></b></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:30.15pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Adjustments</font></b></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:30.15pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Restated</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12pt"> <td width="673" colspan="6" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:504.8pt; PADDING-RIGHT:5.4pt; HEIGHT:12pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">ASSETS</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.3pt"> <td width="319" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:239.2pt; PADDING-RIGHT:5.4pt; HEIGHT:15.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">CURRENT ASSETS</font></b></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:15.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:15.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:15.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Cash </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 152,693 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (17,078) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 135,615 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Prepaid expenses </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;12,396 </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (11,396) </font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="285" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:214.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Total current assets </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 165,089 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (28,474) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 136,615 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="319" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:239.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Property, plant and equipment net </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,792 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,792) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="319" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:239.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Deferred loan costs, net </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,425 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,425 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="319" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:239.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Patents </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 372,201 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (372,201) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="319" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:239.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Loans receivable </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 1,884,150</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 1,884,150 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="319" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:239.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Advances to related parties </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,000</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:13.5pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="285" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:214.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Total assets </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 543,507 </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1,486,683</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,030,190 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:13.5pt"> <td width="673" colspan="6" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:504.8pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="319" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:239.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">CURRENT LIABILITIES</font></b></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Accounts payable and accrued expenses </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 630,356 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (602,255) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 28,101 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Accrued salaries </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 467,996 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (467,996) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Notes payable - net of debt discount </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,001,646 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,769,063) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 232,583 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Accrued interest </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 302,674 </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (129,319) </font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 173,355 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="285" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:214.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Total current liabilities </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; 3,402,672 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2,968,633) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 434,039 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="319" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:239.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Long-term notes payable </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 691,806 </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">755,320-</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; 1,447,126 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="285" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:214.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;Total liabilities </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 4,094,478 </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (2,213,313) </font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,881,165 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="319" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:239.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">STOCKHOLDERS' EQUITY (DEFICIT)</font></b></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock, $0.001 par value; 500,000,000</font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="285" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:214.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">shares authorized. 95,069,482 shares </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="285" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:214.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">issued and outstanding </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 173,325 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (78,255) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 95,070 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Additional paid in capital</font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 27,324,277 </font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (21,502,566) </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,821,711 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Deferred equity</font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,680,000)</font></p></td> <td width="120" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; (1,680,000)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="304" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:228.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Deficit accumulated during the development stage</font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (29,368,573)</font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 25,280,817</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; (4,087,756)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="285" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:214.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Total stockholders' equity (deficit)</font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (3,550,971)</font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;3,699,996</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 149,025</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:13.5pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"></td> <td width="285" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:214.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Total liabilities and stockholders' equity</font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 543,507 </font></p></td> <td width="120" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1.25in; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;1,486,683</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,030,190 </font></p></td></tr></table></div> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The effect of the restatements on our balance sheet as of August 31, 2011 is as follows:</font></p> <div align="center"> <table width="643" style="MARGIN:auto auto auto 4.7pt; WIDTH:482.2pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:31.5pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="306" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:229.5pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="105" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="FONT-SIZE:10pt">As previously Reported</font></b></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="FONT-SIZE:10pt">Adjustments</font></b></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="FONT-SIZE:10pt">Restated</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12pt"> <td width="643" colspan="6" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:482.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">ASSETS</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="339" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:254.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">CURRENT ASSETS</font></b></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Cash </font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38,320 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (16,348)</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21,972 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Prepaid expenses </font></p></td> <td width="105" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12,396 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (11,396)</font></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="306" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:229.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Total current assets </font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50,716 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (27,744)</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 22,972 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="339" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:254.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Property, plant and equipment, net</font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">2,558</font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">(2,558)</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="339" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:254.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Deferred loan costs, net</font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">4,700</font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">4,700</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="339" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:254.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Patents </font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 363,561 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (363,561)</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;-</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="339" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:254.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Loan receivable</font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 257,653</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">257,653</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="339" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:254.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Advances to related parties</font></p></td> <td width="105" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,000</font></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">5,000</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:8.5pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:8.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:8.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="306" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:229.5pt; PADDING-RIGHT:5.4pt; HEIGHT:8.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Total assets </font></p></td> <td width="105" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:8.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 421,535 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:8.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (131,210)</font></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:8.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 290,325 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:13.5pt"> <td width="643" colspan="6" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:482.2pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="339" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:254.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">CURRENT LIABILITIES</font></b></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Accounts payable and accrued expenses </font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 585,240 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (578,195)</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7,045 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Accrued salaries </font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 393,821 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (393,821)</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Notes payable - net of debt discount </font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 1,827,868 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp; (1,763,290)</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64,578 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Accrued interest </font></p></td> <td width="105" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 216,389 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (206,425)</font></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9,964 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="306" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:229.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Total current liabilities </font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;3,023,318 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">(2,941,731)</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 81,587 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="339" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:254.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Long-term notes payable, net of debt discount </font></p></td> <td width="105" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 499,072 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (499,072)</font></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="306" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:229.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;Total liabilities </font></p></td> <td width="105" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 3,522,390 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;(3,440,803)</font></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 81,587 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="339" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:254.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">STOCKHOLDERS' EQUITY (DEFICIT)</font></b></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Common stock, $0.001 par value; 500,000,000</font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="306" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:229.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">shares authorized. 61,825,039 issued and outstanding</font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;140,080 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (78,255)</font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 61,825 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Additional paid in capital</font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp; 26,535,284</font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">(21,869,546)&nbsp;&nbsp; </font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 4,665,738</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Deferred equity</font></p></td> <td width="105" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (1,680,000)</font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="90" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (1,680,000)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="325" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:243.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Deficit accumulated during the development stage</font></p></td> <td width="105" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp; (28,096,219)</font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 25,257,394 </font></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;(2,838,825)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="306" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:229.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Total stockholders' equity (deficit)</font></p></td> <td width="105" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (3,100,855)</font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 3,309,593 </font></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp; 208,738 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:13.5pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"></td> <td width="19" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:14pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"></td> <td width="306" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:229.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Total liabilities and stockholders' equity</font></p></td> <td width="105" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 421,535 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (131,210)</font></p></td> <td width="90" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:67.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 290,325 </font></p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The effect of the restatements on our statement of operations for the three months ended November 30, 2011 is as follows:</font></p> <div align="center"> <table width="657" style="MARGIN:auto auto auto 4.65pt; WIDTH:492.55pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:48.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="97" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">As previously Reported</font></b></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Adjustments</font></b></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Restated</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="369" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:276.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">REVENUES</font></b></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.05pt"> <td width="369" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:276.6pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">GENERAL AND ADMINISTRATIVE EXPENSES</font></b></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Payroll and payroll taxes</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 286,535 </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 205,443 </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 491,978 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Research and development</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12,168 </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (12,168)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:9.9pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:9.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:9.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Professional fees</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:9.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 518,123 </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:9.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (7,580)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:9.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 510,543 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Travel and entertainment</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,393 </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (468)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 925 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Rent</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 7,052 </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (7,052)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Insurance</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,184 </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (2,184)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Office expense</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 607 </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (607)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Telephone and internet</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 375 </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (375)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">General and administrative</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,384 </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (892)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;492 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Depreciation and amortization expense</font></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 766 </font></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (766)</font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Loss from operations</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (830,587)</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (173,351)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (1,003,938)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.75pt"> <td width="369" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:276.6pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">OTHER INCOME (EXPENSE)</font></b></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Finance cost</font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="97" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Interest, net</font></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (441,767)</font></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 196,774 </font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;(244,993)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:18.85pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:18.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="354" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:265.5pt; PADDING-RIGHT:5.4pt; HEIGHT:18.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net loss</font></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:18.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp; (1,272,354)</font></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:18.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23,423</font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:18.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp; (1,248,931)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:16.2pt"> <td width="369" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:276.6pt; PADDING-RIGHT:5.4pt; HEIGHT:16.2pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Net loss per share (basic and diluted)</font></b></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:16.2pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.01)</font></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:16.2pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="COLOR:windowtext; FONT-SIZE:10pt">N/A</font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:16.2pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.02)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:14.25pt"> <td width="369" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:276.6pt; PADDING-RIGHT:5.4pt; HEIGHT:14.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Weighted average number of shares outstanding during the period-basic and diluted</font></b></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.95pt; PADDING-RIGHT:5.4pt; HEIGHT:14.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; 136,507,915 </font></p></td> <td width="97" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.65pt; PADDING-RIGHT:5.4pt; HEIGHT:14.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="COLOR:windowtext; FONT-SIZE:10pt">N/A</font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.35pt; PADDING-RIGHT:5.4pt; HEIGHT:14.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 67,112,080 </font></p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The effect of the restatements on our statement of operations for the three months ended November 30, 2010 is as follows:</font></p> <div align="center"> <table width="624" style="MARGIN:auto auto auto 4.7pt; WIDTH:467.9pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:48.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="102" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">As previously Reported</font></b></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Adjustments</font></b></p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:48.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Restated</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="337" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">REVENUES</font></b></p></td> <td width="102" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.05pt"> <td width="337" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.7pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">GENERAL AND ADMINISTRATIVE EXPENSES</font></b></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Payroll and payroll taxes</font></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 186,778 </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">(186,778)</font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Professional fees</font></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 25,430 </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (20,480)</font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,950 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Advisor fees</font></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;225,000 </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (225,000)</font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Rent</font></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17,064 </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (17,064)</font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Office expense</font></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 417 </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (149)</font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 268 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Telephone and internet</font></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 791 </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (791)</font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">General and administrative</font></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 951 </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (876)</font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 75 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Depreciation and amortization expense</font></p></td> <td width="102" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 950 </font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (950)</font></p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Loss from operations</font></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (457,381)</font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 452,088 </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; (5,293)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.2in"> <td width="337" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.7pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">OTHER INCOME (EXPENSE)</font></b></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Finance cost</font></p></td> <td width="102" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="94" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Interest, net</font></p></td> <td width="102" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (9,403)</font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9,403 </font></p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.7pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:15.7pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.6pt; PADDING-RIGHT:5.4pt; HEIGHT:15.7pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net loss</font></p></td> <td width="102" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:15.7pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (466,784)</font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:15.7pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 461,491 </font></p></td> <td width="91" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:15.7pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (5,293)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:18.45pt"> <td width="337" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.7pt; PADDING-RIGHT:5.4pt; HEIGHT:18.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Net loss per share (basic and diluted)</font></b></p></td> <td width="102" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:18.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;(0.01)</font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:18.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="COLOR:windowtext; FONT-SIZE:10pt">N/A</font></p></td> <td width="91" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:18.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (0.00)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:13.5pt"> <td width="337" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.7pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Weighted average number of shares outstanding during the period-basic and diluted</font></b></p></td> <td width="102" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:76.5pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 52,170,000 </font></p></td> <td width="94" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:70.6pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="COLOR:windowtext; FONT-SIZE:10pt">N/A</font></p></td> <td width="91" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.1pt; PADDING-RIGHT:5.4pt; HEIGHT:13.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; 52,170,000 </font></p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">&nbsp;</font></b></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The effect of the restatements on our statement of cash flows for the three months ended November 30, 2011 is as follows:</font></p> <div align="center"> <table width="684" style="MARGIN:auto auto auto 4.7pt; WIDTH:513.35pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:20.25pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="334" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:250.55pt; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">As previously Reported</font></b></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Adjustments</font></b></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Restated</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.5pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:17.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">CASH FLOWS FROM OPERATING ACTIVITIES</font></b></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:17.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:17.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net loss</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,272,354)</font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;23,423</font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp; (1,248,931)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Adjustments to reconcile net loss to net</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">cash used by operations:</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Depreciation expense</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 766 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (766)</font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Stock based compensation expense</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 451,043 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 366,979 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 818,022 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Amortization of deferred loan costs</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 275 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 275 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Amortization of debt discount</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 209,256 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (166,628) </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 42,628 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Interest accrued on notes payable</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 86,561 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 76,830 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 163,391 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Increase in prepaid expenses</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Increase in accounts payable</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="334" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:250.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">and accrued expenses</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45,116 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;(24,060)</font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; 21,056 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Loans receivable</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">(179,371)</font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;(179,371)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Increase in accrued salaries</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 74,175 </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (74,175)</font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:11.65pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:11.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net cash used by operating activities</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:11.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (405,437)</font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:11.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; 22,507 </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:11.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (382,930)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">CASH FLOWS FROM INVESTING ACTIVITIES</font></b></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Purchase of property and equipment</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Investment in patents</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8,640)</font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,640 </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:8.95pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:8.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net cash used by investing activities</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:8.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (8,640)</font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:8.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,640 </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:8.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">CASH FLOWS FROM FINANCING ACTIVITIES</font></b></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:9pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Proceeds from issuance of common stock</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Proceeds from notes payable</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 528,450 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (31,877)</font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 496,573 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Payments of notes payable</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:10.75pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:10.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net cash provided by financing activities</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:10.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 528,450 </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:10.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (31,877)</font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:10.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 496,573 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net increase (decrease) in cash</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;114,373 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (730)</font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 113,643 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Cash and equivalents, beginning of period</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 38,320 </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (16,348)</font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 21,972 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:8.95pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:8.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Cash and equivalents, end of period</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:8.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 152,693 </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:8.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (17,078)</font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:8.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 135,615 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="378" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:283.85pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Supplemental cash flow information:</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:5.4pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Cash paid for interest</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:5.4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:5.85pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:5.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:5.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Cash paid for income taxes</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:5.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:5.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:5.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="364" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:272.75pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Significant non-cash investing and financing activities</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Notes payable - officer debentures</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$ &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 1,408,579 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 1,408,579 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:9.45pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Notes payable converted to common stock</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 160,000 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 160,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.1in"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="349" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:261.65pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common Stock issued at par</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12,467 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (12,467)</font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:1in; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr></table></div> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The effect of the restatements on our statement of cash flows for the three months ended November 30, 2010 is as follows:</font></p> <div align="center"> <table width="674" style="MARGIN:auto auto auto 4.7pt; WIDTH:505.3pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:58.5pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:58.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:58.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:58.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="307" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:230.3pt; PADDING-RIGHT:5.4pt; HEIGHT:58.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:58.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">As previously Reported</font></b></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:58.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Adjustments</font></b></p></td> <td width="100" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:58.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Restated</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="307" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:230.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="351" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:263.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">CASH FLOWS FROM OPERATING ACTIVITIES</font></b></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="337" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net loss</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (466,784)</font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 461,491 </font></p></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;(5,293)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="337" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Adjustments to reconcile net loss to net</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.4pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">cash used by operations:</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:18.9pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.4pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Depreciation expense</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 950 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (950)</font></p></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.25in"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.4pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Amortization of debt discount</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33,130 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (33,130)</font></p></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.4pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Increase in accounts payable</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; </font></p></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.2in"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="307" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:230.3pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">and accrued expenses</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;243,326 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; (299,535)</font></p></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.2in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (56,209)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.25in"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="322" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:241.4pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Increase in accrued salaries</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 169,333 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; (169,333)</font></p></td> <td width="100" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.05pt"> <td width="351" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:263.6pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net cash used by operating activities</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; (20,045)</font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (41,457)</font></p></td> <td width="100" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (61,502)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="351" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:263.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">CASH FLOWS FROM INVESTING ACTIVITIES</font></b></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:18.45pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:18.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="337" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.5pt; PADDING-RIGHT:5.4pt; HEIGHT:18.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Investment in patents</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:18.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (22,945)</font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:18.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22,945 </font></p></td> <td width="100" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:18.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.05pt"> <td width="351" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:263.6pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net cash used by investing activities</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (22,945)</font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 22,945 </font></p></td> <td width="100" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="351" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:263.6pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">CASH FLOWS FROM FINANCING ACTIVITIES</font></b></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="337" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Proceeds from notes payable</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30,001 </font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (30,001)</font></p></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="337" colspan="3" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:252.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Related party advances</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 61,503 </font></p></td> <td width="100" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 61,503 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:14.8pt"> <td width="351" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:263.6pt; PADDING-RIGHT:5.4pt; HEIGHT:14.8pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net cash provided by financing activities</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:14.8pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 30,001 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:14.8pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 31,502 </font></p></td> <td width="100" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:14.8pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 61,503 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.95pt"> <td width="351" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:263.6pt; PADDING-RIGHT:5.4pt; HEIGHT:17.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net increase (decrease) in cash</font></p></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (12,989)</font></p></td> <td width="108" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:17.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 12,990 </font></p></td> <td width="100" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:17.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.25in"> <td width="351" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:263.6pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Cash and equivalents, beginning of period</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17,647 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (16,632)</font></p></td> <td width="100" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,015 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.5pt"> <td width="351" colspan="4" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:263.6pt; PADDING-RIGHT:5.4pt; HEIGHT:17.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Cash and equivalents, end of period</font></p></td> <td width="114" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,658 </font></p></td> <td width="108" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:81pt; PADDING-RIGHT:5.4pt; HEIGHT:17.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (3,642)</font></p></td> <td width="100" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:75.2pt; PADDING-RIGHT:5.4pt; HEIGHT:17.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,016 </font></p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">&nbsp;</font></b></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The effect of the restatements on our statement of statement of stockholders&#146; equity (deficit) for the three months ended November 30, 2010 is as follows:</font></p> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <div align="center"> <table width="785" style="MARGIN:auto auto auto 4.7pt; WIDTH:588.95pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:3.85pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:3.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:3.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:3.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:3.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:3.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:3.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Accumulated</font></b></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:3.85pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Total </font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.1in"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Additional </font></b></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">During the</font></b></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:0.1in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Stockholders'</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:9.45pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"></td> <td width="155" colspan="2" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:116pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Common Stock</font></b></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Paid In</font></b></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Development</font></b></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:9.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Equity</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:19.3pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:19.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:19.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Shares</font></b></p></td> <td width="66" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:19.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Par Value</font></b></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:19.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Capital</font></b></p></td> <td width="103" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:19.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Deferred Equity</font></b></p></td> <td width="99" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:19.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Stage</font></b></p></td> <td width="92" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:19.3pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">(Deficit)</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Balance - September 24, 1998 (inception)</font></b></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued for cash</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">47,170,000 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 47,170 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (41,720)</font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,450 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Contributions-noncash expenses</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 138,600 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; 138,600 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued for cash</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 5,000,000 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 5,000 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45,000 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;50,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net loss for the period from September 24, 1998(inception) to August 31, 2009</font></p></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="66" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="103" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="99" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (340,716)</font></p></td> <td width="92" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (340,716)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Balance - August 31, 2009 (restated)</font></b></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;52,170,000 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; 52,170 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;141,880 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (340,716)</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (146,666)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Contributions-noncash expenses</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 12,600 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 12,600 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Net loss for the year ended August 31, 2010</font></p></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="66" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="103" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="99" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; (22,365)</font></p></td> <td width="92" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">(22,365)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">Balance - August 31, 2010 <font style="COLOR:windowtext">(restated)</font></font></b></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">52,170,000</font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">52,170</font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">154,480</font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">-</font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (363,081)</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (156,431)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued for services, $0.42 per share</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 5,000,000 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 5,000 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 2,095,000 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; (1,680,000)</font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 420,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued for services, $0.42 per share</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; 3,000,000 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">3,000 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">1,257,000 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">1,260,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Converted notes payable to common stock, $0.36per share</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;927,666 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 928 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 458,454 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 459,382 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Converted notes payable to common stock, $0.36per share</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 556,600 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;557 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 275,072 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; 275,629 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued for services, $0.724 per share</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 77,624 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; 77 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 56,122 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 56,199 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued for services, $0.724 per share</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 46,574 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; 47 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 33,672 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;33,719 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:12.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued for services, $0.724 per share</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 46,575 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; 46 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 33,673 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:12.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 33,719 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Issuance of notes payable-beneficial conversion feature</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp;&nbsp; </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; 145,833 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; 145,833 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Additional capital contributed</font></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 156,432 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 156,432 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net loss for the year ended August 31, 2011</font></p></td> <td width="88" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="66" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="96" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td> <td width="103" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td> <td width="99" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; (2,475,744)</font></p></td> <td width="92" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; (2,475,744)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:15.75pt"> <td width="240" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:180.05pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Balance - August 31, 2011 (restated)</font></b></p></td> <td width="88" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:66.3pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; 61,825,039 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.7pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$ 61,825 </font></p></td> <td width="96" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:72.2pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; 4,665,738 </font></p></td> <td width="103" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:77.55pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; (1,680,000)</font></p></td> <td width="99" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:74pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp; (2,838,825)</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.15pt; PADDING-RIGHT:5.4pt; HEIGHT:15.75pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 208,738 </font></p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">&nbsp;</font></b></p> <div align="center"> <table width="787" style="MARGIN:auto auto auto -17.2pt; WIDTH:590.5pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:31.5pt"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Converted notes payable to common stock, $0.01875 per share</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 2,666,667 </font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp; 2,667 </font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 47,333 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:31.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:27pt"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Converted notes payable to common stock, $0.01035 per share</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,830,918 </font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,831 </font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 45,169 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 50,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.5in"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:0.5in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Converted notes payable to common stock, $0.00675 per share</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.5in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,888,888 </font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:0.5in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 8,889 </font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:0.5in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 51,111 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:0.5in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.5in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:0.5in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 60,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:31.05pt"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued for services, $0.57 per share</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 391,304 </font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 391 </font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 222,652 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 223,043 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:31.95pt"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:31.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued for services, $0.057 per share</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:31.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,000,000 </font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:31.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 4,000 </font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:31.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 224,000 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:31.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:31.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:31.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 228,000 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.25in"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued at $0.57 per share</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 234,782 </font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp; 235 </font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; 133,591 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 133,826 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:27pt"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued at $0.057 per share</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 2,400,000 </font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 2,400 </font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 134,400 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:27pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 136,800 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.25in"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Common stock issued at $0.0098 per share</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 9,831,884 </font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">9,832 </font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 86,521 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 96,353 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.25in"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Issuance of notes payable-reissuance</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 154,074 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 154,074 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:31.05pt"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Issuance of notes payable-beneficial conversion feature</font></p></td> <td width="92" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">-</font></p></td> <td width="68" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">-</font></p></td> <td width="98" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57,122 </font></p></td> <td width="106" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">-</font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">-</font></p></td> <td width="91" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:31.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57,122 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:27.45pt"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:27.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="COLOR:windowtext; FONT-SIZE:10pt">Net loss for the period ended November 30, 2011</font></p></td> <td width="92" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:27.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="68" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:27.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="98" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:27.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="106" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:27.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -&nbsp;&nbsp; </font></p></td> <td width="83" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:27.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,248,931)</font></p></td> <td width="91" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:27.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (1,248,931)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.05pt"> <td width="248" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:186pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in"> <p style="MARGIN:0in 0in 0pt"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">Balance - November 30, 2011 (restated)</font></b></p></td> <td width="92" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:69.1pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp; 95,069,482 </font></b></p></td> <td width="68" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:51.3pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$ 95,070 </font></b></p></td> <td width="98" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:73.6pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 5,821,711 </font></b></p></td> <td width="106" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:79.65pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp; (1,680,000)</font></b></p></td> <td width="83" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">$(4,087,756)</font></b></p></td> <td width="91" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:68.35pt; PADDING-RIGHT:5.4pt; HEIGHT:17.05pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><b><font style="COLOR:windowtext; FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 149,025</font></b></p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">&nbsp;</font></b></p> <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Healthcare of Today, Inc. (HOTI) provides financial, accounting, legal, administrative and similar services to the Company at a monthly fixed fee of $10,000, commencing March 1, 2011. </font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company is authorized to issue 500,000,000 shares of common stock, par value $0.001 per share. </font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On September 2, 2011, the Company issued 391,304 shares of common stock for services rendered under consulting agreements.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On October 13, 2011, the Company issued 4,000,000, shares of common stock for services rendered under consulting agreements.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On November 8, 2011, the Company converted $50,000 of notes into 2,666,667 shares of common stock.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On November 17, 2011, the Company converted $50,000 of notes into 4,830,918 shares of common stock.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On November 29, 2011, the Company converted $60,000 of notes into 8,888,888 shares of common stock.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company issued an additional 12,466,666 shares to Healthcare of Today, Inc., pursuant to the original OTS acquisition agreement and closing whereby in the event that additional common shares were issued to other parties, then additional common shares would also be issued to Healthcare of Today, Inc. so that its resulting ownership percentage of the then outstanding common shares would remain at 60 percent. Though the Company agreed to return its stock in OTS to Healthcare of Today, Inc. in exchange for the return of the 78,255,000 shares of stock previously issued to Healthcare of Today, Inc., pursuant to the agreement to rescind the acquisition of OTS, the additional 12,466,666 shares that were issued were not returned and are considered to be issued and outstanding as of November 30, 2011. These shares have been recorded at fair market value and are included in payroll related expenses on the statement of operations and stock based compensation on the statement of cash flows for the three months ended November 30, 2011.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">As a result of these transactions, there were 95,069,482 common shares outstanding at November 30, 2011.</font><font style="FONT-SIZE:10pt"></font></p> <p style="MARGIN:0in 0in 0pt"><b><font style="FONT-SIZE:10pt">&nbsp;</font></b></p> <!--egx--><p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The following is a summary of notes payable at November 30, 2011 and August 31, 2011:</font></p> <table width="664" style="MARGIN:auto auto auto 4.65pt; WIDTH:498.35pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:22.95pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:22.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Description</font></p></td> <td width="126" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:22.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">November 30, 2011</font></p></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.1pt; PADDING-RIGHT:5.4pt; HEIGHT:22.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="115" colspan="2" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:86pt; PADDING-RIGHT:5.4pt; HEIGHT:22.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">August 31, 2011</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:20.25pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Asher Enterprises, Inc.</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:20.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:56.25pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:56.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature April 11, 2012 and is convertible 180 days after issuance into shares of the Company&#146;s common stock at a price discounted from average trading price. $53,000 Note less discount of $21,326 for conversion.</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:56.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 31,674 </font></p></td> <td width="16" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:56.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:56.25pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 17,083 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:18.9pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Asher Enterprises, Inc.</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:18.9pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:61.65pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:61.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature May 18, 2012 and is convertible 180 days after issuance into shares of the Company&#146;s common stock at a price discounted from average trading price. $40,000 Note less discount of $21,703 for conversion.</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:61.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 18,297 </font></p></td> <td width="16" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:61.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:61.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 6,680 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.1pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Asher Enterprises, Inc.</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:52.65pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:52.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature July 5, 2012 and is convertible 180 days after issuance into shares of the Company&#146;s common stock at a price discounted from average trading price.</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:52.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 32,500 <font style="BACKGROUND:yellow"></font></font></p></td> <td width="16" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:52.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:52.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">- </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:16.2pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:16.2pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Magna Group</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:16.2pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:16.2pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:16.2pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:48.6pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:48.6pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Convertible notes payable to The Magna Group. The notes accrue interest at 12% per annum and mature November 4, 2012 and are convertible into shares of Allezoe common stock at a price discounted from the average trading price. $150,000 in Notes less discount of $57,122 for conversion.</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:48.6pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">92,878 <font style="BACKGROUND:yellow"></font></font></p></td> <td width="16" colspan="2" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:48.6pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:48.6pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">- </font></p></td></tr> <tr> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; BACKGROUND-COLOR:transparent; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0"></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; BACKGROUND-COLOR:transparent; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0"></td> <td width="15" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; BACKGROUND-COLOR:transparent; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0"></td> <td width="1" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; BACKGROUND-COLOR:transparent; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; BACKGROUND-COLOR:transparent; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0"></td></tr></table> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <table width="664" style="MARGIN:auto auto auto 4.65pt; WIDTH:498.35pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.1pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Convertible debentures </font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:62.1pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:62.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Convertible notes payable to related parties &#150; officers by OTS. The notes accrue interest at 12% per annum, mature December 15, 2012, and are convertible one year after issuance into shares of Company common stock at a price discounted from average trading price. No beneficial conversion recorded as note transferred back to OTS. See Note 8.</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:62.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,447,126 <font style="BACKGROUND:yellow"></font></font></p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:62.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:62.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; - </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.1pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Crystal Falls Investments, LLC.</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:17.1pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:52.65pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:52.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Convertible notes payable to Crystal Falls. The notes accrue interest at 9% per annum and mature January 31, 2012 and are convertible into shares of Allezoe common stock at a price discounted from the average trading price. $100,000 Note less discount of $42,765 for conversion.</font></p></td> <td width="126" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:52.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 57,235 </font></p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:52.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:52.65pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 40,815 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:16.6pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:16.6pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Total</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:16.6pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 1,679,710 </font></p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:16.6pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:16.6pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 64,578 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:4pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Less: current portion</font></p></td> <td width="126" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">232,584 </font></p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">64,578 </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:3.5pt"> <td width="409" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:306.75pt; PADDING-RIGHT:5.4pt; HEIGHT:3.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Long-term debt</font></p></td> <td width="126" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:94.5pt; PADDING-RIGHT:5.4pt; HEIGHT:3.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;1,447,126 </font></p></td> <td width="16" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:11.8pt; PADDING-RIGHT:5.4pt; HEIGHT:3.5pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="114" style="BORDER-BOTTOM:windowtext 2.25pt double; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:85.3pt; PADDING-RIGHT:5.4pt; HEIGHT:3.5pt; BORDER-TOP:windowtext 1pt solid; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;- </font></p></td></tr></table> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Notes payable consist of borrowings under convertible debenture arrangements. In July 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $53,000 with interest payable at 8% per annum with a maturity date of January 31, 2012. The indebtedness including interest is convertible into common stock at 58% of the average lowest three (3) trading prices during the ten (10) trading day period ending on the latest complete trading day prior to conversion. In August 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $40,000 with interest payable at 8% per annum with a maturity date of January 31, 2012. The indebtedness including interest is convertible into common stock at 58% of the average lowest three (3) trading prices during the ten (10) trading day period ending on the latest complete trading day prior to conversion. In July 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $100,000 with interest payable at 9% per annum with a maturity date of January 31, 2012. The indebtedness including interest is convertible into common stock at $.29 per share. In October 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $32,500 with interest payable at 8% per annum with a maturity date of July 4, 2012. The indebtedness including interest is convertible into common stock at 58% of the average lowest three (3) trading prices during the ten (10) trading day period ending on the latest complete trading day prior to conversion. In November 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $50,000 with interest payable at 12% per annum with a maturity date of November 4, 2012. The indebtedness including interest is convertible into common stock at 50% of the average lowest price during the ten (10) trading day period ending on the latest complete trading day prior to conversion.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">In November 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $260,000 with interest payable at 12% per annum with a maturity date of November 4, 2012. The indebtedness including interest is convertible into common stock at 75% of the average lowest price during the three (3) trading day period ending on the latest complete trading day prior to conversion. This was an assignment of part of the convertible notes payable to related parties &#150; officers by OTS where $261,453 was assigned to a creditor for $260,000. In November 2011, the Company converted $160,000 of the note into 16,386,473 shares of common stock. The Company accounted for the borrowings under these arrangements in accordance with ASC 470-20 Debt with Conversions and Other Options. The fair value of the beneficial conversion feature is calculated using the intrinsic value method at the time of issuance or commitment date. The company records a debt discount for the calculated value, which is amortized over the debt term.</font></p> <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">In December, 2011, the Company issued 18,247,619 common shares on conversion of $101,000 in loan principal (see Note 7) and 36,231,884 common shares for $250,000 in consulting fees. HOTI was issued 32,687,701, common shares for stock based compensation.</font><font style="FONT-SIZE:10pt"></font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt">&nbsp;</p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">In December, 2011, the Company entered into an Acquisition Agreement (the "Acquisition Agreement") with &#201;lan Health Services, Inc. (the "Seller"), pursuant to which it will acquire BioCube, Inc., a Nevada corporation (&#147;BioCube&#148;), which will then become our wholly-owned subsidiary as filed in &#147;ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT&#148; of the 8-K dated January 5, 2012.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Effective March 19, 2012, the Company, Healthcare of Today, Inc. and &#201;lan Health Services, Inc. agreed to rescind the acquisition of Organ Transport Systems, Inc. (&#147;OTS&#148;) from Healthcare of Today, Inc. by the Company, which closed in February, 2011.&nbsp; Under the terms of the rescission, the Company agreed to return its stock in OTS to Healthcare of Today, Inc. in exchange for the return of the 78,255,000 shares of stock issued to Healthcare of Today.&nbsp; However, since Healthcare of Today, Inc. had previously transferred all of the shares of the Company received in the earlier transaction to third parties, of which 48,037,610 were transferred to &#201;lan Health Services, Inc. for the assumption of debt, it was agreed that &#201;lan Health Services would return the 48,037,610 shares held by it immediately, and then would credit the balance of 30,217,390 common shares against the planned acquisition of BioCube, Inc. by the Company from &#201;lan Health. The market value of the shares to be received as a credit at March 19, 2012 was $0.0155 per share, or a total of $468,370, which has been recorded as &#147;Loan Receivable&#148; on the balance sheet in March 2012.&nbsp; The net effect of the rescission transaction has been to return OTS as a subsidiary of Healthcare of Today, Inc., to remove OTS as a subsidiary of the Company.&nbsp; The table below summarizes the effect of the rescission transaction in March 2012:</font></p> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <div align="center"> <table width="513" style="MARGIN:auto auto auto -6.35pt; WIDTH:384.9pt; BORDER-COLLAPSE:collapse" cellpadding="0" cellspacing="0"> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:4pt"> <td width="281" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:210.7pt; PADDING-RIGHT:5.4pt; HEIGHT:4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"></td> <td width="83" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="FONT-SIZE:10pt">Shares</font></b></p></td> <td width="66" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.85pt; PADDING-RIGHT:5.4pt; HEIGHT:4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="FONT-SIZE:10pt">Price</font></b></p></td> <td width="82" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:61.85pt; PADDING-RIGHT:5.4pt; HEIGHT:4pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:center; MARGIN:0in 0in 0pt" align="center"><b><font style="FONT-SIZE:10pt">Value</font></b></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.45pt"> <td width="281" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:210.7pt; PADDING-RIGHT:5.4pt; HEIGHT:17.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Acquisition of OTS-February 18, 2011</font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">78,255,000 </font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.85pt; PADDING-RIGHT:5.4pt; HEIGHT:17.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$ 0.5500 </font></p></td> <td width="82" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:61.85pt; PADDING-RIGHT:5.4pt; HEIGHT:17.45pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">N/A </font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:0.25in"> <td width="281" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:210.7pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Allezoe Shares Returned by &#201;lan in March 2012</font></p></td> <td width="83" style="BORDER-BOTTOM:windowtext 1pt solid; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">(48,037,610)</font></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.85pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">&nbsp;$ 0.0155 </font></p></td> <td width="82" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:61.85pt; PADDING-RIGHT:5.4pt; HEIGHT:0.25in; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><font style="FONT-SIZE:10pt">$ (744,583)</font></p></td></tr> <tr style="PAGE-BREAK-INSIDE:avoid; HEIGHT:17.95pt"> <td width="281" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:210.7pt; PADDING-RIGHT:5.4pt; HEIGHT:17.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">Stock still due to Allezoe on BioCube closing</font></p></td> <td width="83" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:62.5pt; PADDING-RIGHT:5.4pt; HEIGHT:17.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><b><font style="FONT-SIZE:10pt">(30,217,390)</font></b></p></td> <td width="66" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:49.85pt; PADDING-RIGHT:5.4pt; HEIGHT:17.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><b><font style="FONT-SIZE:10pt">&nbsp;$ 0.0155 </font></b></p></td> <td width="82" style="BORDER-BOTTOM:#f0f0f0; BORDER-LEFT:#f0f0f0; PADDING-BOTTOM:0in; BACKGROUND-COLOR:transparent; PADDING-LEFT:5.4pt; WIDTH:61.85pt; PADDING-RIGHT:5.4pt; HEIGHT:17.95pt; BORDER-TOP:#f0f0f0; BORDER-RIGHT:#f0f0f0; PADDING-TOP:0in" valign="bottom"> <p style="TEXT-ALIGN:right; MARGIN:0in 0in 0pt" align="right"><b><font style="FONT-SIZE:10pt">&nbsp;$ (468,370)</font></b></p></td></tr></table></div> <p style="MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <!--egx--><p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company is authorized to issue 500,000,000 shares of common stock, par value $0.001 per share. </font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On September 2, 2011, the Company issued 391,304 shares of common stock for services rendered under consulting agreements.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On October 13, 2011, the Company issued 4,000,000, shares of common stock for services rendered under consulting agreements.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On November 8, 2011, the Company converted $50,000 of notes into 2,666,667 shares of common stock.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On November 17, 2011, the Company converted $50,000 of notes into 4,830,918 shares of common stock.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">On November 29, 2011, the Company converted $60,000 of notes into 8,888,888 shares of common stock.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">The Company issued an additional 12,466,666 shares to Healthcare of Today, Inc., pursuant to the original OTS acquisition agreement and closing whereby in the event that additional common shares were issued to other parties, then additional common shares would also be issued to Healthcare of Today, Inc. so that its resulting ownership percentage of the then outstanding common shares would remain at 60 percent. Though the Company agreed to return its stock in OTS to Healthcare of Today, Inc. in exchange for the return of the 78,255,000 shares of stock previously issued to Healthcare of Today, Inc., pursuant to the agreement to rescind the acquisition of OTS, the additional 12,466,666 shares that were issued were not returned and are considered to be issued and outstanding as of November 30, 2011. These shares have been recorded at fair market value and are included in payroll related expenses on the statement of operations and stock based compensation on the statement of cash flows for the three months ended November 30, 2011.</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">&nbsp;</font></p> <p style="TEXT-ALIGN:justify; MARGIN:0in 0in 0pt"><font style="FONT-SIZE:10pt">As a result of these transactions, there were 95,069,482 common shares outstanding at November 30, 2011.</font><font style="FONT-SIZE:10pt"></font></p> 0001080602 2011-09-01 2011-11-30 0001080602 2011-11-30 0001080602 2011-08-31 0001080602 2010-09-01 2010-11-30 0001080602 1998-09-24 2011-11-30 0001080602 2010-11-30 0001080602 1998-09-24 2010-08-31 0001080602 2010-09-01 2011-08-31 0001080602 us-gaap:CommonStockMember 1998-09-24 2010-08-31 0001080602 us-gaap:AdditionalPaidInCapitalMember 1998-09-24 2010-08-31 0001080602 us-gaap:DeferredCompensationShareBasedPaymentsMember 1998-09-24 2010-08-31 0001080602 us-gaap:AccumulatedOtherComprehensiveIncomeMember 1998-09-24 2010-08-31 0001080602 us-gaap:CommonStockMember 2010-08-31 0001080602 us-gaap:AdditionalPaidInCapitalMember 2010-08-31 0001080602 us-gaap:DeferredCompensationShareBasedPaymentsMember 2010-08-31 0001080602 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-08-31 0001080602 2010-08-31 0001080602 us-gaap:CommonStockMember 2010-09-01 2011-08-31 0001080602 us-gaap:AdditionalPaidInCapitalMember 2010-09-01 2011-08-31 0001080602 us-gaap:DeferredCompensationShareBasedPaymentsMember 2010-09-01 2011-08-31 0001080602 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2010-09-01 2011-08-31 0001080602 us-gaap:CommonStockMember 2011-08-31 0001080602 us-gaap:AdditionalPaidInCapitalMember 2011-08-31 0001080602 us-gaap:DeferredCompensationShareBasedPaymentsMember 2011-08-31 0001080602 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-08-31 0001080602 us-gaap:CommonStockMember 2011-09-01 2011-11-30 0001080602 us-gaap:AdditionalPaidInCapitalMember 2011-09-01 2011-11-30 0001080602 us-gaap:DeferredCompensationShareBasedPaymentsMember 2011-09-01 2011-11-30 0001080602 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-09-01 2011-11-30 0001080602 us-gaap:CommonStockMember 2011-11-30 0001080602 us-gaap:AdditionalPaidInCapitalMember 2011-11-30 0001080602 us-gaap:DeferredCompensationShareBasedPaymentsMember 2011-11-30 0001080602 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2011-11-30 0001080602 1998-09-23 shares iso4217:USD iso4217:USD shares Net of accumulated amortization of $1,075and $800 Net of debt discount of $142,917 and $128,422 $0.001 par value, 500,000,000 shares authorized, 95,069,482 and 61,825,039 shares issued and outstanding Expenses paid by shareholder Discount on notes payable EX-101.SCH 6 alzm.ob-20111130.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 000050 - Statement - STATEMENT OF STOCKHOLDERS' EQUITY link:presentationLink link:definitionLink link:calculationLink 200000 - Disclosure - Organization, Consolidation and Presentation of Financial Statements link:presentationLink link:definitionLink link:calculationLink 250000 - Disclosure - Accounting Changes and Error Corrections link:presentationLink link:definitionLink link:calculationLink 815000 - Disclosure - Fair Value Measures and Disclosures link:presentationLink link:definitionLink link:calculationLink 000020 - Statement - BALANCE SHEETS link:presentationLink link:definitionLink link:calculationLink 500000 - Disclosure - Equity link:presentationLink link:definitionLink link:calculationLink 000010 - Document - Document and Entity Information link:presentationLink link:definitionLink link:calculationLink 290000 - Disclosure - Accounting Policies link:presentationLink link:definitionLink link:calculationLink 275000 - Disclosure - Risks and Uncertainties link:presentationLink link:definitionLink link:calculationLink 845000 - Disclosure - Related Party Disclosures link:presentationLink link:definitionLink link:calculationLink 000040 - Statement - STATEMENT OF OPERATIONS link:presentationLink link:definitionLink link:calculationLink 460000 - Disclosure - Debt link:presentationLink link:definitionLink link:calculationLink 000060 - Statement - STATEMENT OF CASH FLOWS link:presentationLink link:definitionLink link:calculationLink 870000 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 770000 - Disclosure - Income Taxes link:presentationLink link:definitionLink link:calculationLink 000030 - Statement - BALANCE SHEETS (PARENTHETICAL) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 7 alzm.ob-20111130_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 alzm.ob-20111130_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 alzm.ob-20111130_lab.xml XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT Significant Accounting Policies [Text Block] Fair Value of Financial Instruments, Policy [Policy Text Block] Use of Estimates, Policy [Policy Text Block] Adjustments to reconcile net income (loss) to net cash provided by (used in) continuing operations: Additional Paid-in Capital Shares outstanding Current Assets Supplemental disclosuers of cash flow information: Net Income (loss) Net Income (loss) Stock issued during period, Value Income taxes Additional paid in capital Stockholder's Equity (Deficit) Document Fiscal Period Focus Entity Common Stock, Shares Outstanding Debt Disclosure [Text Block] Common Stock {1} Common Stock Dues and subscriptions Telephone and internet Deferred loan costs Entity Well-known Seasoned Issuer Fair Value Measures and Disclosures Summary of Deferred Tax Liability Not Recognized [Table Text Block] Income Tax, Policy [Policy Text Block] Cash and Cash Equivalents, Policy [Policy Text Block] Concentration Risk Disclosure [Text Block] Conversion of notes payable to stock Income taxes, net Proceeds from notes payable Capital contributions-noncash expenses Net loss per common share (basic and diluted) Loss from operations Office expense Total Liabilities Advances to related parties Entity Public Float Subsequent Events Compensation Related Costs, Policy [Policy Text Block] NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES Finance cost Professional fees Payroll and payroll taxes Document Type Increase (Decrease) in cash and cash equivalents NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES Amortization Shares authorized Stockholders' Equity: Total Assets Related Party Transactions Disclosure [Text Block] Debt Going Concern Note Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Beginning Balance Cash and Cash Equivalents, at Carrying Value, Ending Balance Stock based compensation expense Adjustments to paid in capital Earnings Per Share: Common Stock Accounts payable and accrued liabilities Total Noncurrent Assets Accrued interest payable Stock issued during period, Value, services Stock issued during period, Shares, founder shares Weighted average number of shares outstanding during the period - basic and diluted Repairs and maintenance Revenues Assets {1} Assets Entity Voluntary Filers Document and Entity Information Fair Value Disclosures [Text Block] Stockholders' Equity Note Disclosure [Text Block] Development Stage Enterprises Stock issued during period, Shares, services Deferred Equity Income (loss) before income taxes Interest, net Total Current Liabilities Liabilities & Stockholders' Equity Entity Registrant Name Issuance of Common Stock Additional capital contributed NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES: Accounts payable and accrued expenses Accounts payable and accrued expenses Increase in prepaid expenses Stock issued during period, Value, founder shares Total Expenses General & Administrative Common stock, par value Deferred equity Shareholders' Equity: Document Period End Date Supplemental disclosures of non-cash investing and financing activities: NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES: Stock issued during period, Shares Net income (loss) qualified Travel and entertainment Shares issued Shares issued, Shares issued, Notes payable Loans receivable, net Current Fiscal Year End Date Amendment Flag Income Taxes Equity Interest Interest Loans receivable Statement of Cash Flows Weighted average number of common shares outstanding Deficit accumulated during the development stage Statement [Line Items] Entity Current Reporting Status Stockholders' Equity, Policy [Policy Text Block] Risks and Uncertainties Accounting Changes and Error Corrections [Text Block] Accounting Changes and Error Corrections Statement of Stockholders' Equity Other income (expense) Insurance Income (Loss) from Continuing Operations before Taxes Current Liabilities Total Current Assets Entity Central Index Key Income Tax Disclosure [Text Block] Amortization of debt discount Statement, Equity Components [Axis] Long-term notes payable Nature of Operations [Text Block] Organization, Consolidation and Presentation of Financial Statements Related party advances Accumulated Other Comprehensive Income (Loss) General and administrative Total Stockholders' Equity (Deficit) Stockholders' Equity Stockholders' Equity Cash Document Fiscal Year Focus Related Party Disclosures Equity Component Prepaid expenses Statement of Financial Position Subsequent Events [Text Block] Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block] Earnings Per Share, Policy [Policy Text Block] Accounting Policies Net Income (Loss) Income Statement Total Liabilities and Stockholders' Equity (Deficit) Accrued interest Entity Filer Category EX-101.PRE 10 alzm.ob-20111130_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 R9.htm IDEA: XBRL DOCUMENT v2.4.0.6
Risks and Uncertainties
3 Months Ended
Nov. 30, 2011
Risks and Uncertainties  
Concentration Risk Disclosure [Text Block]

Concentrations of Credit Risk

 

The Company maintains its cash in a bank deposit account in a bank which participates in the Federal Deposit Insurance Corporation (FDIC) Program. As of November 30, 2011 and August 31, 2011, the Company had no balances in excess of federally insured limits.

 

EXCEL 13 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\T968X,C!E-E]F9#DX7S0Y861?83-E8E\X8CEF M.#(V.3$U934B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I7;W)K#I7;W)K#I.86UE M/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D]R9V%N:7IA=&EO;E]# M;VYS;VQI9&%T:6]N7V%N9#PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D%C8V]U;G1I;F=?0VAA;F=E#I. M86UE/@T*("`@(#QX.E=O#I% M>&-E;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D1E8G0\+W@Z3F%M93X-"B`@("`\>#I7;W)K M#I7;W)K#I7;W)K#I%>&-E;%=O#I7;W)K#I3='EL97-H965T($A2968],T0B M5V]R:W-H965T&-E M;"!84"!O3X-"CPO:'1M;#X-"@T*+2TM M+2TM/5].97AT4&%R=%\T968X,C!E-E]F9#DX7S0Y861?83-E8E\X8CEF.#(V M.3$U934-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&5F.#(P939? M9F0Y.%\T.6%D7V$S96)?.&(Y9C@R-CDQ-64U+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R M2!);F9O'0^06QL97IO92!-961I8V%L($AO M;&1I;F=S($EN8SQS<&%N/CPO'0^,3`M43QS<&%N/CPO2!&:6QE3PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^4VUA;&QE3QS<&%N/CPO M'0^3F\\2!6;VQU;G1A3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T968X M,C!E-E]F9#DX7S0Y861?83-E8E\X8CEF.#(V.3$U934-"D-O;G1E;G0M3&]C M871I;VXZ(&9I;&4Z+R\O0SHO-&5F.#(P939?9F0Y.%\T.6%D7V$S96)?.&(Y M9C@R-CDQ-64U+U=O'0O:'1M;#L@8VAA'0^/'-P M86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M6%B;&4\ M+W1D/@T*("`@("`@("`\=&0@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$2`H1&5F:6-I="D\+W-TF%T:6]N(&]F("0Q+#`W-6%N9"`D.#`P/"]T9#X-"B`@ M("`@(#PO='(^#0H@("`@("`\='(@8VQA7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T* M("`@("`@/'1R(&-L87-S/3-$&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S M/3-$;G5M/B@Q+#(T."PY,S$I/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XP/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@ M("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$7!E.B!T97AT+VAT;6P[(&-H87)S M970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@ M:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M M;#L@8VAA2!A="!3 M97`N(#(S+"`Q.3DX/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\ M2!A="!! M=6'!E;G-E3X-"CPO:'1M;#X-"@T*+2TM+2TM/5]. M97AT4&%R=%\T968X,C!E-E]F9#DX7S0Y861?83-E8E\X8CEF.#(V.3$U934- M"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&5F.#(P939?9F0Y.%\T M.6%D7V$S96)?.&(Y9C@R-CDQ-64U+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R'!E;G-E/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XX,3@L M,#(R/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%SF%T:6]N/"]T9#X-"B`@("`@("`@/'1D M(&-L87-S/3-$;G5M<#XR-S4\6%B;&4@86YD(&%C8W)U960@97AP96YS97,\+W1D/@T*("`@ M("`@("`\=&0@8VQA6EN9R!686QU92P@16YD:6YG($)A;&%N M8V4\+W1D/@T*("`@("`@("`\=&0@8VQA&5S+"!N970\+W1D/@T*("`@("`@ M("`\=&0@8VQA3X-"CPO:'1M M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\T968X,C!E-E]F9#DX7S0Y861?83-E M8E\X8CEF.#(V.3$U934-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO M-&5F.#(P939?9F0Y.%\T.6%D7V$S96)?.&(Y9C@R-CDQ-64U+U=O'0O:'1M;#L@8VAA M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I M;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/B9N8G-P M.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@ M34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ M,'!T/E1H92!#;VUP86YY('=A'!L;W)A=&EO;B!A8W1I=FET:65S('=E6QE M/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$1D].5"U325I%.C$P<'0^3VX@1F5B'!L;W)A=&EO M;BP@86QO;F<@=VET:"!A;&P@2!T:&4@9FEN86YC:6%L(')E2!W97)E('-I9VYI9FEC86YT;'D@9W)E871E2!A8W%U:7)E9"X@07,@ M82!R97-U;'0L('1H92!&96)R=6%R>2`Q."P@,C`Q,2!T2!A2!B96EN9R!D979E;&]P960@8GD@0FEO0W5B92P@ M26YC+B!F;W(@=&AE(&1I6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P M:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/B9N8G-P.SPO M9F]N=#X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%2 M1TE..C!I;B`P:6X@,'!T)SX\8CX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ M,'!T/DYA='5R92!O9B!/<&5R871I;VYS/"]F;VYT/CPO8CX\9F]N="!S='EL M93TS1$9/3E0M4TE:13HQ,'!T/CPO9F]N=#X\+W`^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S M='EL93TS1$9/3E0M4TE:13HQ,'!T/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T M)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/E1H92!#;VUP86YY(&AA M2!F;W)M960@82!W:&]L;'DM;W=N960@2P@ M4W5R95-C2P@<&%T M96YT('!E;F1I;F<@=&5C:&YO;&]G>2!T:&%T('=O=6QD(&5N86)L92!H96%L M=&AC87)E('!R;W9I9&5R2!T M2!497AT($)L;V-K73PO=&0^#0H@("`@("`@(#QT9"!C M;&%S'0^/"$M+65G>"TM/CQP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\8CX\9F]N="!S='EL93TS M1$9/3E0M4TE:13HQ,'!T/E5S92!O9B!%6QE/3-$1D].5"U325I%.C$P<'0^/"]F;VYT/CPO<#X@/'`@6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$1D].5"U325I%.C$P<'0^5&AE('!R M97!A6QE/3-$1D].5"U325I% M.C$P<'0^)FYB6QE/3-$ M1D].5"U325I%.C$P<'0^36%K:6YG(&5S=&EM871E2=S(&9I;F%N M8VEA;"!S=&%T96UE;G1S(&%R92!P2P@86YD(&9I>&5D(&%S6QE/3-$ M1D].5"U325I%.C$P<'0^1V]I;F<@0V]N8V5R;CPO9F]N=#X\+V(^/&9O;G0@ M6QE/3-$)U1%6%0M04Q)1TXZ:G5S M=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M M4TE:13HQ,'!T/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$)U1%6%0M M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S='EL M93TS1$9/3E0M4TE:13HQ,'!T/E1H92!A8V-O;7!A;GEI;F<@9FEN86YC:6%L M('-T871E;65N=',@;V8@=&AE($-O;7!A;GD@:&%V92!B965N('!R97!A2!I6QE/3-$)U1%6%0M04Q)1TXZ M:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1$9/ M3E0M4TE:13HQ,'!T/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S M='EL93TS1$9/3E0M4TE:13HQ,'!T/DUA;F%G96UE;G0@:6YT96YD2!W M:71H('1H92!A8FEL:71Y('1O(&-O;G1I;G5E(&EN(&5X:7-T96YC92X@/"]F M;VYT/CPO<#X\'0O:F%V87-C3X-"B`@("`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`T+C=P M=#L@5TE$5$@Z-3`T+CAP=#L@0D]21$52+4-/3$Q!4%-%.F-O;&QA<'-E)R!C M96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<],T0P/B`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`\ M=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#L@*#(X+#0W-"D@/"]F;VYT/CPO<#X\+W1D M/B`\=&0@=VED=&@],T0Q,30@6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#M02P@<&QA;G0@ M86YD(&5Q=6EP;65N="!N970@/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@] M,T0Q,C`@6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SXF;F)S<#M$969E6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@] M,T0S,3D@8V]L6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#M,;V%N6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/ M3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#L@)FYB6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LF;F)S<#LF;F)S<#L@,2PX.#0L,34P(#PO9F]N=#X\+W`^/"]T9#X\+W1R M/B`\='(@6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#M! M9'9A;F-E6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#L@)FYB6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#M4;W1A;"!A6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O'0@,BXR M-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^/&(^/&9O;G0@6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&(^/&9O;G0@6QE M/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SXF;F)S<#M!8V-O=6YT6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LD)FYB6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#LD)FYB6QE M/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q M-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)V)O6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@*#0V-RPY.38I(#PO M9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3$T('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\+V9O;G0^ M/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS:61E M.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O M6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O M;G0@6%B;&4@+2!N970@;V8@9&5B="!D:7-C;W5N="`\ M+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R,"!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#L@,C,R+#4X,R`\+V9O;G0^/"]P/CPO=&0^/"]T6QE M/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q M-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)V)O6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,S`R M+#8W-"`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R,"!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,36QE/3-$)W!A9V4M8G)E86LM:6YS M:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$)U1%6%0M M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#L@-#,T+#`S.2`\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED M=&@],T0S,3D@8V]L6%B;&4@/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@] M,T0Q,C`@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-CDQ+#@P-B`\+V9O M;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R,"!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F M,&8P9C`[('!A9&1I;F6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SXF;F)S<#L@,2PT-#6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SXF;F)S<#M4;W1A;"!L:6%B:6QI=&EE6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#L@*#(L,C$S+#,Q,RD@/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@] M,T0Q,30@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#L@,2PX.#$L,38U(#PO9F]N=#X\+W`^/"]T9#X\+W1R/B`\='(@6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY35$]#2TA/3$1%4E,G($51 M54E462`H1$5&24-)5"D\+V9O;G0^/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@] M,T0Q,C`@6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/ M3E0M4TE:13HQ,'!T)SY#;VUM;VX@6QE/3-$ M)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@F5D+B`Y-2PP-CDL-#@R('-H87)E6QE/3-$)V)O6QE M/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q M-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG M/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F M,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I M;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE M/3-$)V)O6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#L@*#(Q+#4P,BPU-C8I(#PO9F]N=#X\+W`^/"]T M9#X@/'1D('=I9'1H/3-$,3$T('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#L@-2PX,C$L-S$Q(#PO9F]N=#X\+W`^/"]T9#X\+W1R/B`\='(@ M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#L@)FYB6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY$969I8VET(&%C8W5M=6QA=&5D(&1U M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LF;F)S<#L@*#0L,#@W+#6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@ M=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@*#,L-34P+#DW,2D\+V9O;G0^ M/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$R,"!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P M9C`[('!A9&1I;F6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O M;G0@3PO M9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3(P('-T>6QE/3-$)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R+6QE M9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G M(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$1D].5"U325I%.C$P<'0^ M)FYB6QE/3-$)TU!4D=)3CIA M=71O(&%U=&\@875T;R`T+C=P=#L@5TE$5$@Z-#@R+C)P=#L@0D]21$52+4-/ M3$Q!4%-%.F-O;&QA<'-E)R!C96QL<&%D9&EN9STS1#`@8V5L;'-P86-I;F<] M,T0P/B`\='(@6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P M<'0G(&%L:6=N/3-$8V5N=&5R/CQB/CQF;VYT('-T>6QE/3-$1D].5"U325I% M.C$P<'0^061J=7-T;65N=',\+V9O;G0^/"]B/CPO<#X\+W1D/B`\=&0@=VED M=&@],T0Y,"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P M="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$1D]. M5"U325I%.C$P<'0^05-31513/"]F;VYT/CPO8CX\+W`^/"]T9#X\+W1R/B`\ M='(@6QE M/3-$1D].5"U325I%.C$P<'0^0U524D5.5"!!4U-%5%,\+V9O;G0^/"]B/CPO M<#X\+W1D/B`\=&0@=VED=&@],T0Q,#4@6QE/3-$)V)O6QE/3-$1D].5"U3 M25I%.C$P<'0^)FYB6QE/3-$)U1%6%0M M04Q)1TXZ6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P M<'0^)FYB6QE/3-$1D].5"U325I%.C$P M<'0^)FYB'!E;G-E6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@ M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q M-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P<'0^ M)FYB6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I M9#LG/B`\=&0@=VED=&@],T0S,SD@8V]L6QE/3-$)U1%6%0M M04Q)1TXZ6QE/3-$1D].5"U325I%.C$P<'0^ M*#(L-34X*3PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.3`@6QE/3-$)W!A M9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S,SD@8V]L M6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P<'0^-"PW M,#`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$P."!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@ M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O M6QE/3-$1D]. M5"U325I%.C$P<'0^-"PW,#`\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@] M,T0S,SD@8V]L6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM M:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S,SD@8V]L6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)W!A M9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S,SD@8V]L M6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@ M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)' M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$ M1D].5"U325I%.C$P<'0^)FYB6QE/3-$)V)O6QE/3-$1D]. M5"U325I%.C$P<'0^)FYB6QE/3-$)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[ M('!A9&1I;F6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$ M)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0V-#,@ M8V]L6QE/3-$)V)O6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^/&(^/&9O;G0@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$ M)V)O6QE/3-$ M1D].5"U325I%.C$P<'0^)FYB6QE/3-$)W!A9V4M8G)E86LM:6YS:61E M.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O M6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O M;G0@6QE/3-$ M)V)O6QE/3-$ M1D].5"U325I%.C$P<'0^)FYB6QE/3-$1D].5"U325I%.C$P<'0^)FYB M6QE/3-$)W!A9V4M8G)E86LM:6YS M:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^ M/&9O;G0@6QE/3-$)V)O6QE/3-$)U1%6%0M M04Q)1TXZ6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P M<'0^)FYB6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O'0@,7!T('-O;&ED M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)W!A M9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$1D].5"U325I%.C$P<'0^ M*#(L.30Q+#6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)W!A M9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S,SD@8V]L M6QE/3-$1D].5"U325I%.C$P M<'0^)FYB6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$ M)V)O'0@,7!T('-O;&ED.R!B;W)D97(M M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N M9"UC;VQO6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)W!A9V4M8G)E86LM M:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S,SD@8V]L6QE/3-$)V)O6QE M/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q M-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`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`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ M(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O3PO9F]N M=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3`U('-T>6QE/3-$)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z M("-F,&8P9C`[('!A9&1I;F6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$ M)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@ M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO M6QE M/3-$)V)O6QE/3-$)U1%6%0M04Q) M1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R M/CQB/CQF;VYT('-T>6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SY!6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)' M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/CQF;VYT('-T>6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY!9&IU6QE M/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)W!A9V4M M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S-CD@8V]L6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&(^/&9O;G0@ M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#L@,C@V+#4S-2`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`\+V9O M;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#DW('-T>6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E M86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@ M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@ M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,2PS M.3,@/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y-R!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@ M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SY296YT/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y M-R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)V)O6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED M=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#L@,BPQ.#0@/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y-R!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@ M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO M6QE/3-$ M1D].5"U325I%.C$P<'0^)FYB6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY/ M9F9I8V4@97AP96YS93PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.3<@ M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-C`W M(#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.3<@6QE/3-$1D]. M5"U325I%.C$P<'0^)FYB6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I M9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ M(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$ M)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SY'96YE6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#L@,2PS.#0@/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED M=&@],T0Y-R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY$97!R96-I871I;VX@86YD(&%M;W)T M:7IA=&EO;B!E>'!E;G-E/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y M-R!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI M9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/ M3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-S8V(#PO9F]N M=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.3<@6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)V)O6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#L@*#$W,RPS-3$I/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y-"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@ M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY/ M5$A%4B!)3D-/344@*$584$5.4T4I/"]F;VYT/CPO8CX\+W`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`\=&0@ M=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)TU!4D=) M3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z M("-F,&8P9C`[('!A9&1I;F6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)V)O M'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY.970@;&]S6QE/3-$)V)O'0@ M,BXR-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$ M)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S-CD@ M8V]L6QE/3-$ M)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)TU!4D=) M3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$1D].5"U325I%.C$P<'0^5&AE(&5F9F5C="!O M9B!T:&4@6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\ M=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)V)O'0@,7!T M('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ M(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G M(&%L:6=N/3-$8V5N=&5R/CQB/CQF;VYT('-T>6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY!6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY2159%3E5%4SPO9F]N M=#X\+V(^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$P,B!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z M("-F,&8P9C`[('!A9&1I;F6QE/3-$ M)V)O'0@,7!T('-O;&ED.R!B;W)D97(M M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LD)FYB6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&(^/&9O M;G0@6QE/3-$)V)O6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\ M=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)TU! M4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@7)O;&P@86YD('!A>7)O;&P@=&%X M97,\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$P,B!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@ M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY0 M6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,C4L M-#,P(#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.30@6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A M=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)V)O6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#L@)FYB6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#L@*#(R-2PP,#`I/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y,2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@ M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY296YT/"]F M;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Q,#(@6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY/9F9I M8V4@97AP96YS93PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3`R('-T M>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#L@-#$W(#PO9F]N=#X\+W`^/"]T9#X@/'1D M('=I9'1H/3-$.30@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SY496QE<&AO;F4@86YD(&EN=&5R;F5T/"]F;VYT/CPO<#X\+W1D M/B`\=&0@=VED=&@],T0Q,#(@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY'96YE6QE/3-$ M)V)O6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#L@.34Q(#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.30@6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG M/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F M,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I M;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@F%T:6]N(&5X<&5N6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\+V9O;G0^ M/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS:61E M.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#L@-#4R+#`X."`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T M:#TS1#DQ('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#LF;F)S<#L@*#4L,CDS*3PO9F]N=#X\+W`^/"]T9#X\+W1R M/B`\='(@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY/5$A% M4B!)3D-/344@*$584$5.4T4I/"]F;VYT/CPO8CX\+W`^/"]T9#X@/'1D('=I M9'1H/3-$,3`R('-T>6QE/3-$)V)O6QE/3-$)W!A M9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`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`\+V9O;G0^ M/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS:61E M.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$ M1D].5"U325I%.C$P<'0^)FYB6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY.970@;&]S6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ M,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY.+T$\+V9O;G0^/"]P M/CPO=&0^(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z("-F,&8P M9C`[('!A9&1I;F6QE/3-$)V)O6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&(^/&9O;G0@6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#L@-3(L,36QE/3-$)V)O'0@,BXR M-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#L@-3(L M,36QE M/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)TU!4D=)3CIA=71O(&%U=&\@875T;R`T+C=P=#L@5TE$ M5$@Z-3$S+C,U<'0[($)/4D1%4BU#3TQ,05!313IC;VQL87!S92<@8V5L;'!A M9&1I;F<],T0P(&-E;&QS<&%C:6YG/3-$,#X@/'1R('-T>6QE/3-$)W!A9V4M M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@ M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)' M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/CQF;VYT('-T>6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY!6QE/3-$)V)O6QE/3-$)W!A9V4M8G)E86LM:6YS:61E M.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SY.970@;&]S6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LD)FYB6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LD)FYB6QE/3-$)V)O6QE/3-$)W!A M9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL M93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P M9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SY$97!R96-I871I;VX@97AP96YS93PO9F]N M=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3$T('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-S8V(#PO M9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.38@6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SY3=&]C:R!B87-E9"!C;VUP96YS871I;VX@97AP M96YS93PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3$T('-T>6QE/3-$ M)V)O6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#L@-#4Q+#`T,R`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T M:#TS1#DV('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,S8V+#DW.2`\+V9O M;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#DV('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@.#$X+#`R M,B`\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E M86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@ M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O M6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,C6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY!;6]R=&EZ M871I;VX@;V8@9&5B="!D:7-C;W5N=#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I M9'1H/3-$,3$T('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#L@,C`Y+#(U-B`\+V9O;G0^/"]P/CPO=&0^(#QT M9"!W:61T:#TS1#DV('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#L@*#$V-BPV,C@I(#PO9F]N=#X\ M+W`^/"]T9#X@/'1D('=I9'1H/3-$.38@6QE/3-$)V)O6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#L@.#8L-38Q(#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H M/3-$.38@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6%B;&4\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$Q M-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC M;VQO6QE/3-$ M)V)O6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#L@ M/"]F;VYT/CPO<#X\+W1D/CPO='(^(#QT6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SYA;F0@86-C'!E;G-E6QE M/3-$)V)O6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-#4L,3$V(#PO9F]N=#X\+W`^/"]T M9#X@/'1D('=I9'1H/3-$.38@6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG M/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F M,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I M;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)V)O6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S M<#LF;F)S<#L@)FYB6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXH,36QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LH,36QE/3-$ M)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`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`W(#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.38@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@*#,X,BPY,S`I M/"]F;VYT/CPO<#X\+W1D/CPO='(^(#QT6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SY#05-(($9,3U=3($923TT@24Y615-424Y'($%# M5$E6251)15,\+V9O;G0^/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Q,30@ M6QE M/3-$)V)O6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#L@*#@L-C0P*3PO9F]N=#X\+W`^/"]T9#X@ M/'1D('=I9'1H/3-$.38@6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@."PV-#`@/"]F;VYT M/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y-B!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P M9C`[('!A9&1I;F2!I;G9E6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@ M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+2`\+V9O M;G0^/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS M:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S-S@@8V]L6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^/&(^/&9O;G0@6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6UE;G1S(&]F(&YO M=&5S('!A>6%B;&4\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$Q-"!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@ M8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#L@+2`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`\+V9O;G0^/"]P/CPO=&0^ M/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG M/B`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`[('!A9&1I;F6QE/3-$)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R+6QE M9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$ M)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R M9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@] M,T0S-S@@8V]L6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)V)O6QE/3-$)V)O M6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$)V)O6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB M6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)V)O6QE/3-$)W!A9V4M M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD("9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N M8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P.R9N8G-P M.RT@/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y-B!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@ M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)V)O M6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^/&9O;G0@6%B;&4@8V]N=F5R=&5D('1O(&-O;6UO;B!S M=&]C:SPO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3$T('-T>6QE/3-$ M)V)O6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB M6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM M:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$1D].5"U325I%.C$P<'0^5&AE(&5F M9F5C="!O9B!T:&4@6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I M9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C M9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ M(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ8V5N M=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/CQF M;VYT('-T>6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SY!9&IU6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)W!A9V4M8G)E M86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S-3$@8V]L6QE/3-$)V)O6QE/3-$)W!A9V4M8G)E86LM M:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE M/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^/&9O;G0@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q M-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SYC87-H('5S960@8GD@;W!E6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+2`\ M+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM M:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SY!;6]R=&EZ871I;VX@;V8@9&5B="!D:7-C;W5N=#PO9F]N=#X\+W`^/"]T M9#X@/'1D('=I9'1H/3-$,3$T('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,S,L,3,P(#PO9F]N M=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3`X('-T>6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6%B;&4\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS M1#$Q-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`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`\=&0@=VED=&@],T0Q-2!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@ M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/ M3E0M4TE:13HQ,'!T)SY);F-R96%S92!I;B!A8V-R=65D('-A;&%R:65S/"]F M;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Q,30@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#L@,38Y+#,S,R`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$P M."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI M9#L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SXF;F)S<#L@*#$V.2PS,S,I/"]F;VYT/CPO<#X\+W1D/B`\ M=&0@=VED=&@],T0Q,#`@6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@)FYB6QE M/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S M-3$@8V]L2!O M<&5R871I;F<@86-T:79I=&EE6QE/3-$)V)O'0@,7!T M('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ M(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@ M*#8Q+#4P,BD\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)W!A M9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S-3$@8V]L M6QE/3-$)V)O6QE/3-$)W!A9V4M M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0Q-2!S='EL93TS M1"=B;W)D97(M8F]T=&]M.B`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`[ M('!A9&1I;F6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,C(L.30U(#PO9F]N=#X\+W`^/"]T M9#X@/'1D('=I9'1H/3-$,3`P('-T>6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O M6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&(^ M/&9O;G0@6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY06%B;&4\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T M:#TS1#$Q-"!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)U1%6%0M M04Q)1TXZ6QE/3-$ M)V)O6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@)FYB6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@ M=VED=&@],T0Q-2!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)V)O M'0@,7!T('-O;&ED.R!B;W)D97(M;&5F M=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC M;VQO6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#L@-C$L-3`S(#PO9F]N=#X\+W`^/"]T9#X\+W1R/B`\='(@6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY.970@8V%S:"!P2!F:6YA;F-I;F<@86-T:79I=&EE6QE/3-$)V)O'0@ M,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#L@,S$L-3`R(#PO9F]N=#X\+W`^/"]T9#X@/'1D M('=I9'1H/3-$,3`P('-T>6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM M:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S-3$@8V]L6QE/3-$)V)O6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#L@*#$R+#DX.2D\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T M:#TS1#$P."!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`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`[('!A9&1I;F6QE/3-$)W!A9V4M8G)E86LM:6YS:61E M.B!A=F]I9#LG/B`\=&0@=VED=&@],T0S-3$@8V]L6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LD)FYB6QE/3-$)V)O'0@,BXR M-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&(^/&9O M;G0@6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)' M24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$ M1D].5"U325I%.C$P<'0^)FYB6QE/3-$)TU!4D=)3CIA M=71O(&%U=&\@875T;R`T+C=P=#L@5TE$5$@Z-3@X+CDU<'0[($)/4D1%4BU# M3TQ,05!313IC;VQL87!S92<@8V5L;'!A9&1I;F<],T0P(&-E;&QS<&%C:6YG M/3-$,#X@/'1R('-T>6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG M/B`\=&0@=VED=&@],T0R-#`@6QE/3-$)V)O M6QE/3-$)V)O6QE/3-$)V)O6QE/3-$)U1%6%0M M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N M=&5R/CQB/CQF;VYT('-T>6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SY3=&]C:VAO;&1E6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P M<'0G(&%L:6=N/3-$8V5N=&5R/CQB/CQF;VYT('-T>6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY#;VUM;VX@4W1O8VL\+V9O;G0^ M/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y-B!S='EL93TS1"=B;W)D97(M M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN M(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/CQF;VYT('-T>6QE/3-$)T-/ M3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY086ED($EN/"]F;VYT M/CPO8CX\+W`^/"]T9#X@/'1D('=I9'1H/3-$,3`S('-T>6QE/3-$)V)O3PO9F]N M=#X\+V(^/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM M:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0R-#`@6QE/3-$)V)O'0@,7!T('-O;&ED.R!B M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)U1% M6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$ M8V5N=&5R/CQB/CQF;VYT('-T>6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/ M3E0M4TE:13HQ,'!T)SY#87!I=&%L/"]F;VYT/CPO8CX\+W`^/"]T9#X@/'1D M('=I9'1H/3-$,3`S('-T>6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ M8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`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`@/"]F;VYT/CPO<#X\+W1D/CPO='(^(#QT M6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^/&9O;G0@'!E;G-E6QE/3-$ M)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SXF;F)S<#L@,3,X+#8P,"`\+V9O;G0^/"]P/CPO M=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I M9#LG/B`\=&0@=VED=&@],T0R-#`@6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S M<#L@)FYB6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^/&9O;G0@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P M.R9N8G-P.R`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#DV('-T>6QE M/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)U1%6%0M M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@*#,T,"PW,38I/"]F;VYT M/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y,B!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B!W:6YD;W=T97AT(#%P="!S;VQI9#L@8F]R9&5R+6QE9G0Z("-F,&8P M9C`[('!A9&1I;F6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#L@*#,T,"PW,38I/"]F;VYT/CPO<#X\+W1D/CPO M='(^(#QT6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^/&(^/&9O;G0@6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LU,BPQ-S`L,#`P(#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$-C8@ M6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#L@*#,T,"PW,38I/"]F;VYT/CPO M<#X\+W1D/B`\=&0@=VED=&@],T0Y,B!S='EL93TS1"=B;W)D97(M8F]T=&]M M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@] M,T0R-#`@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/ M3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\+V9O;G0^/"]P/CPO=&0^ M(#QT9"!W:61T:#TS1#DR('-T>6QE/3-$)V)O6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM:6YS M:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0R-#`@65A6QE/3-$ M)V)O'0@,7!T('-O;&ED.R!B;W)D97(M M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N M9"UC;VQO6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$1D].5"U325I%.C$P M<'0^)FYB6QE/3-$1D].5"U325I%.C$P<'0^)FYB M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SXF;F)S<#LF;F)S<#L@*#(R+#,V-2D\+V9O;G0^/"]P/CPO=&0^ M(#QT9"!W:61T:#TS1#DR('-T>6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN M9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$1D].5"U325I%.C$P<'0^0F%L86YC92`M($%U9W5S M="`S,2P@,C`Q,"`\9F]N="!S='EL93TS1$-/3$]2.G=I;F1O=W1E>'0^*')E M6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P M<'0^-3(L,3

6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$1D].5"U3 M25I%.C$P<'0^)FYB6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY#;VUM M;VX@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LF;F)S<#LF;F)S<#L@-2PP,#`@/"]F;VYT/CPO<#X\+W1D/B`\=&0@ M=VED=&@],T0Y-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B M;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C M:V=R;W5N9"UC;VQO6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#L@)FYB6QE/3-$)V)O M6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#L@,RPP,#`L,#`P(#PO M9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$-C8@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/ M3E0M4TE:13HQ,'!T)SXF;F)S<#L@)FYB6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY#;VYV97)T960@;F]T97,@<&%Y M86)L92!T;R!C;VUM;VX@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#L@.3(X(#PO M9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.38@6QE/3-$)V)O6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#L@-#4Y+#,X,B`\+V9O;G0^ M/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS:61E M.B!A=F]I9#LG/B`\=&0@=VED=&@],T0R-#`@6%B M;&4@=&\@8V]M;6]N('-T;V-K+"`D,"XS-G!E6QE M/3-$)V)O6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#L@,C6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#L@)FYB6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$ M)V)O6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#L@-S<@ M/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y-B!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SXF;F)S<#L@)FYB6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0R-#`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`\ M=&0@=VED=&@],T0Y-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P M.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@ M8F%C:V=R;W5N9"UC;VQO6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#L@)FYB6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$)W!A9V4M8G)E86LM M:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0R-#`@6QE M/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SXF;F)S<#LF;F)S<#L@,30U+#@S,R`\+V9O;G0^/"]P/CPO=&0^/"]T6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@ M=VED=&@],T0R-#`@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#L@)FYB6QE/3-$)V)O6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SY.970@;&]S6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#L@+2`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W M:61T:#TS1#DV('-T>6QE/3-$)V)O'0@ M,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T M;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#L@*#(L-#6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SY"86QA;F-E("T@075G=7-T(#,Q+"`R,#$Q("AR97-T871E9"D\+V9O M;G0^/"]B/CPO<#X\+W1D/B`\=&0@=VED=&@],T0X."!S='EL93TS1"=B;W)D M97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D M9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)TU!4D=)3CHP:6X@,&EN M(#!P="<^/&(^/&9O;G0@6QE/3-$)TU!4D=)3CIA=71O(&%U=&\@875T;R`M,36QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I M;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#L@,BPV-C<@/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y."!S M='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@ M(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO M6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-3`L,#`P(#PO9F]N=#X\+W`^/"]T M9#X\+W1R/B`\='(@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/ M3E0M4TE:13HQ,'!T)SY#;VYV97)T960@;F]T97,@<&%Y86)L92!T;R!C;VUM M;VX@6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ M,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\ M+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#@S('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N M8G-P.R`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$ M)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E M86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0R-#@@6%B;&4@=&\@8V]M;6]N('-T;V-K+"`D,"XP,#8W-2!P97(@6QE/3-$)V)O6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@."PX.#@L.#@X M(#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$-C@@6QE/3-$)V)O6QE/3-$)T-/3$]2 M.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@-3$L,3$Q(#PO9F]N=#X\+W`^ M/"]T9#X@/'1D('=I9'1H/3-$,3`V('-T>6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ M6QE/3-$)V)O6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O M;G0@6QE/3-$ M)V)O6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#L@,SDQ+#,P-"`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W M:61T:#TS1#8X('-T>6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@,SDQ(#PO9F]N=#X\ M+W`^/"]T9#X@/'1D('=I9'1H/3-$.3@@6QE/3-$)V)O6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[ M($9/3E0M4TE:13HQ,'!T)SY#;VUM;VX@6QE/3-$)U1% M6%0M04Q)1TXZ6QE/3-$)V)O M6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$ M)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@ M,C,T+#6QE M/3-$)V)O6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#L@ M,C,U(#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H/3-$.3@@6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M M4TE:13HQ,'!T)SY#;VUM;VX@6QE/3-$ M)V)O6QE/3-$ M)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S M<#LF;F)S<#L@,BPT,#`L,#`P(#PO9F]N=#X\+W`^/"]T9#X@/'1D('=I9'1H M/3-$-C@@6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/ M3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#L@,3,T+#0P,"`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T M:#TS1#$P-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D M97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R M;W5N9"UC;VQO6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE: M13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#L@,3,V+#@P,"`\+V9O;G0^/"]P/CPO=&0^/"]T6QE M/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0R M-#@@6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^/&9O;G0@6QE M/3-$)V)O6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@.2PX,S$L.#@T(#PO9F]N=#X\+W`^ M/"]T9#X@/'1D('=I9'1H/3-$-C@@6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S M<#LF;F)S<#L@)FYB6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E M>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P.R`\+V9O;G0^/"]P M/CPO=&0^(#QT9"!W:61T:#TS1#DQ('-T>6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I M9#LG/B`\=&0@=VED=&@],T0R-#@@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6%B;&4M6QE/3-$)V)O6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)U1%6%0M04Q)1TXZ6QE M/3-$)V)O6QE M/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXM/"]F;VYT M/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y."!S='EL93TS1"=B;W)D97(M8F]T M=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@<&%D9&EN9RUB M;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T M)SXM/"]F;VYT/CPO<#X\+W1D/B`\=&0@=VED=&@],T0Y,2!S='EL93TS1"=B M;W)D97(M8F]T=&]M.B`C9C!F,&8P.R!B;W)D97(M;&5F=#H@(V8P9C!F,#L@ M<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)V)O M6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SY. M970@;&]S6QE/3-$)T-/3$]2.G=I;F1O=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF M;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S M<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#LF;F)S<#L@+29N8G-P.R9N8G-P M.R`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`L(#(P,3$@*')E6QE/3-$)V)O M'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R M+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z M("-F,&8P9C`[('!A9&1I;F6QE/3-$)V)O'0@,BXR M-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O'0@,BXR-7!T(&1O=6)L93L@8F]R9&5R+6QE9G0Z M("-F,&8P9C`[('!A9&1I;F6QE/3-$)V)O'0@,BXR-7!T M(&1O=6)L93L@8F]R9&5R+6QE9G0Z("-F,&8P9C`[('!A9&1I;F6QE/3-$)T-/3$]2.G=I;F1O M=W1E>'0[($9/3E0M4TE:13HQ,'!T)SXF;F)S<#LD)FYB7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`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`P:6X@,'!T)SX\9F]N="!S='EL93TS M1$9/3E0M4TE:13HQ,'!T/E1H92!#;VUP86YY(&UI;FEM:7IE2!;4&]L:6-Y(%1E>'0@0FQO M8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X+2T^ M/'`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`L(#(P M,3$@86YD(#(P,3`@:&%V92!B965N('!R97!A2!A8V-E<'1E9"!A8V-O=6YT:6YG('!R:6YC:7!L97,@*"8C,30U.T=! M05`F(S$T-CLI(&9O6QE/3-$1D].5"U325I%.C$P M<'0^)FYB6QE/3-$1D]. M5"U325I%.C$P<'0^26X@;6%N86=E;65N="8C,30V.W,@;W!I;FEO;BP@86QL M(&%D:G5S=&UE;G1S("AC;VYS:7-T:6YG(&]N;'D@;V8@;F]R;6%L(')E8W5R M28C,30V.W,@ M9FEN86YC:6%L('-T871E;65N=',@;F]T(&UI2!;4&]L:6-Y(%1E>'0@0FQO8VM=/"]T M9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X+2T^/'`@6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$1D].5"U325I%.C$P<'0^5&AE($-O M;7!A;GD@861O<'1E9"!T:&4@<')O=FES:6]N'!E M;G-E('1H92!E2!T:&4@=F5S M=&EN9R!P97)I;V0N(%1H92!#;VUP86YY)B,Q-#8[2!T:&4@;G5M8F5R M(&]F('-H87)E6QE/3-$1D].5"U325I%.C$P<'0^3F]N M+45M<&QO>65E(%-T;V-K($)A6QE/3-$1D].5"U325I%.C$P<'0^/"]F;VYT/CPO<#X@/'`@ M6QE/3-$)U1% M6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S M='EL93TS1$9/3E0M4TE:13HQ,'!T/E-H87)E+6)A6UE;G0@87=A M2!497AT($)L;V-K73PO=&0^#0H@("`@ M("`@(#QT9"!C;&%S'0^/"$M+65G>"TM/CQP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S M='EL93TS1$9/3E0M4TE:13HQ,'!T/E1H92!#;VUP86YY(&ES(&%U=&AO6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@ M,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/B9N8G-P.SPO9F]N M=#X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE. M.C!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/D]N M(%-E<'1E;6)E2!I6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$1D].5"U325I%.C$P<'0^3VX@ M3V-T;V)E6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@ M,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/B9N8G-P.SPO9F]N M=#X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE. M.C!I;B`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`L(#(P M,3$\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS1#$U('-T>6QE/3-$)V)O M6QE/3-$)U1%6%0M M04Q)1TXZ6QE/3-$)V)O6QE/3-$)W!A9V4M M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0T,#D@6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF M>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE: M13HQ,'!T/DYO=&4@<&%Y86)L92!T;R!!28C,30V.W,@8V]M;6]N('-T;V-K(&%T(&$@<')I8V4@9&ES8V]U;G1E M9"!F6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)V)O6QE/3-$1D].5"U325I% M.C$P<'0^)FYB6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A M=F]I9#LG/B`\=&0@=VED=&@],T0T,#D@6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P M:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/D%S:&5R($5N M=&5R<')I6QE/3-$)V)O6QE M/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0T M,#D@6QE/3-$)U1%6%0M04Q) M1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS M1$9/3E0M4TE:13HQ,'!T/DYO=&4@<&%Y86)L92!T;R!!2`Q."P@,C`Q,B!A;F0@:7,@8V]N=F5R M=&EB;&4@,3@P(&1A>7,@869T97(@:7-S=6%N8V4@:6YT;R!S:&%R97,@;V8@ M=&AE($-O;7!A;GDF(S$T-CMS(&-O;6UO;B!S=&]C:R!A="!A('!R:6-E(&1I M6QE/3-$)U1%6%0M04Q)1TXZ6QE/3-$)W!A9V4M8G)E86LM:6YS M:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0T,#D@6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE. M.C!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/D%S M:&5R($5N=&5R<')I6QE/3-$)V)O6QE/3-$)W!A9V4M8G)E86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED M=&@],T0T,#D@6QE/3-$)U1% M6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S M='EL93TS1$9/3E0M4TE:13HQ,'!T/DYO=&4@<&%Y86)L92!T;R!!7,@869T97(@:7-S=6%N8V4@:6YT;R!S:&%R M97,@;V8@=&AE($-O;7!A;GDF(S$T-CMS(&-O;6UO;B!S=&]C:R!A="!A('!R M:6-E(&1I6QE/3-$0D%#2T=2 M3U5.1#IY96QL;W<^/"]F;VYT/CPO9F]N=#X\+W`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`\=&0@=VED=&@],T0T,#D@6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%2 M1TE..C!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T M/D-O;G9E6%B;&4@=&\@0W)Y6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$ M)V)O6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)W!A9V4M8G)E86LM:6YS M:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0T,#D@6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@ M6QE/3-$)V)O6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$)V)O6QE/3-$ M)V)O6QE/3-$ M1D].5"U325I%.C$P<'0^,C,R+#4X-"`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W M:61T:#TS1#$V('-T>6QE/3-$)V)O6QE/3-$)V)O6QE M/3-$1D].5"U325I%.C$P<'0^3&]N9RUT97)M(&1E8G0\+V9O;G0^/"]P/CPO M=&0^(#QT9"!W:61T:#TS1#$R-B!S='EL93TS1"=B;W)D97(M8F]T=&]M.B!W M:6YD;W=T97AT(#(N,C5P="!D;W5B;&4[(&)O'0@ M,7!T('-O;&ED.R!B;W)D97(M6QE/3-$)U1%6%0M04Q) M1TXZ'0@ M,7!T('-O;&ED.R!B;W)D97(M6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$1D].5"U325I%.C$P<'0^ M)FYB6QE/3-$1D].5"U3 M25I%.C$P<'0^3F]T97,@<&%Y86)L92!C;VYS:7-T(&]F(&)O2`R,#$Q+"!T:&4@0V]M<&%N>2!E;G1E2!P2!B;W)R;W=E9"`D-#`L,#`P('=I=&@@:6YT97)E2!P97)I;V0@96YD M:6YG(&]N('1H92!L871E2`R,#$Q+"!T:&4@0V]M<&%N>2!E;G1E M2!B;W)R;W=E9"`D,S(L-3`P('=I M=&@@:6YT97)E2!P2!E;G1E2!P6QE/3-$ M)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N M="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/B9N8G-P.SPO9F]N=#X\+W`^(#QP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@ M,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/DEN($YO=F5M8F5R M(#(P,3$L('1H92!#;VUP86YY(&5N=&5R960@:6YT;R!A;B!A2!P97)I;V0@96YD:6YG(&]N('1H92!L871E2!A8V-O=6YT960@ M9F]R('1H92!B;W)R;W=I;F=S('5N9&5R('1H97-E(&%R3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT M4&%R=%\T968X,C!E-E]F9#DX7S0Y861?83-E8E\X8CEF.#(V.3$U934-"D-O M;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&5F.#(P939?9F0Y.%\T.6%D M7V$S96)?.&(Y9C@R-CDQ-64U+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C:&%R3QB3PO'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$2!.;W1E($1I'0@ M0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X=#X\(2TM96=X M+2T^/'`@6QE/3-$1D].5"U325I%.C$P<'0^5&AE($-O M;7!A;GD@:7,@875T:&]R:7IE9"!T;R!I6QE/3-$1D].5"U325I% M.C$P<'0^)FYB6QE/3-$ M1D].5"U325I%.C$P<'0^3VX@4V5P=&5M8F5R(#(L(#(P,3$L('1H92!#;VUP M86YY(&ES2!I6QE/3-$1D].5"U325I% M.C$P<'0^)FYB6QE/3-$ M1D].5"U325I%.C$P<'0^3VX@3F]V96UB97(@."P@,C`Q,2P@=&AE($-O;7!A M;GD@8V]N=F5R=&5D("0U,"PP,#`@;V8@;F]T97,@:6YT;R`R+#8V-BPV-C<@ M3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\T968X,C!E-E]F9#DX7S0Y861?83-E8E\X8CEF M.#(V.3$U934-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO-&5F.#(P M939?9F0Y.%\T.6%D7V$S96)?.&(Y9C@R-CDQ-64U+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@ M("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0@0FQO8VM=/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$=&5X M=#X\(2TM96=X+2T^/'`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`[($)/4D1%4BU,1494.B-F,&8P9C`[(%!!1$1) M3D6QE M/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)T)/4D1%4BU"3U143TTZ(V8P9C!F,#L@0D]2 M1$52+4Q%1E0Z(V8P9C!F,#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/ M54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z-2XT<'0[(%=) M1%1(.C0U<'0[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B=4:6UE'0@,7!T('-O;&ED.R!"3U)$15(M3$5&5#HC9C!F,&8P.R!0041$ M24Y'+4)/5%1/33HP:6X[($)!0TM'4D]53D0M0T],3U(Z=')A;G-P87)E;G0[ M(%!!1$1)3D6QE M/3-$)U1%6%0M04Q)1TXZ6QE/3-$)T)/4D1%4BU"3U143TTZ M(V8P9C!F,#L@0D]21$52+4Q%1E0Z(V8P9C!F,#L@4$%$1$E.1RU"3U143TTZ M,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q% M1E0Z-2XT<'0[(%=)1%1(.C(W<'0[(%!!1$1)3D6QE/3-$)T9/3E0M1D%-24Q9 M.B=4:6UE6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@ M6QE/3-$)T)/4D1%4BU"3U143TTZ(V8P9C!F,#L@ M0D]21$52+4Q%1E0Z(V8P9C!F,#L@4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+ M1U)/54Y$+4-/3$]2.G1R86YS<&%R96YT.R!0041$24Y'+4Q%1E0Z-2XT<'0[ M(%=)1%1(.CDY<'0[(%!!1$1)3D6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R M.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQF;VYT('-T M>6QE/3-$)T9/3E0M1D%-24Q9.B=4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B=4:6UE6QE/3-$)T9/3E0M1D%-24Q9.B=4:6UE6QE/3-$ M)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ,&EN(#!I;B`P<'0G(&%L:6=N M/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B=4:6UE6QE/3-$ M)T)/4D1%4BU"3U143TTZ(V8P9C!F,#L@0D]21$52+4Q%1E0Z(V8P9C!F,#L@ M4$%$1$E.1RU"3U143TTZ,&EN.R!"04-+1U)/54Y$+4-/3$]2.G1R86YS<&%R M96YT.R!0041$24Y'+4Q%1E0Z-2XT<'0[(%=)1%1(.C$U,W!T.R!0041$24Y' M+5))1TA4.C4N-'!T.R!"3U)$15(M5$]0.B-F,&8P9C`[($)/4D1%4BU224=( M5#HC9C!F,&8P.R!0041$24Y'+51/4#HP:6XG('9A;&EG;CTS1'1O<#X@/'`@ M6QE/3-$)TU!4D=)3CHP:6X@ M,&EN(#!P="<^/&9O;G0@6QE/3-$)T)/4D1%4BU" M3U143TTZ=VEN9&]W=&5X="`Q+C5P="!D;W5B;&4[($)/4D1%4BU,1494.B-F M,&8P9C`[(%!!1$1)3D6QE/3-$)T9/3E0M1D%- M24Q9.B=4:6UE6QE/3-$)T)/4D1%4BU"3U143TTZ=VEN M9&]W=&5X="`Q+C5P="!D;W5B;&4[($)/4D1%4BU,1494.B-F,&8P9C`[(%!! M1$1)3D6QE/3-$)T9/3E0M1D%-24Q9.B=4 M:6UE&EM871E;'D@ M)#4T."PP.#0@9'5R:6YG('1H92!T:')E92!M;VYT:',@96YD960@3F]V96UB M97(@,S`L(#(P,3$N/"]F;VYT/CPO<#X@/'`@2!A(&-O2!A&EM871E;'D@)#,V."PS-S0@870@3F]V M96UB97(@,S`L(#(P,3$N/"]F;VYT/CPO<#X@/'`@2!P97)F;W)M960@82!C;VUP"!P;W-I=&EO;G,@ M:6X@86-C;W)D86YC92!W:71H(')E8V]G;FET:6]N(&%N9"!M96%S=7)E;65N M="!S=&%N9&%R9',@97-T86)L:7-H960@8GD@1D%30B!!4T,@-S0P+3$P+3(U M+B!);B!T:&ES(')E9V%R9"P@86X@=6YC97)T86EN('1A>"!P;W-I=&EO;B!R M97!R97-E;G1S('1H92!#;VUP86YY)B,Q-#8['!E8W1E9"!T2!R96%S;VYA8FQY('!O28C,30V.W,@8V]N=&EN=6EN9R!P;VQI M8WD@:7,@=&\@6QE/3-$ M1D].5"U325I%.C$P<'0^)FYB'0O M:F%V87-C3X-"B`@("`\ M=&%B;&4@8VQA'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/"$M+65G>"TM/CQP('-T>6QE/3-$)TU!4D=)3CHP M:6X@,&EN(#!P="<^/&(^/&9O;G0@6QE/3-$1D]. M5"U325I%.C$P<'0^)FYB6QE/3-$1D].5"U325I%.C$P<'0^5&AE(&-A6QE/3-$1D].5"U325I%.C$P<'0^ M)FYB6QE/3-$ M)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N M="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/E1H92!#;VUP86YY(&9O;&QO=W,@ M86-C;W5N=&EN9R!G=6ED86YC92!R96QA=&EN9R!T;R!F86ER('9A;'5E(&UE M87-U6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P M:6X@,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/B9N8G-P.SPO M9F]N=#X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%2 M1TE..C!I;B`P:6X@,'!T)SX\=3X\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ M,'!T/DQE=F5L(#$\+V9O;G0^/"]U/CQF;VYT('-T>6QE/3-$1D].5"U325I% M.C$P<'0^)FYB6QE/3-$1D].5"U325I%.C$P M<'0^)B,Q-3`[('%U;W1E9"!P6QE/3-$ M1D].5"U325I%.C$P<'0^/&9O;G0@6QE/3-$ M)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\=3X\ M9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/DQE=F5L(#,\+V9O;G0^/"]U M/CQF;VYT('-T>6QE/3-$1D].5"U325I%.C$P<'0^)FYB6QE/3-$1D].5"U325I%.C$P<'0^)B,Q-3`[('5N;V)S97)V86)L M92!I;G!U=',@9F]R('1H92!A2!U2!F;W(@=&AE(&%S2!A="!T:&4@;65A6QE/3-$)U1% M6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S M='EL93TS1$9/3E0M4TE:13HQ,'!T/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T M>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T M)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/E1H92!A2!I2!I;G!U="!T:&%T(&ES('-I9VYI9FEC M86YT('1O('1H92!F86ER(&UE87-UF4@=&AE('5S92!O9B!O8G-EF4@=&AE('5N;V)S97)V86)L92!I;G!U M=',\:3XN/"]I/CPO9F]N=#X\+W`^(#QP('-T>6QE/3-$)U1%6%0M04Q)1TXZ M:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N="!S='EL93TS1$9/ M3E0M4TE:13HQ,'!T/B9N8G-P.SPO9F]N=#X\+W`^(#QP('-T>6QE/3-$)U1% M6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\8CX\9F]N M="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/E)E8W5R6QE/3-$1D].5"U325I%.C$P<'0^26X@86-C;W)D M86YC92!W:71H(&%C8V]U;G1I;F<@<')I;F-I<&QE7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T* M#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O M;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA2!$:7-C;&]S=7)E'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M'0^/"$M+65G>"TM/CQP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@ M,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/DAE86QT:&-A2!F:7AE9"!F964@ M;V8@)#$P+#`P,"P@8V]M;65N8VEN9R!-87)C:"`Q+"`R,#$Q+B`\+V9O;G0^ M/"]P/B`\<"!S='EL93TS1"=-05)'24XZ,&EN(#!I;B`P<'0G/CQF;VYT('-T M>6QE/3-$1D].5"U325I%.C$P<'0^)FYB'0O:F%V87-C3X- M"B`@("`\=&%B;&4@8VQA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$6QE/3-$1D].5"U325I%.C$P<'0^ M/"]F;VYT/CPO<#X@/'`@6QE/3-$1D].5"U325I%.C$P<'0^26X@1&5C96UB97(L(#(P,3$L('1H92!# M;VUP86YY(&5N=&5R960@:6YT;R!A;B!!8W%U:7-I=&EO;B!!9W)E96UE;G0@ M*'1H92`B06-Q=6ES:71I;VX@06=R965M96YT(BD@=VET:"`F(S(P,3ML86X@ M2&5A;'1H(%-E2!A2`U+"`R,#$R+CPO9F]N=#X\+W`^(#QP('-T>6QE/3-$ M)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@,'!T)SX\9F]N M="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/B9N8G-P.SPO9F]N=#X\+W`^(#QP M('-T>6QE/3-$)U1%6%0M04Q)1TXZ:G5S=&EF>3L@34%21TE..C!I;B`P:6X@ M,'!T)SX\9F]N="!S='EL93TS1$9/3E0M4TE:13HQ,'!T/D5F9F5C=&EV92!- M87)C:"`Q.2P@,C`Q,BP@=&AE($-O;7!A;GDL($AE86QT:&-A2P@26YC+B!B>2!T:&4@0V]M<&%N>2P@=VAI M8V@@8VQO2XF;F)S<#L@2&]W979E2P@26YC+B!H860@<')E=FEO=7-L>2!T2!R96-E:79E9"!I;B!T:&4@ M96%R;&EE2!T:&4@ M0V]M<&%N>2!F2!O9B!T:&4@0V]M M<&%N>2XF;F)S<#L@5&AE('1A8FQE(&)E;&]W('-U;6UA6QE/3-$)TU!4D=)3CHP:6X@,&EN(#!P M="<^/&9O;G0@6QE/3-$)W!A9V4M8G)E M86LM:6YS:61E.B!A=F]I9#LG/B`\=&0@=VED=&@],T0R.#$@6QE/3-$)V)O'0@,7!T('-O;&ED.R!B;W)D97(M;&5F=#H@(V8P9C!F M,#L@<&%D9&EN9RUB;W1T;VTZ(#!I;CL@8F%C:V=R;W5N9"UC;VQO6QE/3-$)U1%6%0M04Q)1TXZ8V5N=&5R.R!-05)'24XZ M,&EN(#!I;B`P<'0G(&%L:6=N/3-$8V5N=&5R/CQB/CQF;VYT('-T>6QE/3-$ M1D].5"U325I%.C$P<'0^5F%L=64\+V9O;G0^/"]B/CPO<#X\+W1D/CPO='(^ M(#QT6QE/3-$)V)O6QE/3-$ M)TU!4D=)3CHP:6X@,&EN(#!P="<^/&9O;G0@6QE/3-$)V)O6QE/3-$1D].5"U325I% M.C$P<'0^-S@L,C4U+#`P,"`\+V9O;G0^/"]P/CPO=&0^(#QT9"!W:61T:#TS M1#8V('-T>6QE/3-$)V)O6QE/3-$)U1%6%0M04Q) M1TXZ6QE/3-$1D].5"U3 M25I%.C$P<'0^3B]!(#PO9F]N=#X\+W`^/"]T9#X\+W1R/B`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htm IDEA: XBRL DOCUMENT v2.4.0.6
Accounting Changes and Error Corrections
3 Months Ended
Nov. 30, 2011
Accounting Changes and Error Corrections  
Accounting Changes and Error Corrections [Text Block]

Recent Accounting Pronouncements

 

In September 2011, the FASB issued an amendment to Topic 350, Intangibles—Goodwill and Other, which simplifies how entities test goodwill for impairment. Previous guidance under Topic 350 required an entity to test goodwill for impairment using a two-step process on at least an annual basis. First, the fair value of a reporting unit was calculated and compared to its carrying amount, including goodwill. Second, if the fair value of a reporting unit was less than its carrying amount, the amount of impairment loss, if any, was required to be measured. Under the amendments in this update, an entity has the option to first assess qualitative factors to determine whether the existence of events or circumstances leads the entity to determine that it is more likely than not that its fair value is less than its carrying amount. If after assessing the totality of events or circumstances, an entity determines that it is not more likely than not that the fair value of the reporting unit is less than its carrying amount, then the two-step impairment test is unnecessary. If the entity concludes otherwise, then it is required to test goodwill for impairment under the two-step process as described under paragraphs 350-20-35-4 and 350-20-35-9 under Topic 350. The amendments are effective for annual and interim goodwill impairment tests performed for fiscal years beginning after December 15, 2011 and early adoption is permitted. The Company is currently evaluating whether early adoption is necessary.

 

The Company continually assesses any new accounting pronouncements to determine their applicability to the Company. Where it is determined that a new accounting pronouncement affects the Company’s financial reporting, the Company undertakes a study to determine the consequence of the change to its financial statements and assures that there are proper controls in place to ascertain that the Company’s financials properly reflect the change.

 

NOTE 3.  RESTATEMENT OF THE FINANCIAL STATEMENTS

 

The Company is restating its previously issued financial statements as of and for the three months ended November 30, 2011 to reflect the rescission of its subsidiary Organ Transport Systems, Inc. (“OTS”) in March 2012. The rescission of OTS resulted in the removal of all OTS transactions from the Company’s previously reported financial statements as of and for the three months ended November 30, 2011 and 2010.

 

The effect of the restatements on our balance sheet as of November 30, 2011 is as follows:

As previously Reported

Adjustments

Restated

ASSETS

CURRENT ASSETS

 Cash

 $            152,693

 $               (17,078)

 $             135,615

 Prepaid expenses

                 12,396

              (11,396)

             1,000

 Total current assets

            165,089

            (28,474)

      136,615

 Property, plant and equipment net

         1,792

              (1,792)

                -  

 Deferred loan costs, net

              4,425

                      -  

          4,425

 Patents

       372,201

        (372,201)

                  -  

 Loans receivable

                  -  

    1,884,150

    1,884,150

 Advances to related parties

                  -  

           5,000

             5,000

 Total assets

 $            543,507

 $            1,486,683

 $          2,030,190

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES

 Accounts payable and accrued expenses

 $            630,356

 $             (602,255)

 $               28,101

 Accrued salaries

       467,996

           (467,996)

               -  

 Notes payable - net of debt discount

      2,001,646

          (1,769,063)

      232,583

 Accrued interest

        302,674

          (129,319)

          173,355

 Total current liabilities

  3,402,672

           (2,968,633)

       434,039

 Long-term notes payable

           691,806

755,320-

  1,447,126

 Total liabilities

     4,094,478

      (2,213,313)

      1,881,165

STOCKHOLDERS' EQUITY (DEFICIT)

Common stock, $0.001 par value; 500,000,000

shares authorized. 95,069,482 shares

issued and outstanding

           173,325

               (78,255)

          95,070

Additional paid in capital

       27,324,277

     (21,502,566)

       5,821,711

Deferred equity

      (1,680,000)

                     -  

  (1,680,000)

Deficit accumulated during the development stage

    (29,368,573)

     25,280,817

   (4,087,756)

Total stockholders' equity (deficit)

     (3,550,971)

       3,699,996

           149,025

Total liabilities and stockholders' equity

 $            543,507

 $            1,486,683

 $          2,030,190

 

 

The effect of the restatements on our balance sheet as of August 31, 2011 is as follows:

As previously Reported

Adjustments

Restated

ASSETS

CURRENT ASSETS

 Cash

 $          38,320

 $         (16,348)

 $        21,972

 Prepaid expenses

      12,396

         (11,396)

        1,000

 Total current assets

         50,716

      (27,744)

     22,972

 Property, plant and equipment, net

2,558

(2,558)

            -  

 Deferred loan costs, net

4,700

            -  

4,700

 Patents

    363,561

       (363,561)

 -

 Loan receivable

            -

           257,653

257,653

 Advances to related parties

            -

               5,000

5,000

 Total assets

 $        421,535

 $         (131,210)

 $      290,325

LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)

CURRENT LIABILITIES

 Accounts payable and accrued expenses

 $        585,240

 $        (578,195)

 $          7,045

 Accrued salaries

          393,821

          (393,821)

                -  

 Notes payable - net of debt discount

    1,827,868

   (1,763,290)

      64,578

 Accrued interest

    216,389

        (206,425)

          9,964

 Total current liabilities

 3,023,318

(2,941,731)

     81,587

 Long-term notes payable, net of debt discount

      499,072

       (499,072)

                 -  

 Total liabilities

    3,522,390

 (3,440,803)

           81,587

STOCKHOLDERS' EQUITY (DEFICIT)

Common stock, $0.001 par value; 500,000,000

shares authorized. 61,825,039 issued and outstanding

 140,080

        (78,255)

        61,825

Additional paid in capital

   26,535,284

(21,869,546)  

    4,665,738

Deferred equity

     (1,680,000)

                  -  

    (1,680,000)

Deficit accumulated during the development stage

  (28,096,219)

     25,257,394

 (2,838,825)

Total stockholders' equity (deficit)

     (3,100,855)

       3,309,593

   208,738

Total liabilities and stockholders' equity

 $        421,535

 $         (131,210)

 $      290,325

 

The effect of the restatements on our statement of operations for the three months ended November 30, 2011 is as follows:

As previously Reported

Adjustments

Restated

REVENUES

 $                    -  

 $                    -  

 $                   -  

GENERAL AND ADMINISTRATIVE EXPENSES

Payroll and payroll taxes

           286,535

       205,443

        491,978

Research and development

            12,168

          (12,168)

                      -

Professional fees

           518,123

             (7,580)

      510,543

Travel and entertainment

              1,393

           (468)

          925

Rent

           7,052

     (7,052)

                     -

Insurance

               2,184

    (2,184)

                     -

Office expense

        607

              (607)

                  -

Telephone and internet

                375

               (375)

              -

General and administrative

        1,384

         (892)

           492

Depreciation and amortization expense

            766

       (766)

                  -

Loss from operations

        (830,587)

        (173,351)

    (1,003,938)

OTHER INCOME (EXPENSE)

Finance cost

                    -  

                  -  

              -  

Interest, net

       (441,767)

     196,774

 (244,993)

Net loss

 $   (1,272,354)

 $          23,423

 $  (1,248,931)

Net loss per share (basic and diluted)

 $            (0.01)

N/A

 $           (0.02)

Weighted average number of shares outstanding during the period-basic and diluted

   136,507,915

N/A

                         67,112,080

 

The effect of the restatements on our statement of operations for the three months ended November 30, 2010 is as follows:

As previously Reported

Adjustments

Restated

REVENUES

 $                     -  

 $                   -  

 $                  -  

GENERAL AND ADMINISTRATIVE EXPENSES

Payroll and payroll taxes

             186,778

(186,778)

                     -  

Professional fees

               25,430

        (20,480)

         4,950

Advisor fees

             225,000

        (225,000)

                     -  

Rent

               17,064

       (17,064)

                     -  

Office expense

                    417

          (149)

        268

Telephone and internet

              791

        (791)

                     -  

General and administrative

                  951

           (876)

             75

Depreciation and amortization expense

                  950

          (950)

                    -  

Loss from operations

      (457,381)

       452,088

   (5,293)

OTHER INCOME (EXPENSE)

Finance cost

                        -  

                      -  

                     -  

Interest, net

            (9,403)

        9,403

                     -  

Net loss

 $       (466,784)

 $       461,491

 $        (5,293)

Net loss per share (basic and diluted)

 $             (0.01)

N/A

 $          (0.00)

Weighted average number of shares outstanding during the period-basic and diluted

     52,170,000

N/A

   52,170,000

 

The effect of the restatements on our statement of cash flows for the three months ended November 30, 2011 is as follows:

As previously Reported

Adjustments

Restated

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss

 $        (1,272,354)

 $          23,423

 $  (1,248,931)

Adjustments to reconcile net loss to net

cash used by operations:

Depreciation expense

                  766

      (766)

                  -

Stock based compensation expense

            451,043

      366,979

           818,022

Amortization of deferred loan costs

                         -

            275

                275

Amortization of debt discount

          209,256

    (166,628)

        42,628

Interest accrued on notes payable

          86,561

      76,830

    163,391

Increase in prepaid expenses

                     -

              -

           -

Increase in accounts payable

  

  

and accrued expenses

      45,116

 (24,060)

   21,056

Loans receivable

                     -

(179,371)

 (179,371)

Increase in accrued salaries

          74,175

    (74,175)

             -

Net cash used by operating activities

          (405,437)

  22,507

       (382,930)

CASH FLOWS FROM INVESTING ACTIVITIES

Purchase of property and equipment

                     -

                 -

                  -

Investment in patents

               (8,640)

          8,640

                -

Net cash used by investing activities

             (8,640)

         8,640

                 -

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from issuance of common stock

                            -

                    -

                    -

Proceeds from notes payable

           528,450

     (31,877)

       496,573

Payments of notes payable

                        -

                 -

                 -

Net cash provided by financing activities

           528,450

     (31,877)

      496,573

Net increase (decrease) in cash

        114,373

         (730)

        113,643

Cash and equivalents, beginning of period

             38,320

    (16,348)

           21,972

Cash and equivalents, end of period

 $             152,693

 $       (17,078)

 $        135,615

Supplemental cash flow information:

Cash paid for interest

 $                         -

 $                    -

 $                    -

Cash paid for income taxes

 $                         -

 $                    -

 $                    -

Significant non-cash investing and financing activities

Notes payable - officer debentures

 $                         -

 $     1,408,579

 $     1,408,579

Notes payable converted to common stock

 $             160,000

 $                    -

 $        160,000

Common Stock issued at par

 $               12,467

 $       (12,467)

 $                    -

 

The effect of the restatements on our statement of cash flows for the three months ended November 30, 2010 is as follows:

As previously Reported

Adjustments

Restated

CASH FLOWS FROM OPERATING ACTIVITIES

Net loss

 $           (466,784)

 $            461,491

 $           (5,293)

Adjustments to reconcile net loss to net

cash used by operations:

Depreciation expense

                    950

          (950)

                      -

Amortization of debt discount

           33,130

     (33,130)

                     -

Increase in accounts payable

  

  

and accrued expenses

           243,326

   (299,535)

      (56,209)

Increase in accrued salaries

          169,333

  (169,333)

                     -

Net cash used by operating activities

  (20,045)

      (41,457)

            (61,502)

CASH FLOWS FROM INVESTING ACTIVITIES

Investment in patents

    (22,945)

       22,945

               -

Net cash used by investing activities

           (22,945)

       22,945

                -

CASH FLOWS FROM FINANCING ACTIVITIES

Proceeds from notes payable

             30,001

           (30,001)

                     -

Related party advances

                      -

       61,503

          61,503

Net cash provided by financing activities

               30,001

        31,502

                  61,503

Net increase (decrease) in cash

             (12,989)

         12,990

                   1

Cash and equivalents, beginning of period

           17,647

      (16,632)

              1,015

Cash and equivalents, end of period

 $                 4,658

 $             (3,642)

 $             1,016

 

The effect of the restatements on our statement of statement of stockholders’ equity (deficit) for the three months ended November 30, 2010 is as follows:

 

Accumulated

Total

Additional

During the

Stockholders'

Common Stock

Paid In

Development

Equity

Shares

Par Value

Capital

Deferred Equity

Stage

(Deficit)

Balance - September 24, 1998 (inception)

                    -

 $           -  

 $                    -  

 $                      -  

 $                    -  

 $                   -  

Common stock issued for cash

47,170,000

    47,170

     (41,720)

                -  

               -  

        5,450

Contributions-noncash expenses

           -

        -

      138,600

                 -  

            -  

  138,600

Common stock issued for cash

    5,000,000

    5,000

      45,000

                  -  

               -  

    50,000

Net loss for the period from September 24, 1998(inception) to August 31, 2009

                 -  

             -  

                -  

                   -  

     (340,716)

     (340,716)

Balance - August 31, 2009 (restated)

 52,170,000

   52,170

 141,880

                   -

    (340,716)

      (146,666)

Contributions-noncash expenses

                    -

     -

     12,600

                  -

                -  

    12,600

Net loss for the year ended August 31, 2010

             -  

     -  

             -  

                -  

   (22,365)

(22,365)

Balance - August 31, 2010 (restated)

52,170,000

52,170

154,480

-

       (363,081)

       (156,431)

Common stock issued for services, $0.42 per share

    5,000,000

    5,000

     2,095,000

     (1,680,000)

               -

          420,000

Common stock issued for services, $0.42 per share

  3,000,000

3,000

1,257,000

                  -

             -

1,260,000

Converted notes payable to common stock, $0.36per share

 927,666

    928

      458,454

                 -

            -

    459,382

Converted notes payable to common stock, $0.36per share

      556,600

 557

     275,072

                 -

              -

  275,629

Common stock issued for services, $0.724 per share

     77,624

  77

        56,122

               -

              -

    56,199

Common stock issued for services, $0.724 per share

     46,574

   47

     33,672

                  -

              -

 33,719

Common stock issued for services, $0.724 per share

       46,575

   46

     33,673

                 -

              -

       33,719

Issuance of notes payable-beneficial conversion feature

             -   

       -

  145,833

                 -

             -

   145,833

Additional capital contributed

                -

        -

      156,432

                 -

              -

    156,432

Net loss for the year ended August 31, 2011

              -

      -

               -

                      -

    (2,475,744)

   (2,475,744)

Balance - August 31, 2011 (restated)

   61,825,039

 $ 61,825

 $     4,665,738

 $     (1,680,000)

 $   (2,838,825)

 $       208,738

 

Converted notes payable to common stock, $0.01875 per share

       2,666,667

     2,667

                       47,333

                                   -  

                                -  

                        50,000

Converted notes payable to common stock, $0.01035 per share

                 4,830,918

                 4,831

                       45,169

                                   -  

                                -  

                        50,000

Converted notes payable to common stock, $0.00675 per share

                 8,888,888

                 8,889

                       51,111

                                   -  

                                -  

                        60,000

Common stock issued for services, $0.57 per share

                    391,304

                    391

                     222,652

                                   -  

                                -  

                      223,043

Common stock issued for services, $0.057 per share

                 4,000,000

                 4,000

                     224,000

                                   -  

                                -  

                      228,000

Common stock issued at $0.57 per share

         234,782

  235

   133,591

                   -  

                 -  

        133,826

Common stock issued at $0.057 per share

    2,400,000

    2,400

        134,400

                    -  

            -  

        136,800

Common stock issued at $0.0098 per share

      9,831,884

9,832

       86,521

                    -  

                -  

         96,353

Issuance of notes payable-reissuance

                  -  

            -  

      154,074

                   -  

                -  

          154,074

Issuance of notes payable-beneficial conversion feature

-

-

                       57,122

-

-

                        57,122

Net loss for the period ended November 30, 2011

                             -  

                       -  

                               -  

                                   -  

                  (1,248,931)

                  (1,248,931)

Balance - November 30, 2011 (restated)

    95,069,482

 $ 95,070

 $      5,821,711

 $     (1,680,000)

$(4,087,756)

 $       149,025

 

XML 15 R2.htm IDEA: XBRL DOCUMENT v2.4.0.6
BALANCE SHEETS (USD $)
Nov. 30, 2011
Aug. 31, 2011
Nov. 30, 2010
Current Assets      
Cash $ 135,615 $ 21,972  
Prepaid expenses 1,000 1,000  
Total Current Assets 136,615 22,972  
Deferred loan costs 4,425 [1] 4,700  
Loans receivable, net 1,884,150 257,653 0
Advances to related parties 5,000 5,000  
Total Noncurrent Assets 1,893,575 267,353  
Total Assets 2,030,190 290,325  
Current Liabilities      
Accounts payable and accrued liabilities 28,101 7,045  
Notes payable 232,583 [2] 64,578  
Accrued interest 173,355 9,964  
Total Current Liabilities 434,039 81,587  
Long-term notes payable 1,447,126 0  
Total Liabilities 1,881,165 81,587  
Stockholder's Equity (Deficit)      
Common Stock 95,070 [3] 61,825  
Additional paid in capital 5,821,709 4,665,738  
Deferred equity (1,680,000) (1,680,000)  
Deficit accumulated during the development stage (4,087,754) (2,838,825)  
Total Stockholders' Equity (Deficit) 149,025 208,738  
Total Liabilities and Stockholders' Equity (Deficit) $ 2,030,190 $ 290,325  
[1] Net of accumulated amortization of $1,075and $800
[2] Net of debt discount of $142,917 and $128,422
[3] $0.001 par value, 500,000,000 shares authorized, 95,069,482 and 61,825,039 shares issued and outstanding
XML 16 R6.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENT OF CASH FLOWS (USD $)
3 Months Ended 158 Months Ended
Nov. 30, 2011
Nov. 30, 2010
Nov. 30, 2011
Net Income (loss) $ (1,248,931) $ (5,293) $ (4,087,754)
Capital contributions-noncash expenses 0 0 151,200
Stock based compensation expense 818,022 0 2,898,174
Amortization 275 0 1,075
Amortization of debt discount 42,628 0 193,533
Accrued interest payable 163,391 0 173,355
Increase in prepaid expenses 0 0 (1,000)
Loans receivable (179,371) 0 (437,024)
Accounts payable and accrued expenses 21,056 (56,210) 28,101
NET CASH PROVIDED BY (USED IN) OPERATING ACTIVITIES (382,930) (61,503) (1,080,340)
Additional capital contributed 0 0 156,432
Issuance of Common Stock 0 0 55,450
Proceeds from notes payable 496,573 0 1,009,073
Related party advances 0 61,503 (5,000)
NET CASH PROVIDED BY (USED IN) FINANCING ACTIVITIES 496,573 61,503 1,215,955
Increase (Decrease) in cash and cash equivalents 113,643 0 135,615
Cash and Cash Equivalents, at Carrying Value, Beginning Balance 21,972 1,016 0
Cash and Cash Equivalents, at Carrying Value, Ending Balance 135,615 1,016 135,615
Interest 0 0 4,500
Income taxes, net 0 0 0
Conversion of notes payable to stock $ 1,568,579 $ 0 $ 1,867,074
ZIP 17 0001080602-12-000022-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001080602-12-000022-xbrl.zip M4$L#!!0````(`!LPZT"2X\3,*GT``.2."@`4`!P`86QZ;2YO8BTR,#$Q,3$S M,"YX;6Q55`D``]5._4_53OU/=7@+``$$)0X```0Y`0``[%UM<]LVMOY\[\S] M#]RY]];)C&7S36])TQW%CEO/)K9K.^W>_=*!24C"AB)4@I2M_OI[`%`2*%$D M14*RDW9F.^N(Y#D/SCL.0.+[OS]-`F.&(T9H^.[(.C&/#!QZU"?AZ-T18;35 MZ[7[+>OH[S_\UW]^_[=6R[B)J)]XV#<>YL:'\Q\'MRPA,388'<:/*,+'QL"? MH9#?<$8GTR3&D7$9AG2&8N#`CN$?WLDQ7)O.(S(:Q\:KL]>&;9J]EFU:EM%J M<3Y/#U%@`+"0O?$Q>7?O@X[\^G5R_%W=9EF.F]RRO/SX^G@B2-!K!3:9S2D(6<^P+:D^,9.Y^=!;W M6J?__/3QSAOC"6IM/!60\$O>W;MR9Q<,O/R"VH@Q7R0[X$]8: M(31=/C%$[$'8>*R5_347IOYU1>/`*=_L?W?#!OF!#9 M+1X:0@YOXOD4OSMB9#(-.&KQVSC"PW='*/AC$19' M*(ROT*08Z2`(\!\4&Y^P3SP4&#_1@#LVXTXH&>617.-W!C`B%%R&/G[Z!YX7 M,C3!,\R>V3%ME?P:A27]LR2*^!@)`W#_AU%41?JM%L0*QY+TMU%8'P*=3&AX M%U/OR]T8@A2[3F+N*5P81A(2R4E>.LIPOUR$#A][9`(*@I^N+HY^Z+?-3M_M M98=9P&4-T`4)<'0&0$XU;/*51S/'RL(K"N(<1HR'V+QE+ M0!S5Z6^AL.'_*QNZ@%^*1P`1P,[Z_MK36ZC+"%%._VZ\F@E;3KMCM;\_5V^EV[@.Q-A*>(^!^>ICADN`YP MB#(K^EERM3GE#J4RIP%C.&:II]3212>CBPR]NISRM6-GM+.=T3D>8OC5OR`A M+RG.*(O9%5YG2?QW1^D3OVUYXK=TT+\1OYHP7-=61+&%:@VL5<3C=E6-5^'] MD:*0W6(/DQEZ"'`IVWS]]WJNU58X;U)MQ#3?%-K=3MNIS/,\P1<1G=SB`!*- M?X,@&6!V14.OMM6W,^Y50E\?EEQAU,WVEW-_Q?"\-\U7>ZCJKZ M"OQJ#,LV'=/JF^ML=B:>/X2^Z=@;(LO2]CP*M06[07-NT(/0AU^B!/L?"7H@ M`>%*K3.LGF5:"N,*7#3#RA5(UW3;#5!=T1@O[BX(\NIM.T=V&S364\Q.)585 M3!51=-QVMU>!S260@CH]KL0IWW.[CM-6Q+Y&L3ZWW''U^QVW&B]%R_6K$M=Q M3:>O)(@-HHUXY@ZQ9[5[W>HL:3BZQ]&DNKWD:]%UNY;=45/A)MV&C'-':^[" MLE'0@@K#LCKM7,G68[.C^K)3B]54^1<4)$4!9_W6G8,.3-6[BIS7Z>V"JU+L ML7IJ6BID-_!]PMNB,+>#B<5E>(:F)$9!G5*J9UM=4_'5+:2;L\\OFSN==M?I M[<9^45WSA@;,J$2#^,/O"]6;LJXI3.^=B,=MMMYV9X97ROXGH$#,FLO`%;F*F M;1P@2!40*D5)B1$*>,LH; MSB7R[JLAJ9"')C15;?X`6(JU`Q/26J*YQ2CXP&+(\)S=44M3?H-N); M/99KY5LB]%Z[W:_.^SH>XRA5@I[A9.U.3RNW8GE:MCI3V\[N<[QH M??"%!RV2S)*LRZVJE6KA5BS+3J:/7<#P>HHCQ->OFUNFVU=6T#;H-N!:*%=U M?4`CTY*JHV"8AVH_>5*$/A49:JE M$%$&OTZT/L>JXM;&L22[V:9=D:F(*KS<:!Q"0`A.7YV+KY.NS[=0O&V[[^R! M:;&$G0Y?,>M4Y'L9>G2"/U+&^!+L&;`A80*6GH8>&C80>VM#[N7<=((KU$TK MJYR#(BM68&M#@SN"NT%S[E/L>BBW4L"=^FJ:;<2;(Z@:J?:&H$0MEN.X?7=' M'*ME0^(7;QPI=\] M>L+L'/Y@,?&:!#7;[?4=:Q?OW`KC(,/1&P:?=2PEQB-76'8*G+L,1USGAJ@E MD*[1K,VONO]JX5>Y/5W$C[?Y2,SUHM,15U3K,-O%31IQJF3$;BFS#R@*^>L% M-S@2&^#?(T8\*//.29#$6-4A\Q?W["9@\R13JQ?STXZM6!^`S:R'[5?,WX3" M_F`&,6"$KY+)`XZNAQLO$6S%O,N;"YVN9=EF3X%:D_TAAK!M$F-ULZOL.H8@ M%OO$RP'I(K#<;R]V;0P\F!8R4KF,-OEBXV^>V/O!.-V;.'#RC" M8Q@3F6$B,MC+'\4AS5TZ>3[,O*BRJY-F`DUE#`=`7M596Z[5M5_H&/;FML^C MD;WX[G,,)<\5[)[=VQ=:X?FBN:TGO;:K>.V*Z;X@5G51]X7@W6\6W:^H]YB#`>\Y\^Q?X'G/=OL$?RIB%ERZF M_]D]X'K27,5`D0_A8".HZIN6W:D:^IYY1/O-D\^MKOUETN<=V?,8G(P99=`; M9N.JH>L%#$-WIGX!0]IS+G\!(]QGMG_^X>T3^L#_=\)B80#W=,MK<6+5]0GL\S%#7P;=&H:,=0_/P MH%\L-1RUY705]M8W%;I=^0<9W:6Q]W#66R1E$T MK&BU(6ED`;N]`UW1^O;U5OJ.!5O;=3?6FS1CT31QTRTA'1%R#\!R-KRU.ZZS M(U-MO9W%?BRKU*I[E3N M?@VNC_L+::'JJ6RU(6ED`34^(UEN??OJP^UF@QN?Y=T'&+W]'=V2JA4KUS\@ M>]BVIOH*;/'K24Y_O??Z8II(F4%4ME=NL/97,:1O;`?HFKZ^I79F\:?.:D6%E]T,.TQ4>#$C_/:ZF<7Q0;=3':2O4SEF?*7] M&PU!Q8;;^YUO;OA_YFZFSCCU-4EA3]W,C#@WNYF%8?,@WE6]3U4G'NKHCS4M M=[1C>!G=S,:.NOFA+=VP&K'Z]FUD_5FY\@K($&02U""-^-I;\_\MP M^='W\@/B=OK89`D;G:AV^"3EX5"5G!+1MFRS`30(#OQHCNNAT/<@]']%483` M>"]H=(>C&?$PNX[.`D0F#?)BS^J9MA*9=F*[)\"5E?W\6,M.7^CWK*ZK`_&J M`H<[!Q,*A?8?#7NG=C=WO\(:?0THJNISCQA*7-6L(0KEPO60SWC."1-G-M]$ M>$*228.FMMVQU;,XRSAIQ%5958?#5**ZOM-VG+K`-F/RVJ',C3ZP;G6)*F5,]"&JK\8](2H[U\`L+GP*4'VD M*&2WV,-D5FY&VSXPG#F6>YU>B1`&GH@6BR.\[R/D-S`7VS+7OAY?@9UNA"7? M(>\`R&>&6'J(E5D81DL1@MK/$!O?1'1&?.R_GW^&R:!2@`^\F,S*SDPOZS`Y M/;OO9%MM%9GN`VNQTCM6VW1>"-328-(S';>Y7&]0%(?\O%4YV4IMY@R01.0A M$7T"+6FA`A^MN*H?'<*PF56>B$2:F5GI46<9% M(Z;*:CPR7S\:@"TN,7%[:\14J;BTC/A/&DES8+BFLRS%N29[+\\9T M5$+KKEB=YSZ@[J+U9T5:=NBPU>ZKD^*:6,4S8L_3NODT:'183D?=A;F=APXH M5>/O7E&4*,MI@V75@C((??Y_?&%GA@*^6#4`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`-NG^S8@&&?'!M#&DUP%,P-"&4A_,,W/J$0C3#?FG%L?(S]$^,5I&'C M.S29OOUOR^V^Y:_MH'"^^*'W]O6Q\8B8P??615,:(7EFJ8\C@S\8H$=FT*'X M6X1+_H]S##_SR$Q#XPY/(:<_P.VV>VQ8_7[/>"3Q6#R`5B%*;L`TQ`Y,3L)N M'T/HX?\98N\A,U!L_(^(U\841<:,!^43@3)\8-.WJ[^N0QACY(V-_K%AFV;W MF#_)N0W",`$1_8A#T&P`(L-\J8,S4[<#&LBXQ8P&HF,N1HZFTXC.`".1EL0? M6D,O(!KIKDTCID9;8A?X%T.3PQ"#1ZLQ@>A9@F#"*[:CHB+#&&8R:M4(0J:A#XM\P$JN&!C,""^2V*97(# MI_"3#%,PNH4U!P0]D$`\>0)R"!G^/0'+#N;'!D`7W@AYDA&(H7`W,'W``@Y+ MHAD1-@EWDQAN7X;_A33!6+&4&\<:>D'B\]0!8^-W#64W%@6IT4NQ`DO`+P:V MO,YX_A&;TT]`O#(+".W9Q\:8/H([1EDU^A@FG]R+`?`XS1*JUWJ4Q=*G8S+! M')UZ=1%R.!;%O80_,S(*R1`\CTO(&$':B$7"!%N`E#$"R`'\#G+''A!8M M'U0N>DD4"8,%D7!;2U4)0WB8&^\)/4L><.J6"\V":Y%PF'*%P8Q7@A\B;^D- M'/N80.D2B5"[:;!3^`-8BQ(""(.H;K&(!F,TPU)#O"\;H/J*A88IN!]\-QT MD8E6@4.DAD>:!%#"A6)C@1('IG+M$.8-`$4*@V&\"E'R)^.G9`*A_P8F"$%` M)VA&(@ANKR"LO9:A=P*99CE1P$^)"-4B^DY(+`/'4(E^4!6@1%:YGGCE`8*- MQ[>+1%QPQN)U,HZ)#H=8%,$PWHK-)H MNI^)?VZ"@A8A\-[#G/Q]P.>+S2;HVCS@/A`)H9+[F_P*/`>>2064D^P>BE/)X<\-7 M'X"``CBGO(6U+.[;;W\<#&Y6Y<]K$8Y(:A1Y0SN&JS!%2]+9'KC6!011PS); M/TNWO<4C_A(DMZ^[UC__FLEM`02Q<++L=ZGU)V\$I+,=*!=7GV8P7HE)#).= MH5#672'(7E1SO(04:6;UP&MUUA-"RF.,5]!I]"[9RQK>MAC]=IW\7O6E*67;_$B6:TOK9NG\2K39U'D] MX\J1-:8P)9@IKYHFOOCBU4:G0#ZSZ%VD*4Q4OFE7!\0!I1!M7>H MNFUW;\J`%I'T#,(ZB0T^@+_<5?\\<8*@"H+_F.CD\0T@HN*"4BS\`OX%S@S" M3ZLKY8J<#?(6$^0&[D=LT0:_P+YHR9^GSUZ&8'&B=CM;M5&-5Q?GEV>OH4RG MHPA-1"<,=)V?%`?)"$1@.%9>'Y@WV$)(?"C@/`0*_,2S):*WY9ETE2%= M*<\N<*C%"J\*\N&L-+Q,X^GR(G\5.%.BR*>%G$3]#Z%.79I8BD5TS"M'0)`Q MK_)A$B!BFYR$0&RV3/-_Q:)VNL89!/11Q%Y>[BR^*F3$Z&DIG(B(7IQ8M0AQ MO)BXP$\@4R8"JFC;^U4+E3^]MWU"7T2S;VGO6[P"/^'((RRS4F7\._%'_(83 MXS+F"SI@K##K!-WS;0^4]S[G!N15QC]0N%HQ6QI1:L]8.I.HJ\$A9"OR&!C% MJ6&`-3`L;O!(Y/T_>]_:G#BR9?M7,N+VO4%%I!F]):H_T2ZJFS@NN\:F^]SY M**/$Z+20:$FXVOWK)Q\2"`-&/"128L=,]*$,"&GGRKU7[N=BQL*FS'KR*Y*_ MZ>F;P:G<1L$9&2@\7>%`3D7)%,HB"X4RDK&\VS'WZ(ZG;LB9._^%D!Y4$0N\ MT4W$/9I12-CMSB(6\EGP@`)34CX+S5$IOXI@8Y^[B.A?6#14N)3212'^(W[* M\YD'%X7R[5?O*];FE+Y*7ST_/;N0AW/;:9/0+7.X7G`.Y]?NZ= M;Y.$^\"F_LN4(C+PJ="]S/LH+-%\$=--PA(,LM2E&?/9,QO-MV5,6/0B3*JBR1W!7$V3U9KN#7'9K1)IM]_;[=?]T/#))^%D"5DNW8`\T-Z)OF'9`

1ZCR,S_0&]?H?8= M;@:35J'`E(_D\A.?=K_^F759;8]N_P1_*2_^V8W7:0B(\?S7WT>[V#G`M'8,[^:^^KZ`0_$4TM33!S.4WB? M1>;8#T*-&N>2KW2O4Y87+OB^Y@>U8DYN,76O<'H2J@XSQ4&/./E?!;T5Y\*0 M\6'FQA5\SO-9VO`K)=4L5)1E!WUA?Z0W01\7O=`WDYP@L]P%:GF77UI>B5UZ ME4&XGAG]T9UF9S&>@"@^G9UQJ6'^D35)Q&BQ3&!F"0I4][UEGYZ1=$HOTJ'2 M6WTF%YWX"%7EV7&N\*L\+2[+5A,L>BGF/'6;G;>768$K0L'Y+Y=I?AIAW]EU MZY^$;WR\:I).?_YR=-?J7B`_N3F^R3]%WQN.OK(U::)(SHE3987K=D9EP_B4<&(O5"7P]FN`&292%%-8??XWG[3.%>PS;9DW/ MQCR1!_ZPU)P.N:^2RO<[M?29-97.,!;4-%M07FUPPY\)%1\*#CGGY[>N%W&/ M(=]$+%4KR2,[S)0B:A21K3HW&MTHHI?/VMBB/DG>K+ M=^#.\U;6+\*5-?M4_G;N.7EARC-7/PG73#$91R^B;H*JBC45DQD5\41NN+HW M?^E*RG)4>=X;JT]@'7>SR(=PIN1:B]\.T[]9.AO]TRM)UMR1:[';51X$%\2- M>-IB&W(>X-STX2X2X>O)S=#2`FZ[1+XB:_K+CRSD)EPN%%+5GZPK#QH MY4QZ;P:Y"+W%6!"\1CEI(6K.IHV)FL1)[7 MX91N>Y>$\Z>4U,=+LG:K628H/]VFK$'#MHS30K@S61[SV1??$4LA&,0;/;SC M)$(112O959^CS,(L<_M\^@Q"ZXJ0!N$^MF>2_F`&X^.0)OVM M59[MUA_-,J`R;*X2"D7TA5^`A&3BI]EQDD+9?UT>)NG;W%3D/Y:Y),>L<TM@4X>8G6),ACR('_)PG\:13Q MHCRZ2X*\O_YVN4N9$7()VCZ)F$AYJ(X5IR54WWB+@.R$Z_:H-=[FL/TLK8Q3 M[LK:<@/N@KF(EO\QU*XQI]_YY>'QR^#QYO;A[J[__6GP>4R%YLX3(KZ+QB0( MYJP")'S)+J<4WDGHUMUX9W4K\=I]?.__.KCYY7'0_]?-\/YI^&7PV7V-?._] MEUB$P$NGV91B-'KY]_C\3A?W?\EGN!E]'JS]^[W_Y,KS_ M-?\P70/ZP?[MOWY]?/C]_@M[\(?'S[PXAN7QA^GJ&_PZIA#3OX=?1K]]5DU] M7OC`X_#7WY:?R'Y\]/!]XX;$YS;NB'V4WD[V?%03^"]A]H!I-'\GEW.`ZFO_ MV_#N?SZ+O-81#XWJ1:@'(U=(G:>L+-7W:ECF7D^.92[8OIB%%79;/E2\+/]L M_8#8L(G'X4*W)-KPFBT=$L:\2J`D%,2'FZ@`Y<>OBJ4R^HBMZ5Q`(T M2S6\X\7[,2%>QD`2KX-+W&_DX>[RE`);;.8*`UL$D[`#$#]MS>ZIX14RL.+8 MV#8M8*K`5"MDJC6RBDLR5,]_/4D[L[Z!BQD+0I$-J:CS]\_-Y;3^F$)TJX?\ M\"?%5[;^)ONN6@3)%IRO/]S:9385<=FGY`^PN5T.?_*U'RGWP*MEEM\ZH$N9 MC(]?:=BP36P;QD>JA.X2..Q<,Q7^NAE5=.G9V/B_EP?PV1D6G.):!=TZ3G'U MK2PNNSL\V?DRF; M/ED8V)J_9?V,XD5`/N7]%?A`L-`-T*/HX,V:]A%<*']VBZW[V,"\.)GZ\PP, MA69\B/6@9'7VO'ME-K>BT&,ONVM^TW>KCZPN\(FABC7G$=/;V%`YAK3B0^1] M/#<;=&/60>+^X0Z_JZ]?-O9^)I,HJZ1__Q!P_+U@OZ\ZRM1MO_!<$RR[D63^8U5+TZ5/Y8UY9/:(7Z2\OLEJ23^\GI7CL M6=[?1=8(NC#?,VM-SN>&9T/566.`]&Y/AIG?4X'1>UR"B5K\Q23*1L#^+HMN_>VW MP3HIB?%%R:[Y8G-1^&)H4-!YN41XX;Y[EY= M44QT7GVW^$'>`RL?-92UK.+M,$1?+B$;,4\O;W6R[,/%.GT41^8NNT6)2>[O M.A!Z$1&_(FXLFV:TV9T^[[*>:9LD5W"K'FQBH`*33]Y\Y&VCZ?$N/.1C23>W M]JZ.9H7&BG/1I=!/1-N0K!6;&$,HAIH2-@V8KPD5D1OP5BSY'&XQ(CL7(GV4 ME'4\]<,MHI6O!?:.&UKU!OJHM\]:$Z"OKA^SH#99?;"V@:"'-[UB=\MC\+R5 MR:KI[W#59WU3--!;ZUB[PDTXIU&K&2X[-&8RI>KFAH]\6.]/GBT++C35739M MFKMOG%GP/H39MEWO8+0B`\7N6AF7$,V8`C?C+OP6"LUTE_WULQY(O*/@\H:: M0AZJWD3?5O86QC?5Q-/$^20I-B1[6?B"%`E`LW-H5(1\@19Q2TZMWO(K*W*4 MY,-2Q9>F/CUEQ.-I-GM[3G<&:^/X#TFR1IOSA9@XNCHP\PF*_E]L&!+O!LKV MD?CIXH7YP'!Q2`[8($/>0BI[J@,:1+4"`8N#[^R.B0QMZ1AP^*4^>,C#KB&Z M\[*_L5:%,>]OV%F$8D(O\3X)ZLZ[@8JNI5G+/8_U&&2GN:R5&)M=4FA\MVSJ M6CRB\!:H&5-D3;G&?-*?NS0OQ2,`Z[[;&/YU841I$B(JTS%1UD^3'LK6,;8< M>\;."508V=[(QLE1K>/YE-JG;(#T,VN\R?G"LC%RPN=?Q863!V\#N>T[^5&# MGC[CZ#EWR?#32>%364=>BCJW8M0=L3+;/LQ_^LO@]N&Q/QH^W']F-9#E$+L= M)U(`>4OV]<6!O`@+,,E0_1$.V(<<*Z8 MC/SVT24S37KMVK'T#?6WN`S?CYWE$QB*4[JXWLD[E[K+[J:%^92'-+R^+H&/ MMN*V>$K<3F@%A\PMP+M.RBL.Z[_KVT_))G/OB"]G4V3XQA2+Z"=K,QFS\R*_ M>ST+)]>2Q]8+W_I'0JWF'DO?VO##_MB%<DKY@%2Z*?HSPD([&.7>WEW#>WG/\]40C.?U[NO%/NHACT_D`.`MKTL,B?O0 MJ[GF_[SC@QJIFEI]\M>(_A2?WAV']Q&?<"K_M$]^TRB[:_#C5,@JDO68C!A3 M*V;5<%_I]NFZF[0C16_44M+WXY?B""^/F;-HGL>_7BA7Y&$]'C;F7>3H1OM) MQ9KAX)XN9BJRM_AS@)_/^F.1C^K+,GE7PLW3BDKVI'9\'-VT1?N M644_HIC/0AZ[&ZY)EGPZ<#T<#UM_"FK[78+ZAO M-EPBF;CC_*VB.L]V01C%,Q8HC!:QX$C/;``02?9/K.5-ZC>`GPV`>N._S_9` MLN!3$KR"0W'[DQ84&%7>>CS-9OJ.V'^4M@%NW\R8*/@]P% M5A9AI_"/8C[>EP6DDL4S2U#@`PU9EBD]Q3]'B[7[*IY]RD%LYU[9J@*\B!N2 MS(F&Q*0VMA*%P^R,977F.1Y+,T-OE(>Y,R6R#-"G$@Y\EN2&OKDAU4I?13%7D M20O9VOFL;(C,6,X8\Y&SZ<^%F7%;YY=M@YG/IK7Y21?XY$NNL_\6+B,OK-L-Y9ON0S!+GAN MZ_(^5J=;-OJ1751DAGYPU6Q:HHO2']$-W:IS,8F0\?V0L>>`N#R7B?Y_N*!6 M(#L*?_7C),5;QH^YA12P!3VHHQ_4V(S=8)S1=#$">":((DN&8G/KU_,]BCD; M^5UW60)O%'HXF]1;YE<#]A0\]K/U1[C66B:1%20B4F-S3SF[TCNG0>;'\[I( MY!:+*V7`R'@II6R+.?.3X\):Y%%(,G, M/Z9D.2!NJ5GY"-)70B9B!($1%KIZ7C9J<8F&XK!GH>OS>7!\[M6; M$!FS[]G[:_Y3?X]XDM;KBTC?R1"S)FE$J,H>9F]@9F,O)84CO*-OY2Y[@SU9W_$XR22%55R2&)BQ(_T9<-M:=O/@A M'^XJ\/&%"I!K6]44!W/^$_2C03;XE^T1GU]RYJ9*E MDO#9MV*3;%YHM6*2V!SIC&!1OAF-$RY8OI7YB?>-BO''NL^V2%$VQLG3[>AF MR?Q+AEA@D%WT;Q&C3,4I-_NFET7B/_PQBB.&TYWIU%O2DM<]8GPOL)QH/JTN M77@;"I)[81.Z87--R_\D*B`RZ[5S6"(_.!9.C2RR%_.SH9B9&Z9Q%'!S,0]< M,870398)R^^.FEN?*\DN%KRMS2\4]]?H@&$%(W(?1@.D;SWG/@Z>1OW1X-O@ M?H0>OJ+1;P/T=7C?O[\=]N_0\JVG8V(ILL5V*M$4W*8Q\/,2`68$,J(:O.74 M>?LF$6-$"^-"RQ3`O9_627]Z3'^E4.G$/"3T(,F.K0_Q"S7S(UY*R])TG]ZH M&9TEC+"/N\5*JP>ZOH6J*BJ;;RS\RWY1$W9G_7?HYS/GQLH?'Y-9]"H\U51K M\H_P(EXW*SU;>D&V[.F"R(2R.K/0>,F;HBIMR3\^"*BK.>,98`K>;+J:BY@> M:P)^H$JFA*7%;!],RAW&Y1).6?_^CTHJ"Y-#UYJLV+IXL4T6[^>)=NU5%;BI M&%U'BNFB/Z/?!KRR7%>ZJEE:6Y[U8[R"UJ^ZLI%]_JC-7UC]':1K- MWCEI/NA(T)-):D8C9*8Y,D%-4XVF8$W;W_CI0HTEU:YF;L[ON(0,*RZ^W\T2 MA;Q6\O]@;N`:QWC,.,9>#@GHN`YTK,)W)T-"W=\/\$*0<,RN)8?2;0`D'@5- M/DA%B)>']I="X$F?IT+;GX1S!CCUH_QHYW1QR@2IZ> M!B6<)6=$C=G5]^%&7U+F==QL.VY=C!/JO:ZV%S?\8=N)G-O?'Q^9#^YP!!U+ M36H\)95@([6L+4BM"JF5X#SU2:T,S:E;:B:_#UFAU]Y^6^Z1MF)<.AF#'$N@F(]F6L'Q]8 M,]`W1YW^[9X&X`'PU.7A9'@#=@2`NR`(;[9'DH"/`1\KB^!-MXK4I.4H_$63T-`-/&P[0``A4[CH%54P%F!FA8H0$8$#"@\ECJ>Z_9 MD$#6GEX,.Z*"XV.=JK,R4$;8("4#S`@PVS3,GMW98+(ZP^J(%A2V7C&X=@.N M!BZG=UM8U\H?"LI:TP/*6B4061.K6NL0VV6+6BLO9BW8/HV2'6K^V'SP@,A" MKBZTQ)*9O[I[.IJ&CDW%!MP![C[$R;F!IV+#L;#EZ+60_;J!5XKP`_`J5GA( MPXJN8+4G"<%OSW@22>G8.<9,W`W[OPSOAJ/AX`GU[[^@I]'#[;]^>[BC#_7T M_]QYE/R,!O_]^W#T/ZCS9?!U>#L;[F MJ292B`TBV_O$5H>V;Y[;4`;P0COH1OC&^N-QM&"%%W/WC6<.LIXF[G@(G6SRH;/@#/`61%Q'4O1L&::4`\"F+O@*Z0Y6"U5 MRP9,%Y@N,-W3F"XGM8D;N'&U::%`-F14_$=H9\.R<:_2020`E79`I3SQS#`% MQ!-`53O;E+G4&,@GD,_6DL_[*"4K'^L-;U(839!'GE/D^0GWP0++`(.P,\U& M4;%E`!$%B)Q*/U5L6SVL6#H04`#3+GVC:]ATRLRA!V((Q!"(X1F\DGZ8DI@D M59)`*/QMC8;>JK5U1<.6;0""`$%G)8Q:#^MJ#\8A`Z[.B2O5UK%NRM(E&CCF M,1RS:;7A,LBLB<7AK6;@ZR./`]]]]@._XKY1X&R3T<8A'1N<0\,HOFM;^BH) MM(9[EH,M'3RN`*L2*4>Z@16]S%ST.G@Q5+HV@L/<1>'+34KB&0K7`LW@"@+E M4X5-LWHJ=I0JP]&`+TGQ99LFUC7E!KR!5[?T1>\=-@P;JUH9%0#^.UE]4>"_ M`_]=X[FO\-_5X[<#5B*]:=IWO,9*S\"&[0!*`"7EO'>:JF-=K=1[!Y2W/8AA M`VQ4K%JRA+;!A=>$9G5G[H((T2EH7G=AL4'0:I_8P#$BPRI`\GS#COZWT6P6 MA?3+T?A/C'Y2NHJBLEEO[!X7Y&=D*@J;.7/"H"/0^&`HP5#*(S8PE#*L`D00 M((+0(AJ13*EL$N0NTFD4^_\0KXMZ)E:L'C8<#67O`H$``B&]V(!``($``@$$ M`@A$K03"3Q)6N<\:YD>+-$GI"S]\`$PB6EHW_/\U(]"-T!SUV>=I-#8G?NI&P!M`-6] MK].?30FF@36[R@'E@);FH05U-!6;BH9-"UK5`S;VX\7$#D6,K<(L(V!ZP/0J M87I?R(3$,9O+^=?"3]_`8(-2WM&R$5L.SW_;DC,.&+D.C*#+.Q$/?W7L?!I@ MGVT"\6$*#,@DD$D@D\>027_LIVS6^V*V"-R4\DIO$;,(=CHER".O)(CF,\)_ MP'TAU3$)*)>67B/O\!#UL&XYV+3U"GDFH*.1Z"CZF$VL46ONJ'9U1`X*Z!N$ M$M0QL.+8V#8MX'<-YG>0NWFXS"!W4PKV*YI&\1+2:11X)$ZRI@O"M8HZGJ#' M0&S`9.TFP#HV307W;!5@`C`YR/VJ8ZO78V/@@1(#<"I)'3=Z6-',ZNFUWFTA MN^8/=3(\6TBA:Q-,$WGR^81S"3)<[*#*:IIVDN-:N(Y&^0>U6EZT>`Z(+'SG M/`LLD]7:;Z-^JKGPQ#0HJU:J3$<%E%T5RK8R<14;CH4M1Z^%?]<-LU(<'&!V M7IAI6-$5K/8.+'42+]FTGN6_//]UO_#&A$T,+RD]\>&3Q;?CP<[!5J3\\=&4 M(#*9D'&*H@D/B[,1[6Y*6%@\05&(HD6,GMW`#<<$)5-"4N0F[+/]Q>D.RR8Q($<]=C)>[9Q97".U0IC3?> M.?9,J:LM/%.*AX*`S0&G31E$IBN61#+3M)X0B>QB4Y7]^_-"#DJ[)\EFK=B^ M[^Y*OK.2-$'SF+SZT2()WM`CF4=Q2KQ-8W5@VW'%D14*#@!A1TGQ?RA[X23G MU-7O21OALFQ)5*ETR_\H2.Y!.__D+)U]A&]%<->3B64RSTLN_7'P2\9'RFWOS\^#NY'Z'#$'$LMZUO+,FQ2BL2S M,C2LQG*H9@BM!'NI3V9E"`MT5I7!UR,%=G4M%YO$U5>&+@NFZW%BW[K)]-C0 M)MB](XY/[8HQZ0Z;O7XT@(`!7"%\4$>UL&XX1^8H`P6Z)M@@3<4]6X,>3D#\ M@/B=D_A]CPGOSDG^GI,P.7ZR3+/C:M>IF\LG[6M8[UD5TCMIXVP`C),(GLIP M4QW!DSA"!\`Y7,NPQDK`\!K,\!J6QR6%S!J8R-4F_BMJC,:+F$D&N4E"TBHY M,#A"FVVDB@5!"K;5*DDQ^#R;@A34T6QL&P:X,J\7#4C3)/)00KJ1A%SC>QS- M29R^830/7,8V0M$RG7>SQ"@D*1"/]BD0#9NF`RRA;L*%K]]*UMS8X%C M>\L#C;A2&K$;!8]2$H(MT6ZP..9II8\L\LODIPK6M3+:YE3O7XFIG^UIV'VA25GG;\1\-^S_,KP;CH:#)]2__X*>1@^W M__KMX8X^PE,VXG'PW[\/1_^#.E\&7X>WP]$6E0/]O=OM4CZ^OW.8^J=6AV!OG3I,"N]#K44*W47\\CA8L_7ONOO%!C:P`W1V/XP6I MI0'D-1K&%AS?ML>T'!-K!K3\!JR4\!.9MH/5G@DYYH"6XQ!D8\6HPWT$A!`( MH132K(T0GW#G(U#,JU/[2*7FWL:.Y0!1O(JE M1QT5VY:.M5Z%J6%`\F1:\CT:P#*P:9?9_L"X@'$!XSK8@>>S4CF25,FNH%*V M`%C*)O+`,)^,8`)9"]!AXW\+B!Q^WJ/6[U>-J`6#?`,"(=FYJ& M]5Z5-)VY$1R$_J"CUR6% M!A&J?5(#GX4,JP#YWU*?RF^CV2P*Z4>C\9\8_:1T%45EHY+8'2W(S\A4%#:, MXOBI(V`3P2:"391%:F`395@%\..#'[^QC"&94DDDR%VDTRCV_R%>%UFL*MO$ MBMY#?I*P(C+6#31:I$E*7_CA"U"'-GOU5(/R0P?Z=[9YC4_+?[$=K)G0LQ,0 MLK.HGUL02;SW0&#!J=-HBM;W/#_UH]`-T-SU64D_&KMS/W4#(&+7H8*19K&9 M?%AS#&!E;5OPCD:MI=7#IF%].C*?$WA6P]9\7Q4"MBP3V[H##`H8%#"HDQG4 M%S(A<A?0/BI.D6O5]G5%-K)DVUGMEFA5"[5([,-'1L*,[ M+$P)M*O!M`OR[(Z@JI!G5S\I%57R/#%_&@4>B9.L:DVX)%''$ZSU:%8";+1Q M-FB?9T#'JJ)@Y^A4*Z"J+8/$CFX+NM+#9D\']GJ%,$&:XK!(<0W)=MQYU#82 MFWG$3D1/"YEJ;8)I(AT]GW"JYYS%SDRLD&,G!ZV%>6I=C8H.>='B.2"RL,_S M+&>S3,A/9XIC&IK*LE[@RW]Y_FO5]K=P_]MOME+C/R6(3"9DS#N?L\`G&P/HIH0% M/A,4A2A:L`-`]A?VH6A.8I=5&B1H$L7\.^DT)@3-Z(].$T1"CWCH/GHELV<2 M(UW!]/2AJLBGQ()])0BB'\GGCYZ5"GT-1F/"QA.^/U/P(='%[6V9]I;]G8G* M7:016OW'Z%KF:NL9/:UK%C<6W;AW_>]/@\]C>KON/"'9A<$#LK5N3Q(9 M?FP]A2HK:3[?ZSUVY=T]\(3`5@OP,]I9*I:@>4Q>_6B1!&_HDID8^ MK!&>U.BP`!VET>']9Y&DW/Z?#(G]>O92D%"Z.D"B+"0>!2<\2$5`-H2TD?WF MT1\IY%;"P-58V5.&\8#8CJ("?RN7EUJFJ+=5:Z(K(JG;2=9_75P/WCLWZ'^_1?4__)M>#]\&CWV1\,_!FCP M_[\/[I]JX;&RN2IJ6?&&B:T$/9)";,US5=0M-O"&R^`P`F]XS75NY8WB=_I^S?9$H-LJ0&$4T'59U#-L4Y(0I8-4M?I.ZFD.$Y33&P81Y?& MR61`KM8#47&S>J.GXIY=1P$=4#V@>I??J152O4>2$#<>3SG7*_39:H=9!J9W M>:97T-NJAE6KC-IN`K:`\M6#)-01L#FVSDPF,P.$L+'=?\L'5ZNGI;UNKW6D ME#\34-(#*6D=4JO9]QA'$Y(D8GC2A%R/S_%"2WDU/!29JH-5[6C'DF2`VD\_ MVP:U3]A6P2V"7P"Y/I!L/DXD_)HC\/2=A`A2SP?J^;HJ)+,4&:MA@P,A[`D$= MBBT@GX`M<%X"O01ZV6!Z.2(!F4^CD/"L29]E388$(N$-UNS-]&06]+IN0W>? M)@.P"7!#'8HR(+"`,B"F0$R!F$I(3'\E(8E=4C,_]).4C:Q]!1]H@[5V M[3Y0%>L0(&\T9.HR]*CC]"!=\YJ1B5R?<&V@>T#VC?!V;_"YG'9.Q3 MHA>%@OO-HCCU_Q%_J#H*#G/AVDT'2UL"V[)@5%M;4%9)N_$.A4AU;!%&GS4? M(A62S6VOP.L(]!/HYXDTXRY*$C2)HQF*YB3FI/-J&DFV4:_7[F_L.+J"3>?H MY#C)4'.=A+%^U*BVCG53!?L&P?E*@DDLC>83Q_"GIM4%;_]_EL!U.MT%[0`J&<%I4Q6\&J] M$15[K"X!-F"^P'R!^7[`?(>L?),D*495UG!"DE0S_\:/$<$&GXV:46]:(J]*==87[-UC#=FK50K@O@ MH03M`CRV`*L71KAU07*T8#N[I9;+)3F5L5E>[GN0A_K#R M\9%SY`[EQ`3-"47`E`H,=9[=Q!_S&CS/#Q8I\>K()9*>P%P(!)*Y"4I;L',E MR"I=Y>CL6-E15X(F71YU8SY1N23LQ(?/=VSZK_[U$IK++_W5*!RN9LKT`#F5 M-AD<:=?"F\33MI,X_9LPP!,/N:\D=E\("A>S9\JAHHF@40F*%FF24A;EAR_( M6\3L?](I843+C[R;#9(%'.MR@)%,YQ7C+KJ%3<7&/;7"WJC2LR`)<`$TZ$(T M2(*UETLGM/D5LFRLJAI6'.6PO##QTJ7`7?[+\U_/%>@IL3S;;[;*'Q]1,D$F M$S).&>E@U(*E`+DIF=%]1^E'2!D(HZ?97]B'5K7M:!+%_#OI-"8$S>B/3A-$ M0H\RFOOHE7`NHRL8:8JJ(#]!+OM*$$0_DL\?/2L5^H>:4&@IMDYKBLK2MFFJ M3%3N(HW0ZC]&UU[I$,.RN[V">J!;ZZ[__6GPF7+GP)TG)*?2)`CFKL?(6'9Q MI?`.55;CC7>.)?F&T\9TP^RI+AS-UJ0Z!!GJ_D.0%')3E?URNU0"CK4_(Z`> M&5;,_\YQZ.PG:!Z35S]:),$;>B3S*#['R5'F["Q)-E@3P.']9Y&DW/B?C`A5 M5D18CBRFJ@&(>!1\\"`%<:J'$VHM@/S();#J5K3;\=-O& MZA)I(_VU.+%K+JJ7^'`.V&XPML^+XT:[%`#'C@]E:#:7>6*"*IXVG82 MU%\']X/'_AWJWW]!_2_?AO?#I]%C?S3\8X"R+INU<%?)G!.UK'CKG!-22*UQ MSHFZI0;>;QE<1.#]EK:0_;O[%D>!F,X[SUZG[M_DR,KV!IH_.`E<@LRK#NL_ MX[2D,Z&\JD,*E'6RU3ZV[J]Q-.>J5_LDO7!Y/\/J%;2W!-()I+,*TAE'$Y(D M?A2Z`9H0()M@&&HGH)J)#;U,40KP3P">@$Q'4[#A*,!B`3-'H,?`/?/`(CA@ MC\`>@3UNUD6\^DD4`W$$75P--5R]U"A+5!1@B8"R0UBB``W01`!-H*U+4*ZOHK"4GLBM)YUYOYH9^D;!K'*WA-P4)(]0KU3*"Y M@,FSD6#'MH`$`YRJ/)>7F8X(#!48*C#4#[;O%S*/R=CG$^($39U%<>K_(_Y0 M>8@?>G2#6C^=N598?06-MJ\.H*A#$54=>866UU>'*'#B`D4&BMQ4BGP7)0F: MQ-&L,$L9W+=@$;9S!\.TL>X<'0$&7VJ[`5*`BF&RH?='][<%-VG3D8(Z)M9Z M>@E5<2)'4[I:+KV=7*,MTTGXL\K'/\XQF^1A]-O@$0WO;Q^^#5`G&T>R!3UM M'T=2QQ*WS4[+(+.F6:R:908'<3B(PT'\`_OWU0_=<$PH0TD@_;_!K+F=#MC* M';6MX"&`YR:_JGL\K%Q\L(W8O9;P&`3*@)\#/Z^6GP]9:2Y)4HPJK<^%G#&P M$")-!QM*&>\YI'X!SK;@A\.G.NX*>5ZMAL_E7UV,R)HL"M`R$)B+[2F%_70_70:%34L"]O. MT1V2#R*CM6.F#"$%S!R<_F6IV#B^M]!!!+1NR)0BH0"9$Q1.39ECJM,U]CHM M6Y,[ECVM?'3F'-EC.:]!]>T7$2>^VEC?]FS"0$P^YKR1V7P@*%[-G2J&BB6!1"8H6 M:9)2$N6'+\A;Q.Q_TBEA/,N/O)L-C@44ZV)XD4S-[=%4IH956ZEVNK#L7.CR M0`$J=!DJ=/F5ETM%'*8."NQ%O'3ITB[_Y?FO9[>H)9YEG^$[1Z!GYQ0!:I') M9$+&*;/=QH2@ M&?W1:8)(Z%%:>D)R/DB"8 MNQZC--G5E<([=(N/-]XYEBAK"M<^'S/EQL63LZ>Z;$`9I`92JRUY09>I%$4S ME:ZY]Q@BA>!45=I41,?OL]R[:[?5&W_:??D-?[Q[^_82^/CY\0P_?!X_]$;UWU+\=#?\8CH:#IY,= MS"4827UK7H:$U++BIZOF&H\-^[0Q2$QVB9VJ\J'0^?TGF*95]I.C8T'=!T MG6AB"L5P<$\OD](*K`]8'["^DWRL*(U03,91./8#PEJ1B+('^M?CVY(`*[R" M`SZ(3'J1@7F4815`:F+>- M>/=G49SZ_PBR'4V01R8DCBD+#R(WY&."H0H$K.#Y\_DO_ZJ,$PRH79M!?7:2 MI]DF@`I`=1FG?CGPP>E"5IX,4H/31?M/%\\I\OQD'"U"J",":WFBQ5-Z6#,A MZ^;:080ZJF5A2W,^`12N'`KE8W\:`PP0Y@93/Y`:$.:V$>8AZY=)DA2YXW&\ M(!YKJA]&*4G0W'WC\P>`-(.1.RD0;6'3.GID+A"E%F,(V19V]*,G)0$V6H(- MI%HZUDO-U09V+"O/`ZD!.VX?.Q['Q$T(HM>=QV3N^EZ>(`Y9*F"XFI2E`MDG MUP[66I("`&8`L]J`!("IV$`18=F! MT#6*FH#40&JUT>`&CJ5N(^%U0V^9%@)>[VLWW_OR&TVLJI`:?4W8Z&@&5BP% M6@U>T9H7JR%4K)0JA@!6+RO3`JF!F[9MK/4NH@)BP\2(_PJNV6NV4)"G`71* M2K!V5+N'=;O,;%%8ZF8O=>&T5'[1@3#+2OU`:D"8VT:8W^4U<'=OX@9N[%?I M[EW=&:(@1DD4,`T&3%HBBW7VG#[;P&J5'3X#Y&[[3[^AKW=<8P@5HCL@LEI%!N$D&59AJ[6TGT`WQ?Q>,H" M(]$$S6/F`$C?$$N*)W\M_/F,0$=QX.=->@7-.0"L%W\%(`002O0*^LP`@08" M75EFT2M)4D:4>0-%-Z6OKC1H!N9`%H7?<;!E5%BT*&V,!2!8#:`XGJXP9@=X MDD2EUEBBWW5&NUJ"1F@#5@8@$@F$#61 MCD%6EAR$K(JLK*_#^_[]+61E2>!HAN@3B$RJK*Q>ZP)*O4L#MCW!I.I%67,F M5AR-"?$2-(FC&?*39.&&8YZ7-8YFLRBDEXW&?UY+-M9%5K`$]YX=DRYTSCB+H4I\OVD'5I75IG(^QAE!(8E06VX=P:W-0< M;)@51GTDHAD`IW+!9%W%CEUA#PV`1,,@L14F1L_"IJT#`P0&"`RP&@;HOK'$ M_X0Y:6OB?Q)GEH&JO@*W;87^+EG3CP#7LH#O:!<7(!(0*121Y.K4_/JA)#OUB%V694LBQ=-`TJJ'%8D\O#SG\/(R M#=,YMBF,U^/:A+C^G45IIT]@2PJ;$?A0&1_2.HT3HCT3],PJVA-O3N,YBWAS M];8JGE&Q(:R<(L:TMLU$MU.K5=S!0I@>@&E/;KQ6Y<2!&^!&H(4QB[HV"`X( M3HL-CI6GLZF@*YZK6B"DY)K?Q&E:&3M5H5V>QUFDIZ^#<#2&)6WYU#)UM'H` MMUHZX9*0 M)12^J8/)F]%H$W-,Z@8]&DPC`A!EEP9`G^!8'C6\83@6$#1!!#V-1I9#7=;F M;'FX4+J[4)>KY3+A579ZF#1I1HLD^X/$Z2++[\(RSM)W6&H;<",'%@W09%+5 MUJJ?_O4(K]R6K?57V+!UB@U;0S3F"%;#,HPC(B9!,166/.>%-N<;CM2?LG'Q MR>S$:GNE1X4BH'M4IZQ#\A:P"JQ*@]4.Z!Y@EY=3FQ>3(^G^Z-)R2BQ]@-8< MEZ;/LSM.RO!;GSOA9*/JXW2J;#,$N/I$^0_@K0D!`E@!5AFN4`@79="DX.N3 M7&L6#Q(OXGDH[I!FZ7F]W/SDP,TT&KBNA5QL7HH1I-:DBR:3O\DP6\K0"VBU MDW$,.]C*,4R)&M-TV$XB?BW:;)6#3FBG2.$. M3M)P`;X/=%P(H[;A4\<+@`_@XTA\',GJ@YD]/5+?O!0XO7*--AU*/TAKCLGH MYUEZS_.21Z3,]#SP=J0>5G56._D*$7,-:AAZ'+0%L&FSJ`FP`JP=X]R16L"8 ML4W;3X;5UN\$):!:FTU'"`S1F`.G^S9D_[(B^R0NBI70`&$IA$&N"_4?J4][ MG-\4HUZ$F=1V/2W8U/3`-D91GQHO6M2/!EZD"U?]I[\VE_5)IINOHOA^?U?- M>;6IOF5?-;]\]$RRX\5.06)V_>-7MYSPQ8+/RZI(82F^J@H)A"5?GP:;DFQ5 M::7U=ZI?^EZ"IZAW-56?*6]SSHG@/N5M414\%+SG4W;/[ZYY3BR#$M-@AB!$ M)*P^DE0?W56RIWY7T4&O-F\3BFJS]6DTXPZ7`RKWRZ^7'YX)RAV$BX+OF''()1ULV@!;1*LIWVH*DFPIVDV]I24YFJT%_QRPV=08HVU( MVG"-UH:737('JN6PC5LI;Y5[UYJYOG MOY+/7SY\O;@2STXNWE]]_/WCU<K)@1_!'\$?UF:#4I6AE[8.F5:&W4A M<;$>QY0E?@Z\ZX:7),D*[)9'`DL/:29GMNM2S[<[9D:!*P!<;6!FNXS:`>N8 MKPER!9QMD+3MFV<.-0.K10@#!04%!04]9B6[VNR=\WF6SN.$DW3-3:OOBFM0 M5-@TLC<:F`1L&D7G2+1:)V9A;O:,2KR3U&;-E^.WYK#,HMYDL2IX1*X?2+;D M>7W0\^S/D\ MKKD#X=^6/"VX-@QBI.Z4S&A6\8H$3M?B="AE"NT2:C(09IS('7..^RO(S_V6B(;%$=4U.2*"[F MV2K59F%SK'[59H8EED69I0OK!YQ:*"B[WRX(:YP/+/*B^)H-:WY M^Q13"3ZF\YR'!2?BON&\INW?#ZO1A;]+,4I48ZG(U?^15&A"1='U';K^>$MV MBH[LV-XBV@QM-@@'5J\2U1"M-BS7#=.HXKAY=?+*.M]%F_WA(_6FM#/VR3TC MT[:H9;KZ>-2`TS,[V@P"ZEB.3GXT$'#`6+\U+2["),SC/FFQQ*J;&TISH`4FOZL\9`C_18 MXI,<@`+D;K0B[\R;&1J5:F[>=E*DJJH[N6U[?GHC.%89W\>EKNQJM-Z6+`J2 M,].@AMW=*5*8#@$#A]I&-J.VT_4$9L5I$]`RX+:R,Y=1QS`E*0!=$)9TPDGMPJG8'4B>X*;$YJW&GFI93*U@`=IS:'76NYY M4PNX6FU9AN7V\VUUL`'&ZET%2#TY,TT::&H-`!==I5L#FAZW'\CL$0`VLJRM M8'T$ZR.'KX_$-3/"^@CH4E&(7IE7Q%1*9#M'1:I/GEXZ>+ M3^^Q2"/%>@,6:;!((]\B#2I(89%&BM8T$/L.E'!)K`X#9*<$3X6=H/O)J90IPH6(8%&VNDZX)%QJK.Z6+(2]&3^:[8EU-G4=?QA&-CA.VWAD0.F(*"5G MEA`$`[&\H>'7TF8#`,<$8$7UVIPU^H3J-9?U9L;-5U%\WY%^["Y,T((?__#4 M+XH-G((.[7J,JUM.^&+!YV7%=DKQ5'PUP\'\];CH?FESNVX&L= M^?B@`EJO_I--8*S0^"PV>OZVK3?KEPI7948>_[)GWF/4),LPBN+T9GUWX\E/1'R<__"3KD+)FOE[A9)IR[3$PGQC M7>_GM>C?O-?1T;_%5.G+M';INOL/33]1TQRU#\MU)6HT.VA&J>R-%LC4:)ZY MGX+)T&C,D&EOGR=(Z5"QZSBL!3*UVMZC;P=ILI[9S2D*:5W,YZN[5;V-O7`H7LK67T8I`2 MM)ER!'*(-E,@H%]$45S&67I@5)\('99AX*C%AC%LZOO\O,JKS+OR=DMIO*ES M84"@OL_E,RM\F17[G?W3T>*@Q3ER*O+BX#3'V;29K9R-U?X\16?_FVW>2Q*;=R3:VL;S/5$[*3_P M+F]%-K"PH:\Y^3U,5L<;3-+"H8V:`1S6DC9N9(&SXD.,NUH\!R_.:.N)$;BHECQ MJ"X7UOTH(?4\':U/H;4]RKSJ>,6NY[*HYY=HW=][9H8&#MHX'(!"&[IP9C/J MF4;G$K/JF0C`Q0_D<'36JK,?`#SV+8E&0:%Z(A]`/!YJ#K6=-A0+:GMZ:CLM M\_AZ525/%.=IEE8RF_!O2YX6V[::06\CAG3R]Z#E@:7>T0*Y/W&T$&;YU.WL M#$+X3P`A$@A_6`!`IAKKHQ#Y4X+:`=,?I/KTI#H6QA$'7C/Q#`/+YD##$S1` M1@,)VY,JCH$'5/0$`"*5BH:>!D9'AQ[4-H#X7&UO0X'3EF)#@$]-@'_B)4FR MHOA^>O62YW$F1'B>W6TI2_"D*@$I,W*QNED5);%8=:JU$?2FV&6NXXO`(LD, MU_NLIWB180!5=0`J7M88`)0D*O8$3^4++0.@:A@JHUDK\A:$!G3;1+LSRS:H MQ]R.>ZQ4KQ0-D)P8)/!#I/1#3E%._+$XXPN3@YSEO"C#DD<:%F9$!&D,4Q/; M^?7L^:?9""8V\>L'`&8SZOM(,]"NX_>PQO&U\!-5C.0"W9$Y@-3%"K\R:-B. M$&:[U'6AYH2G$8^>KW4SHS=O5^ M^XZ&')=2CN_.03\PXYPUGLS>2/($.Z\DJ"-;?9KQXC$C':OB$^U<+&]/KF.9 M8U/;[]BS6*.6HF_;,_ISK/M.OH^/\J'.+->BAL^0LZTP5OI!!G-<:EMMD`$] M**4>[*%(>L'S^WC."TK>&#/;K$JWD>)6-%=OR[;0=ZK,-*B<#C2\1`,2I(&$ M)Y@PJ1&@9#J0L8UM4M>O)X^N2@225458R+#VC61DS4!W\FP>VT0YM,5=HZZDK;])[GI1"T:5;R@BS#A_`ZX=4Q7/,GJK=6N):KG<`]4;^J&1D> MYX+`]*J:?MJH6W3[;MX;F+XVTA0PVO M#:>`?-8)%Y#/D,]3D<^0U(#:>JISS0#IU$BGWIY.[9DV\JDUC0Y[Z)#GB=#1 M=9%)/;D,4&RZ71NYC"X_?L.6XU)FZJ2E`1I9M+0NNAF(@VY&BO;8P:V>Z0)( M:4AI2&D$C,/8D.U2QX.4UA84Q(:HUK;SMP+"LJBKU1(T8"&+;(:H!A['1QQ$ MM6Y0$U.>QZ"?H9^AGQ$;CEZ":C2U`TVM*U`$`*"I=>W\W9K:@J8&+*30U%#2 M6J%0/9Q!22L*M0YL>3#QC6W4LHGOCT)OUV<39XOG&ZG/KWG*%_$\#A,RK_=: M%[%0Z0L>EBM]%#BVBHPP9Y'S?:1-$UD/]'5&D#;J'QAI>IS9#O4MG00^>AX" M?WR!#Q2.@3.-9#T`]C*DM9_JH->GIM019 MKFE,&/^JL^2"+-<0?1#H0,L.9##'I;:E4_8[$`(A#R$O"0K5PQDDO:)0.W+Z M@[B?FKC_Q$N29$51I[^7MYP\\#`G/(UX1"Y6-ZNB)!:CQ#08ZTWI/SXG84OQ M(EE280:R7_*XH;K$'PEVT/L]*+@>M?U(,('0ES\ZG0"`;@92>P?4)P/%3F-2) M_.;0'(]4'1`YD"ZL<+EU'?=*AAM=GP@P7["8'@S;KOL?2N M6;^W5D8V=5U!):RNI\MC]5T#D)PQZOH&-0RCJP;!ROAD$%+)#]_RJVFE/T6* M]6MU`-$ZC)B&WW*F>2):F\MJ?_+WKZ+X_N2JJP6AWJ>DZN<1S_:L)^8"?CQ_ M*9_K@4S*DOGNOAC0O)2" M.0:'G)MN,-]SCBV[)UU\'ZAK58_N74*ZD`^N^-.UGKDK4Q!PV'Y["5!I"XO. M)>YE@H1GS8::&*8-"16OB.U1ZX@"`U*Y9\',W2MS@&1)D#>5J^UU?3H.*%\F MI]$U9QA.&$Y2#YB`R31@_)F%$8,10YQZ(:'_W2ZF-SD+RO0T,*`,2S\#ZB0= MBZC7CPBDOF70@'5=(5?.X@(8I0#>3C`R78PU`%$*T)T>Q`YE;M=<1`5M->!8 M"MQ-Y4IO4PV#20H0JG.EN:6&\2(%"GO$]U"&FC%S?O"05'?4ZG>:NJ5FN!KF M=)VF9Q'X>@E9/O7]^H\NGAK0*`?R=J*QJQVAG*D&),J!NM/30$89Z^H-*^BJ M`=I7:J'D70&R&860&CEF'K8K@!J[(@KQM6 M=;'C@%-94'<48DW3I*[3_0@KY=PWX%86[$WE2F__#>-)%ARJWS7503G+"^#9='OG4P1E MZO)V6R31Y<_'/+,LZG1.RE/0I`$$?M!&H[/J.]K4[5% M:X!4O=TUK4(Y^:YU3Q]%,GR7.B:6XO5%"G3[^,C%HKQ4RAT*'TOQ@R?"!BZU MG`&J54#LJR'V/PI]'Z9S3K+%\U.9SG,>KW\&H8]`(\_52:=#F`T`Z3"\2R:@ MP>LXO>W)')L:7E?3$Q:'^@"1WN*`L0&XRG0%8P.([`%5[6?B(ST.'(&COLMQ MS5.^B.=QF)!Y?3QU$6)S39P#]+(.LEWO7AZ?T_;(:QR/ M,A.GM6@"Y8X!2SE=CE[60NSJW\FKW0)Q%A*<1C\BG[)[?7?.<6`8EIL%8;X+[\5F)D,.DR)(*3E*H M[]&Z'9%1XJNALQQ&&B#M:B=@@,@!2JE!WL*J&0GD[2I#`.1R@%+VJY,.FC:V MT%BCIEUU#`P;.6`YE:NASR492YFTJN&!P24'*/=`]HQ1T_9I8+&WO?F)8^&T M71$0`%4.*)X2J$>:A,R;8G;.^JV.AGI'*_#Z!'C]*4SJ7)SS'_T_T@4]",:J=`BY[0DK@4,,-J+WU<(_# M('.8338T9-I898#,"\B\J?'A;:MN=6`XD1H;;1PF8.,E-CH0&(?Z)J,>VU;* MY#!`'>B\#(ZH-NX+(-454A43=OVZ!/;13.]!BGYP4+11]4#%\1/6DXC#[(`:IG,(L)XH\.:RVC+Q_:LHOC^YBFPA M`O8]_Y__>U69_G[+,_YO(RSM+@2 M;?]3DLW__I?_^/=_^_/FDU]Y4HG0+V%>/EQ5D`Z;W_XY+N9)5JQR_OUSU;:1 MJ@._\L7__NEGQHS`8/_/Q'^6\:>_5$_UG^?G_.;;^?GF*7=B[6^KHHP7#[O1 M=G"K_\S^Z6 M8?I0%0P-R9UXT-OD0=S]&X_(@M>/\8;5TQX5#7=WQ\4_FMZ0OX;Y_):PQ@28 M[3+;3Y&ZU`5@+V!U`#B>@>JR*JAZFR41SXL/_UC%Y<.7+(GG#TI`Z>I)W\8% M"5?E;9;'_Q3=*CJ^+A)+G.9(C_I8C[I`;%%U]_Q)-5E*Q-10A6/QVW4Y6?98 M3?:07N_U3?@'^IR22[XL&Z?,;,8(?3;8UD5ZK8!1R[!W-'Z=@O=]N.95 M!EXN/K2J_E\AKU@EU:`GX4W.N1B893&3I`%D[)'/\S*K^H-9KW2(O1D/%'TR M0)]\MY/];7W2;.\4@9N\<9H@]7TS:)R*(&92UW7%'V]'7Z'E6[0\\[HTO4U] MRZ`!\]'TW9O>#/8TO;NMZ7WJ^_4?-/TQA*@IDI\*IAS%%1D,$\),:M>K2T'*!6$LZEL_3@8U$:\H9S5%_'$K MIHYK\2QI_6E^7_U">5OQ\,=GVO1L\SQ_B$]LGEW\HYGX7%XQM#+F18VB])7/ M9JM$O'%29.3ZZ4UV2XXB:QXG+JN9;C.S97^D@@[?QLN*"<[%,XK=ZB? M(%N512E>M/KE;8^0\[M0O+.XL6ML[C$C5[?9ZN;VN2*IFJU^QIR7JSRM'V1] MR$%:-_*KCR]^AW^;USKR^V:&]8W6C^OYU'2<%_2W^0>6.;^/_]7>L?8FCB0_ M[TGW'WS:.24C.6`;`R:;B<0DF5WN,IG1)+NG^S0RI@G6&IMUV\EPO_ZJNMLO MPL.!8`SX=+,BX'[4NZJ[JNR%U)GF0=5+7DA(SK9/(6@:\!]2?`&3`!1<_)?S M(9(A37SV&92"`(BQ,OR#+]$'L;E3$J0IC;^G*6,R8%_,I,6S!8F&8]`'TQ?=6N82GDEX M-WP$QI4:X@CI?!E)V2EF]N*_I<\Y+1<0FB%HON0_NK@7XP?9>B0B7K\&T^W;$U1["SATU:VQ5MI\_8Z>(Z-X M5Q3<8J+FPM+7MREN59LEDE,PLZOK60NA\2JLQ6@#/0R`1=.4ME(X1WGX$)[#0`$U3\D-]?$"P7P5,!XY\LD\!TW7#,#@3&K(&K MU(4I'$GE?H3&?K%I="EBXXJJH4@#:OV)1ET6#:B^_!EF`]/-D&?F`G6.RIFO2NV6#GQ0P'#J$T M'L@R9315;F@M=@R9-*<]&M-7!G8ORN$MN`X/'.O6^N^J.`QOH!CV.CAOH)+* MK4FEVI85HX!W\ZE&K7.(_A&'Z\#!^2:?S4?7E'[U MO7!R+-:Z$#H>A\$I!2KWSMX4C;4-];EN8,?=P]/G'*X#T^=7J=`O6U`,X1X& MF"F%GT2<5(2SWJD=ZHEX.RB_-F.)AMMHXH9US;AA?#*P9GP(Y*P]2+& M[3D*R\F:ER#Y>7-C[5_TAC>MHB]ZOWNVW8UUU18WG))#_C'J8KU+G MU"7\XYRZ!*"S6$U#<;1G*R50#;V(=%#4F5=QR/8UDY/YLK`5;F*%(K@ MJH-S%RI9S">+1:1\5`'M'KE"_I0&8/,_F8Y#I1X8?AJP%Z[(TNWMU=&8\E+$ M:&5"6A785H%M55ZPA_I\66B;4?8KHM?.HA(#TPVQ1WU#W5&^A[*T?E[7Y':K M65RN1XF;CI>!P??!)U[UZO.VK#6:FQ;.ET$O'E35P*[ZE5"]_N#3D>."M'$X'NB%I[IC,D[.#:D=MJGJX9!V&1"V&, MPXNR*W'*UX!&EYLB97JK1E8_1`NK[[5YO87@^5RR0A^1(4T\?[NOYRJ7N=T) MZ7:@'#2LHS!K+F*F"H+.6KJQ>.1!**LG2-VD$>ES=J^_T^K5O/?3P+ MB#_&O-V@D`-AC;TQ0!IX8=\A);%[+\FX]"#M4(0_\7C?S76#\_K+V52F(S"H M18C]VYX&%RUU>6QL)74;25T1GUZ9&,4_+JFH.MP7V]]EKI4MSZ4V99>O?<_W MV=O,J12Z`^)GKH3C:AG)]$&P'@G+,JI)/9=WK>C]7_SR/;&F4FX/N!&:+7C;%1\25WZN7JF7YZ8FYVWVT' M4VE@!@3!F[WYYA?H(,?@3Y"!BU?1MFLY(;NNCE>9Z<#'@)F]!V_"^J+M7G3M M[<#&870P\@F13AOOL_?@5!K`WN`O'!(05SI5E>21@3E%<&QO`#ADW\!B^"0F MML.DL/S$(0')#H#G?8EM+KXV1^*(5])NE3RB)7Y%GM>39_NR$R5<+*1.9[?4 M>5?3.FP#+-^$(>6+%7A88K%5O(@&A1LR+9)//R:&C?O%;%?AK^#9;#N;1=29 M[6WSAA12%E%(9$0508Z2^!.E"_6:#K\L6A>%(\H2\F&48$7&5>&!PY^O)+VMG&F*=`T\P[^\B@E`68[GEP`;57^9X"V12!X=FK:/ M<6A((ECF5Q$."<\=198S'2ODI`AIQ#L`//`1M2TQV9@$(^`:,^"<98_9_'$- M),OM'(]M5JC`I(!OQQ)XX46+L&MVU)?DAT982NV!K2<+(87MF6.\!OL?_`*4 MY$^S.?#@<)&^O*B'].S1-"?GB+QK6,WQ*(#[`,']1P>H=OGWO_UT$3US'_8I M^2N$G=\\(3WBIQ!A>![PC0P_G%RKJM)1U.\J_*^AG%SB:O\X.R.//\[.HM6+ MU8A1W:H\A[>1,H`R?,60WI9;:B=F6L'%;IH;,$U75=2H:YOC@52#V+N6/0&V M.:51(6G[/>.[1DO6P<#'UF5BY]2?LWC$1#)T"F&A("+/K;EX<>$U^Q/_#8 M6D9;;L/:4QS"YYS[`/_I/5=)7&G#4K\X,.%OQ'3@RWOB/Z$+*_KFIR:\ M)XX3-:=Y+TN3T$<%$J`2%P*/JLYQ0!_"RJ"?/MK>5=@G?"89],<=>3('H/`] M?^+YC!NDTZ@C?OL7\7CTA8&+\(G9K+`1%Q0B\!*HK-"'GSS'F9YYSVA(**@! M>V!C2`0,.K0=ABDIF;SW_@B=8%Z#S??>MU;Z?KF M4^^N]]#[XT;J_OKMYN8S/);L)-+'QMF_F8(^"Z"`5%GY6%4$UE\P'T3:H&WQMVLE!#` MQ%_\1YC@@9U$@V62[J\C&+Q'L'3R4##N1;M%F?#3Z3O M([=PN:ZECFQ_C]P*9A+CMT4P$"BJ]ZP22`,)+H`+(D>%IH5ET-N"GQ;O$YXA M/ZP1.B^Q]183B87;8'.:368"$I=)+,"U_OP%TC#]!B[M$RHQ<$C`O5B\G9$) M#J1/GFPOI!"WIWLAF"#P8DMSWZ.!3@D!KF+HQ>^)Z3LVHA(G,2U&<-AJ,++] MV$N5<1).&]V0E0;:5H@6T#U-KPW#\C!RG"&9Z,]Y3(,(HM@SYEQ&"2A7(C\[%C<*D7C4U1:':GO/];GT#@"8/&0"#P MSRF7H3P`9-!PGM_*%&SB!O;3TLYZ"WKA-=7&G,O1^;WPSEJB^9W(^S#TS"N> M2]`+;V66J&9LVB'R+:]^-56IM7>?7[7B_MR8QR&E**9J:>5/U-RX'6;_U0KC MGMF;E\JBGU4;*\C>*FWQJMZI&17=7]+]*YZI;DIV8W7/\5U)NUJ1?1[9_T!? M\S5DWS!!56W7])4IJGMH:`5<>YRCVIT)_A_NSZ)('`]763"^7MYA#A^@.&KF M,?L[(^8.TN129QCK43>'J2^.NKFL^S&1-Y4%*2FU9G-M,NNZW#0:.61X\\B\6>_(_-[=J-,`\SK&(0LHS`R^1"KBPM'=H%NNX_'$Z+OAJIOIP5>?UAWFEQ, MS]$';WY"7S+K?I0DSV7GW_R0OF06_^@I?RIR-5XE]2E_@'^,"D;97P/[:>>Y M!TGR\L+$Y&SZ,AK"D><,B$]O_@KM8(JYNG.2GLN.8TRN_N-(]F02B2F)),GFC MH\H-15^`?)ZQ'26C@88;L%SCN.PX2@0WHSQB6B6\+J9(5"^I-I801(_D0:YH M4@!-XE(B8QY-4M5$S;B8B!<]L7Q[36ZU6O"OO:B0J"2`EAKSX.:O@7I=-B!& MZ*A&A?KU4:]U5J"^-0_UAFP8[%^%^DT<(J;NL=1R,&"Y"*8CJ9JL,X722F5# M+TGX3=?:(`7!O7JT<2*6_YM*>E>^#@J35U%J@(B M!ZI>\D)"\A6U+P_W7/R7\R&2(4U\]AF4@@"(L7+\AA)J,XWIS`NU@?6"$<7";)CF M):@ET4NE4Y1=+%W@`B\DA9)TM0%7-4!MQH4=$*!61]8-;;8@-LUM01[\;UIS MFHKS\T;P+.X74;QD#UY&\?#[3Q?`:#`%^_S3!4@7_#G$NB9JC8`+/YR,@F!R M7J\_/S_7*+%JC]Y3_:KW[Y-+T"RJ8B@M1;NH)\/XG/74I!>\A8!8`+#F!]?` MX)>(IC.E"4@_B)BWHRZ45=@/@"W-X.X<02)U"9 M&0BB[UX%@6(TU-U#H!AG#74="*Y5A;.<4@Z64W*PG+(^RUUW#*6CZ>60,+73 M,1!<3=^>A.V.K"G^5-:7L)A@RLX$[=4$4R)Q7(,_(W'YW M;L.9_[4]T`%"\HCNV^7%C[[O#.QS<`X=V[*#S]Q'&-CP*U8Y?CA)3+IP^;@] MQR#!<_&`K?O#IB>7T6-7;/_,_O.Y+NISE[@$?(H]E(GWLL1(@H*):8,C99D3 M.S"=O21,-X;E*\#2KI.(6YP"Q\@2B('0/O)VO'([W*^NP4[Y5!*2-5*AM1*GKL/I[>_+Q'K(+I5J_SDUAI9B";[)JX MWMAVYTTW!]YHIME1%_5DERFH'-O]\WSH>0'6SMW"'](/]E4PG0#5`>NL+.1$ M?.M[3I87D)-KGO]8UQ2E4<>?Z_B@P`L;XWA69D[X&S<533GRL2O`ST**OD>* M[1-LW;7(E4<#>D>"[Y'VL..].&:?.+&4KAP(CY](];7WQ=YT_96_1'#U9N8^ MO>$.4EX.:Q.]>A<+1VRXD^X`JVF8A7GP%C@$5\D;&/%5>/^Q@U'R%L%/_"6` MWV?RRQ8"LJT%2X.'[*U/`7C(+E@>/&2BR2+PD%GP!1XBQ=CUL_@P?2O:&GQ< MH17%$_6A:05GT8S1\,#[5X7KJ19EYRNKT8P6ZIL:/!5HQ,]/+_`OQ`T'"( M'<09,+QBNZBMZ^MM_3KF0#?["O8Y^Y[Y"L-0^)J?D\"'_P-02P,$%`````@` M&S#K0'KRT'@J`P``"Q<``!@`'`!A;'IM+F]B+3(P,3$Q,3,P7V-A;"YX;6Q5 M5`D``]5._4_53OU/=7@+``$$)0X```0Y`0``O9A=;]HP%(:O6VG_(6,7;%)# M2%&E@LJJ-(2!%AI&TGW=3"8Q8#6QJ>WPT5\_.^5S35LFDMPDLGW\OL>/#<=P M=;V(0F4&*4,$-\MZI5I6(/9)@/"X64:,J)>7%W55+U]_?G=Z]5Y5E3XE0>S# M0!DN%:OUQ1BP&'&H,#+B3%"MM1UF"J[5/UF5!0MV$AVA<&-CV+][%>=&DR!TO5;= M"9-"_TG@V905`[U>KVO)Z&ZTD`OX)GQ7_4)[&OPG&KV2SH:KV,N3I\VD)(0# M.%+D^V[0?7'-F@S04$#_M(@?1Q#S]=O`@84YXLLN'A$:)3M44I*%-/AR"ILE MAJ)I"-=]$PI'S1(('Z,*&:IK?8G_P\'RVG8!/@C].$RZ;='>,X8+#G$`@[6U M7$-6*TPRT-)2.`;NC6$;MZ;E=BS+MU+*]K&G96 MD/9%"R2V;YP//M.8[>L M@6M]N^MZO[+AEJ);&+\4[]PYFH;;:=O.CXR.W5:N,&I;RWQ@M1#S0\)B"ATZ M!A@])JJFN)R1$`5)0U2B/H5,U*2DZ8S:"(N"CD#HBAXHBQ4[IO9FE$'.Y3FC M+//>10R;O$902:A)*H9]Y+SYA?E8H4V2+/Z0;Z[PAMN"09X(M$2H* M5&*6-QKK(18_KC*!LY(J"L_*+F]`7>R3"'I@D=$G;U>O*%2[GGGS:@-$OX,P MACT(9%M^96Y'LV'XED=17-_*(_=2"X4B#/J`\F76C%_2+JS&UL550)``/53OU/ MU4[]3W5X"P`!!"4.```$.0$``.U=6W/;N!5^SL[L?U"S#VYG5I:=-&V2V72' MD>5&4\=2):5I^[(#D9"%#05H`5"Q]]<7($6+%`D0DB@12/WBBW0`G/-]N!P< M'H`__7R_"%LK2!DB^-W9Y?G%60MBGP0(W[T[0XRT7[]^]:9]>?;SW[[_[J<_ MM-NM(25!Y,.@-7UH]:[^[HU8A#AL,3+C7P&%/[:\8`6P%.B2Q3+BD+;Z&),5 MX*(%]J/XQS__47RW?*#H;LY;?^S^J?7BXN)U^\7%Y66KW9;MA`A_>2M_3`&# M+:$A9N^>SSE?ONUTOG[]>GX_I>$YH7<=4?!E)Q5\_OUWSY[%PF_O&M6-FW_&$)WSUG:+$,8?K9G,*94H]4<0G^*PG[#[*VSL$ZS84BU(^F ML"T^A5@.G!IU+*O]<)T?ZVH'<`:BD->H<;'N6O4E"X#J!+A0=0W:QA6U%W`Q MA;1.57/U9O1,E=S6<'L&Z<3JH8#^#GJ8(_[0QS-"%_%\5ZTY M"']?G)-I.ZT_UM*X^HP!HJ<@C.2G-^+?7+OPGD,^,/O=YD?`"&^7J."E:^*=G2NJF0^-GZST*Y%!)ZEK7@+#L<9H!- MXPX8Y`S;\HX!3Y7J+LEE%5UT^<\FE=:3'II=>OY M+Z]SY029EIY1LM!"ES9+E!JW(B9:)TNI)PC/6H0&D"9>;*.X=R-*Y1QD`O^V M;*,LE'>;(@,%`ZTCH@O87(%[_)4%,"MZ21;MQ`KKP!U2N`0HZ-TOA2NEFKNW MA-P`?-NR$PU5G!5$[$(4;RIEDWV_4QAQ0RK@=_6\HA_`L&VK=G+-ACO-!80T0-"XR% M@^.&X+L)I`N#Z:E4U%UV2@VW>>14#QF'V:A>NQL,N>R\S[%U9W,(1;OO.'*@/W#(V[RUHU(&:/.>HU&H2A:G(QB?YO)T^N=;XX?R6DXRSBMSX1$\T] M[X6QW+LS!N\6)4&`SO%S8H?>J'<[^=";]+O>35T)LOE*3Y).OV;XEZ@XC+PWCR/*<6]JR< M,]CGC#/;)#VY<3NX<>.)-^E]%/[.X'HP[(V\27]P>\@1I_+ZCNJ\E3?YY+=] M>W[;+>1][),%O"&LZN13N:P#\Y["2.N\L8V2,G&V*R8QA",Q30^6D"8W`50P MM$,%C=*F[77Y-`ES1*RCZUSJ`>S&?(A9=FG-RI:RD0;9:2R8^58*;74NEEI2,D,,A;K)I;JP\ZJH`?TO( M'?2WK;/N*77!&E/WUB$22FRT[D!=/$QO"29;NNIFHS)QAUA16EQ.SNOFR)'Y M"B)^#V>$PD1N`NXANQ)_,([\ MO=RF6E8W4BXQE;'-N@U1SA23)_N.(+]EEW5[H!Z@ M6`Q9EF9_5GAQ2G$'\BO4IEJW&FVK^AXPY(NU]@J%$5W&!M)(`:S0BICQ?#:N1H'AMWNT%CW;,W4!+-ANF]M MC7*];P??IR?L.=R?TG_W2_\=3P;=?WP8W%SU1N/>/S_U)_^I)PVXI-Y3I0.7 M-/V4%FRJ:G)V4N8'$2R#*-X]JLP0+BUSO,%9\B:=BL&:P[]TH):;K9YZJH9Q M@T^6,F9G(2=YU],Q MV1&6N#>T,J?R/N9<)?7AP[5#SAWPL"[WPL%3@,[>3&0:,C"]OZ;!]??_]*Q_D[Y420N;%I]R%;Z]X*68#.0;WX>4K)#H)N\?/HFUNX\?SU1Z/D>KY"KKROO- M=JW(C;ER9WBL"X[**UT0URQA&0$'.,F:8UU8-.<,C:!8A7P4PLUZ.R&*+K7' MA77':*/LX>`SH!2(KGI-Z!C2%?(A&]!N")#2/=BM#A>8W`T4ZX*UFPE'Z.LMB-C) M_JX+_:CE'2!+8ZQU$=FL>H.9#"U<(1:_+GE(X0)%"Q5!E>5<(*K:>.O"J\4Y M?>MEOKK#Y@9%':#-#`+K(J9%M44O6P(4Z.\*JBSF)&/;IEL7N2RJ'+_W5SC+ M$*UD)]/<85-5T$G&BN8;!CX;)3D@[0:`2`@K<&PRRBV_D0!O$5/YOH0N:HD#K475'.!R@N,+D+'`HR&XRSQ*K'*77;/5)!GJ:``V3IS%60 MT^3=S$);#P?RESP+M0)A?,9<]#=*'T37BG-=-3Q5EW6$,@,0%,_F&XROC*/E M,LD'`Z'4_CHD7_MX1N@BCJ%7;.-,2SO`H#$0"@XMN9A6Z91D1!Q@(V^2`O+& M+Z%]O*93^X1F6]`)^(OF*4AH,%"1#M-;@GWQ9Q^OY(VUPIG!08EC(Q\$AH1% ME3=G'ERM`P0?#IVB.S3])J>/PGJ*0)@:ILDX5O4$IHEU`*_3C"6PM51@V=B!$C78X,_`BQ+[+=3]A/ MWM0H5Y=:D"ZO^430EC=^LDX\%(/+KPO(DFI/WD$?6SXRA#(_K!;0XHI.!%/< MUI&!22ZUJ06:=54G`F?=VI'AR6R/:L$H6]^)@,HV>62TK@&BRSS4C;"J[E,ML8KFCXSH.)HR^%LD+U%=U>;` M%RH]$8:%=G7@K3^7/Z:`0?')_P!02P,$%`````@`&S#K0/)"+MVT&P``BVL! M`!@`'`!A;'IM+F]B+3(P,3$Q,3,P7VQA8BYX;6Q55`D``]5._4_53OU/=7@+ M``$$)0X```0Y`0``Y5WI;]PXEO_<`\S_P,T`XP1PQ7$W9M')=&90\=%;&,/7^"&7)Y/OO__)V9?@A0>@^GB*8A)@[-DO2ERF()9'"=/ M08XY9,?X?\+7Q_AOF^<4K1YS\/+L%?CVS9OO)]^^.3T%DPGA$Z'X\SORGWF0 M08`EC+/W+Q[S?//NY.3+ER^OO\[3Z'62KDYPQ^].JH8O_OB';[ZAC=]]S=!> MAR_?5&I-;Y-OF=>I_.6%_;+1&$G&V>L5S^[_'D#W[_( MT'H3P1?E[QY3N.23B]+TA/0_B>$JR.&"*/(M4>3IOQ-%_JG\]54PA]$+0%K^ M=#<32O9VCQ;K=.)*QEN8HF1Q$?<3MM';L=3W>9#F!G+7^CN3_`&O:;"7S+6> M[J1-\B#J)^VN)Y.6+9[D%U?XISVAX=<H,;LF"'V&7PJ__48MIWTUD1MC[EU!]J?,BS619:C M-=Y$,@$Z&XV,87Z>)?1993W#XD=Y", M#D40W^62-;Q*,OS+:YB?!=DCOAX^(7S$^/",!5_,XK.$+-8%7J]O-C!EE\#I M''\$09@+4#<,+V/P#JH"DV^@)AC($Y!6HH$8Y@!1^<#+"$OXBOR9_#+$4H)- M*2:YR+\LL*2X[2L0;H4%R5;:=[Y].H/.1?,+=(!'EQ_R`A%!@N@V0$3&8(/P M!>(C7,]A*OP@97TL?%@:(IE](!4#0#A,4`Q*'O[A6D,5;7QJ3X_#N]MC@*?^ MILB)*8A8$T77M%8[\QN9B+71Y8L2!^YEE'R9 MQ-J/G6W&TJ M[QA(;X^Y"681&!RNL'D2?IYE>`U9G!'D.ERA$N7=' M)+5"N-N8QO1T15@&P]>KY.ED`1$#%_ZAB2G\JU_/DY"^Z%WBNQ>&.-U#+_'O MFN=]>=O>2-(2P01$%7'`J`-&'E#ZOJ!'2PD5<#I,Q%"8N8ASC-.S9+U.8HI? ME;U4LY,1BO2%,H$3XP(8&T#Y'(/2O'KCGWFUFV+J$.LZ7>YVP',XS\]+2U$* M59Y4HM;&>Y]"#*,U"Y,&.]I>^T8IU-#<[K2FPQV6:OB6/B*VVQGC1\C:R'!? M6Y?`_YS^KTV3EY'`^=8M52&U;_@6CKJ);`5$W&&:&C^ND[CT@(A7%U\W,,Z: M4ZML;HQPE2!&2V2!-UR\#X&LF&=ABC;4/\$W\*@TT,20WEPX]+/+480OOS`[ M2[)WW\CW<%%4B&+ACD@X3#X3%J#B`1@37X"DK8WV MQ5!K9G3`%$2_KU\G\TD5-T@1LT31S@'](^:`[PK9-%[L;@XB-]PN/7NCJ(=X MEL(2*F9T(ZNQ\P51/3138:OWS+ETWUFO@_3Y9EDMI0_!URL4S,F._'R=Y,2] M=A6CWTD4GB*^JPH,"YL;N^I6R"(A3=O3/R0HG%4&A$^BTOGQJ$=+L@> M\5I/_B&/8$]!M`LR4^%,KZ^YO:Z+B$8V/.+V2/9W^D.-UR$!LI.V6J:T[C/J MTF2,!Q_G+"+F#F6?]=\BM+I:,"SK"VAF:Z[Q`831H;Q9=-%0V\S;=0X=6WX_ M!CE,41!=8T'Q!S3+X5IDN1.WMV/[E8EBB+PRZ0\Y5,9)CB]$F^"9GAKS!&0^ MOB,H%<*U!:LG9S2_1K&YC]/0MG>C)2-?W<'Q&'AH$Q8/6^'H:&S8,PH9""%< M9)=X)-?DV[QEGZ8`+<+F-L()I(*8(*>B#R3TQ@C8 M73>H@;IR4S: MT=))34*[=M[%PEFRQ-L'.S M7*(05MNF;ZCA#I=[.>2KV!T6JF<*)$1"O84Q#CCLC)R"2"PNJ!'U#0B<\39A M(-2O0T^@`I(UZ@Y&-&-JD!)AB+F"95P0`$/5R]PS2$\LLX@WFBJZ3%M%^>`K M8.HCE#2UT?(8ZC)+PWH.W1;S"(6741(T(<5O8\%#B,/2@E<0HPHH65]@(AUS MV_='J&>7GACS#/Y68!!>/)&W(67F%$%S"SX53H M/K'N4"O(UUAFZ8U7TS!'3[)3>0<"QMCM+JR1C>KB`9Q-[_\#W-[=_#P[OS@' M'_X)7OYTCW^87;\"E[/KZ?79[/I',#U[F/T\>YA=W/N&W>X*:\*W[_0Z?"$* MGFE"TFUJZ7@E"S`1-C=_(5((8N2UR]SL:>B`;R!3C;OU)*0U`VZSDL$LHUDY M+J%PH6LULY*AC,?8\"EQ2Q,LH7^W1]&@>=F_Q.IV:*.D]KTTJ^_C(E,EKZFY MQ5(B@!%2@F?\]XB^M&S*G[U,SB130,N4J9R"H5.?/&"R'*/"WI^M)#BI,[*2 MTX00]&7N10/EY2UIJ]2MJS'+F-)\91;=\\0=K#@5RX4Q=&^BM$B^)/;3*Y:7 MJW0P9MX#.P];7Z"DKQV>Y[#.7(U^6]OZ,_2]K?$(#'5;DP@[X&WMYO;B;OIP MD+LIEDD[729JCWV5G*G%[BU5,!*(8O>?4Z/F&,^7`Q64_ MI),P2J8=EDEJ6N2/24H"V\3V56$/F]EW1.(8F>Y91K!@2]0W0&F,7Y+@1CX? M#I^!PD>X*")XLRS=`DN0LT2*#Q*O8YV>YH]#^N(9@:V60I(ERBSS9/J7*U]? M(:VWHZX3YKH2B&@W9'^T5.O#!ER8XXO/I3V$FQI'E^ZFN>8&\?R0!G$6A-05 M3S_^KPL%8\#T$-<$5=5C(>4'Z@P/)2JPA\*:`.T]P4:94DA.14DZE+T_&^4\ MX3$RR[$T]^9I1#2^>GH2L29=.EWB#6^!M[P=IGY,Z'L,'EH:DX`=P>JCT]." MDZ:V>";(H31!293D#_'&#-I#$6VOSHX3-7:>AFE^%J3I,Q:1)N^1V%'5?0?* MTR`0<:`\#4$.*G8L<=,Q^`!7*";!).!#$)&'8:NI66V/F96,N<_Q1G;U_W;X M%_'"SN`O:+YLG9'[DZI#H#V]5!W2C]IAG%26%43C-TMZ1<9R_H+%"K"`ETEZ M#],G%,+L)CV+`B3,D="-AGGT5!^1C8T'8!Z0$LIAW?O/T_"87@IJQ5?UG]21 MJI8+JM"P3!@YFD>0'$Y_0?GC+CG&)0QR?'90FND-R=NM36YAH&9!'7OER+TO M9617<]+BX=8P,EZTMB),0-C<>GRVS5MT19N4MF&E2+RS^ZJ&KXJ['OO277OZ MD-YPFLUL/E/9N[<<1K4%^;%3JFF'>W08)@7)3<=2I."#!/Y-6L"%.C96JZOY MWMI!0*-]L^2SS<-%+D%-W'2"YDEA`P\6+KE.HI.YK)J\N M^E"G5%+-F!]%NZN\.R0&3^G.WX/0H&6]Y<*;FVTD=;Z/05;:,7Q#<7^%=2D! MKC/=HR.\]*,*?RM0AF2)F_3[#X5GL:A#P9AQ/`9+?,C""&7)Q@X%S6)U:8)8 M-;7NL/L+1*O''"ZF3S`-5O"Z(,7M;I:M>J!ZJ?#Z4C/&M>$P3%!>L08!XPUB MRIPD+V:@!LF.?_49Y(^P_!3`!+0R[/GV&1AJM_E16$&)0SLC_DHWQ$PJ+[78 M:F9N5Q0P-O/DV@0H926&U@$Y$\<^/EN*AMZR)4J5[M)]\`G&A=`_ M?49F6&"T?)O\YAC;CG@\;;HVORB>&QJ-+)E>;#XM,(JV"PGWEU-:1=AGHY#J MP4,&A6$3J_V<1$6)FD:WI/EKD3ZW0ST8X;J(.DC\('6L/Y3PG4#I@QH#W\"GH8MV.7;-N?'D ME<+&0YR4TK`O%^,\Q55O&`?V%J>CLD[O&'Z]QE6EENNR["2LDAU^A,3H+%Q9 M.Y"PL-1V%]AL[2WK=+-]T#?4]E%'>_GM.X$^U?GY`/%U#M9J_YWC'[(6$AS_EU^!)6;DKSF MZ'XK"V#ELC4#("/I::51[GC;`)+H>9320V=2!U=.0YN%B,YL.[F6!`^D+M&9 MW-%5I?Q1\#*-%^V;ON*E3KN[36QI"6J"N!HO\.=@O?DK$%J"/,:@EIHDR.PP MH<.^Q-W!%2)GDC#QF_,YB$U;&;+*VQH3Y;)@1YK')$<["_DM M`Y_.ZM6H1=C3Z&FAC(>V>&:QX54`=!4/OBO([9]'9@>EM,M]=)RTT=-I# M#!04*JM+L*L/88*T("#Q,RU7"0$Z6\TLY,CA,S8WQE]XNN")1MS.DB/3M<." M?%4QFTH0Q=U,W-Z\-)]*%!/4_`CQK1GCAAG3IXLUBJG9$-\HO#%^:BNB5:=/ M;U)&2K,UKB,9>T`2($_281`GL7UAK+B$02\?!-6#UW$`XTV%RW,_!C8M MCRDK7+3?R,(9GL?4Z*1.OLC#*$?$'7O[X"W6^-"E:6^K1.3G0:NN@[B=E6*U M7-96PNT899(5'1#:OJ!".7A>)5N)XMU69;B,DB\DI1S^<18_$8^]>(6/_AR[ M]BZB17$,-R9KI9:#C8$9+6?%9A/1[Q^?[!>UH+UD">(DGM`BNJB2C%IMEY5L M(-@*Y]WB9TNWO(H`]E`S^LLBIQ!KOY=%&2&'A7L=OBSR"OAZ]QGTUUS_2KYC M0UT:JG.3/PJC7C0Z#AO%M2?,AS1XPCJB62M@F@/4FYGL;AZ&Q MJ24KMS&;OB]]!=6H&[F+/,K!@#/LUA%`"&.'FWV2P\JQ1[37 MUYN8;_4O-PE!PF>(#Y((<(B^C8,7!R/[?C8#!967DRUP1!(2B M3_//'6I]TB5J--R.=H!/>QFV7U M!J]ZJI9VL>=:)A'([`VOI$\3`A`W#,K"-ZSIJ$'HF+*/R!9R19$-N.3(:KP1GJ#&U.N"1KVT MUBHLV7^F_8*TJI9J%Q).`&VU#JLFG@\1PLK2J+UG=A33>^?5/YB$XIW4(['6#Y5*W"#Y#@GP80X=M51`J@P\\D[F:7BTA#*!(>6P#]\@UV>GIHI>+I,#LN"]P'T45&/H59G!4I25XMNO-P6EHH>R]D;^:U41+S M#3J2\;;N,2I]^U322K$R=2#@H`#Z#+Z]H$"&9;+!C"78\J])57CD7]E=9 M]Q)58R]T[;(V^N5CFAT&*$9D$Y,'68ZH0_$7Z70XO`!G&W94F4A6[*?' MI:D4['B`3X2+=ZN=EDZ$1E/U/+F,3H]7#S!=:^0JX#:U$*$N%L`L("->37), M&,0^9S&0#;\=IZZ:`(>Y+8(<;]Y,X-HNVXJ MWW"LT#9_ZK$Y1*,7H9H@QV!/%/J:7A>&P'XK#MC)XQOFK2JW] M%Y!8E.\@]:$G-2Y1ATA,?N\!PC&E8AIYZC&*I$8$/E0&BR?R#N0=HCLJ1!V> MJ3%Q3CV=JB`.^HA+3KTI?(1QAIX@,P!\A"0\2G2OUNYOP\>IFZB&#D[;>"#V M6.,0I:9\W#\"T5Z M4$>WC%E61/#MTC]9*>]AQ4L!T_%MPNMCXY7(<%M':)>C[Q+_AA=[*6III9:0 M@+U1)'E53:B>49%2]P4)&@K@51223H!1BKW:%>AY]\8H2[>GZF&4>D]3'!M7 M7LJC]G;L#48ZZ*&>GZ_3O+C.U;=]R3E/U@&*!3L(OZVES'T"$8S<61IO<;X@ M2&O@_(Q^4N6[0PV_6'L#+K+*['UPPF=J`I"2(H">%HWFC[B)#)F>1XFGVIJ6 M;Q-6X%P_G$K)BI5O&.NB%DD0E>;$.<1C,<_@;P5Q5G@B MCQO*/!/"]N;(4XEB!+_W@JU1%"V)ZT^*X`,V'(-NO0GRS*1_99E@% M,;%*WN)9REB2"Q'B>E"R4\ZFG_A&*"5L)W/"%]09'P/&FIIUM\P!Y7Y(>5'Z M:Y5;]L4$%0[O#D$:HWB5527=]1+ZJ'J9WR?TQ#*Z690L2%UD5GOPD++X:"JH M=0/I,G%C9**@`JG3]T@Z6,PR(1+&4DZ)BKQOV%(K0)PL0CX=(Y6X5%<.YK2U M6_+2:OU?F/O],B\=N;3PY=BP89)L[T1:0='MUI8B>X1B6`CJV=+V#3N*H?.C M=Q13,$J,,C[H:;_)*[O9C%>6"F;^7E_C1&\$AN_W(\&UL550)``/53OU/U4[]3W5X"P`!!"4.```$.0$``.U=69,;MQ%^MJO\'QCY M89,J5&!,R`7T1"@@1EJ5[\^P`R/N7`,+P"R M7O8@NS'=_:&!1J.!^>GGAUG46D#*$,&O3BY.ST]:$`T76%A^U+YZVGUVO'=*[_^_9T\/I,&.+BXMEYCDPTU-`" M%9:E#2Y>O'AQEGZ;I^;-A?&:/-_ZCV?9ER5JI!!G;5>.Y3<9F)1$\!9.6N+W MN]N^5.@*BS[-3,FZOVA?F_]ZX^;.-`G,*&2=+/[_F'Q2>#!]BB$,8 MKIXME-B7BD*$I0P1"?*//8E$1R7T)*_Q2:W&O)M]4#VE,V8Q!4&\:BH"8QB] M.C%F.VLJ9;ZC,1B<3LGB+(0H-9+X(Q6_?7ZQ])CO^42@[M"@LH,&J2?YGBN.)M)\O*<[F?-S#<3NX1U&XXIY0,FM@P)40 M1*%#*V%<&C(7C"`Z:1$:0IJ-V4>Q_TJ1$6^VQNZ%KSVS=U&U>CL_/;:=AY`B MPG4(+T&L,GB1SE/+EY2MA^#9L2#H<)%"(=95!*8UIB]^[YG)2\K5F_KOQS)U M)G:7BT-!U.>SZ,.O\%$ZK)?I/#.]1-EZ"'X\%@3=A`I%KQ`+0/0[!%0^YDA) M/0-"KG(]%O\XLCN0V8S@NY@$'^_NN?)LD,0BIA;+,KEOJ)@\P\?$#/5(_?.X M2`V3<82"JXB`0OGA,;<%>^X'1,F'Y?JR;V$0Z:Z9&EV?EQ@?B-1PJU(LUXC1Z1, MYR44%64E&!QM?9R)]1Y&T:^8?,)W$#""8=AG+(%4BH6,WDM,I,I+L#GZFGH3 M\%WQ3^H\1$;I&1Y2A25('&UI710L6_:;89&G]1J-@M(2/-;K[Y_.*DI>\P]V M2:V_[EQW;KJ]NS>]WNANAQQZL9T#)\N+#]NEITX`&Z>@)ZP]!6">=5<8Q6SU M2;G?+C_^(&9[*'`<3*X0!CA`'$S"D"*%WHAU)P?<@UHC,([*JWX)D24'W`8) MX80R50^44M\#%MQO8)__61X7%82N8%+H1K76SRGG'`(=QF#,-.Y<(G+%\I5. MD[=^63&YY5M>%AQT.27RXDHB_)@E["8W4"9\674SL,@5?-`&^';`W)-`&:W M,(!H(<(\.18UA,[#4*?<@?;'=W")!%YQO6YAQ*.^<`AHC""[(3A0CDLZ+N>Q MT:I]H%WT7:<++3(5,N>AJ"IVH%WS76VOM+@O=C[83O<.DP`"8Q0AX8$='*8; M]/;&<"ZZRHENMGA6,%C&JFF7E"#H_@*[$P0D MP3$;@D<1HW!E^285`147W5I$5?8PG'(>@V,-$XZ"#7!,\'4$Z,QBD:DE] MQJ=6=9>]1^\V7N.AG\4M)F(:KWO<7>GL`E+S%8_%G$RNI/PW$"6R@:U"9GTE MV@21JI+.1<"=,$29-$.`PC[N@CF*A6CU"Q<)M5>H2%5V+@)8[4:($_P0L]2D MF7Z:?9<:!J\@4BGN7!1P"1%KFD**Y<\.>H;Z[(3T(3HR#$MOH[3<8<7!S0J?@EFESGW'3FT2S"7+H M.NEAY[9W,WK3&_6[G>M]%4T7&SUF!77QR9:&J.`>ADD$!Y-E*(0^YV9<93&R M`:?M`EZ/BJG-D0TO1,MWX!+N5T!:-*]Y*L MQ>4FC3JCWEL>F@ZN!L/>;6?4']SLZ)DQW)K&>UA4(2VYQ^C/E?(N$@5=RX!MCG&C$+Y/5-E*N\0J:CI M7`I,/QR_AA-"848W`@^07?(_6(R"K>8N^C(D[6=V+ZDF7-KHAZ@F+LM6Y7K:B(Z*;D7E1AR99V;E#Z\O> M[5WOW^_ZH]_W4[E=T^[Q*KAK'FZY&I?W@^8WSYCPVBXS]J?*NQ$6?M9\9[J( M&BF"1<*H\X"TY=^U/*Y`I:\$KU?9.8A*8EZ2&4"R8KUZ6E<@4?6Q\LY9C<;. M(9,[0_@6BBE;NG]6IK.][%!U*;Q!5>-YLXM_NMN M:EHM@L7;`;)-#B5PC9KP!<=F=G%N`9F[:2G=2!%J4'C/-4&+9:)<[8S&_+X` MVL`BSI4R?#T_:'N8]/@6,,-#Z\8W16T1D,S3%_5R06AL-2SYTU[V\-1CS$3' MS+3+[@S,WOJ<7OS2"7A/S5Y6*Q\1#=G]P-K8&,Y%)!+1EU?$;`UD#;_/2-:9 MP\%P1-X+T]AJ"U_,^'R&+J^^)*54_;+$8-CAIO MT9#/J"H-Y%Q%F+)K[@-F94L^XZPVD7.E9YWP?PF+T\31B$@2A5V"%Y#&B"^6 M+^$X?H_B^^PC<;;["H(XD5[UN+?FO>@2^S.FPI`GG8$J=NY^[-U?7@ M_9[NI-PT=[R"ILTSK=HH)7[M9KE_*+2YO84!P@"*X6;V,B*0[;G&5Z6&> MY47O.9"9G=O[XAI1",1KT++?N6%+_;Y&`T8O@#8Q@'/;7&+%+&Z#6Y:F=W#X M'E`*>&>](O0.T@4*(!O0;@20-%YJUH8?6#8SBW-;89M!A\O;F1$:+U_3I!V? MR_1>P*50U[G]KKQX@XE(V5XB%I`$QT,*9RB9R2#2\OD!E5Y]YS:OJB/[YAJ. M]+7OJ@M'#%B]`,[,",[M1U7%YOUL#E"HOCM.R^8I9F7EG=L7JHI\0V+(>.`, MT4)T,\6-9CI&3S&K&L"];:6JU)T@'=79?Z"KA=T[2JAGR&5VD@"6 MPY3(.E$T3E1ERB:<7@!I9`()'XI>HU%N`2&QO=GB/H_21=Z[T;(("*3VO-Z`9F$%2,W#N[WG5@^/O M2\VJJ3*R/N!O/7(RGT>I?4"T*@_LXPFALPPD38FF(;<7?<#8%)(^8/6N]LUM M\M(`-T?B!1Y%I21&?^9CGK5T\;ARU[%,Z`ET504E`%I,OZR<_(;@@/_9QPMQ M#S\/J7%8$UZ+[>V(L$1[%_C.S7H!\>[&DW0(VR_S>9R>B\@ M5*@KP6:=WCG`>9M-%QG0*<#+TI(NP8Q$*,RLA\-A[HGKM]F`:*TPV^&(SKXD M./"IGGV):+X M4F%46LFY$PO7Z(\$A2A^W,R,OY#T%7#AH'+ M77PATCW`4YB^PI520KN$K_6#=#K82[1G]*"C!75&TEB[J%OJ8ZYG,-@I(8#3C]0I&0W,XEXS)7X&Y+$U, M7TMOZ(^&W%Y!:6P2Y[(PZSU?,_2DY%[!)5?:N1LBRB\.-H-)Q^456EH3.'?_ MPQV:8C1!`8["5;D#9TM/Q` M^K2F_;I6BPF*/HC6),OZRM?6]G"SRV;,$G$R:DN>([-Q_', M?'M'<\_\0_SCW$I@K:SYJ*ID<1\WM<::G/1!!\]UVOPM!.)_ ML16Z^78_`ZKN&4<;9'6"[&W@U3Q(,1B;=,K)I/-=-8]%YVV(4NUN4[T= MK%;W;.ZW>-RW)\O:/EZ%CT2`O7FNY`$*C]5Q6/+4O%@C"C`#60V:^9S;I`6+ M7FR(6-Y[&]G&IB_?)6,&_TAXP[W%W@YV51H]FO=6GFQKE5$40WO`7T)N;9%4 ME$>_%)+1V]X1T>!07/E(E=[:09??B!]CP"#_Y/]02P,$%`````@`&S#K0#52 M0EJ)!0``&B8``!0`'`!A;'IM+F]B+3(P,3$Q,3,P+GAS9%54"0`#U4[]3]5. M_4]U>`L``00E#@``!#D!``#M6EM3VS@4?N[.['_0\K!N9^HX!M("F]!Q@RF9 M!L(FZ=Y>&,56@J:.9"292W_]2K*=*,%VPM)V.COF!,ADF`0C!Y`/[) M!V_($RP0X'0J[B!#KX$7WD*B&+IT'B<",=`CA-Y"(2WPUW(0-%Y+6OS`\.Q: M@)?=5V"WV3RP=YNN"VQ;V>'!-9I#(%TC_"A$N&-="Q$?.<[]A$4-CH+&C-XZ MDN`H(;OIVGNNE;%/<;1@]_K_G#<&[S67Z^[)V*`0#$^D5Z>4S4_0%":1Z%@) MN4E@A*<8A3+\",T1$2L,!EE`-D/B`LX1CV&`*FQI?Q;TN[N[QMU>@[*99&FZ MSE_G_9$.,W?\/L+DWAXZ&AJSOJ(4^,;>01@O>*>03S1O1C`!DLB^:$-9"T+7@AK*<1QC,J5Z M\**M/#_*W1^B*=!A'XF'&'5V.)['$=K)WETS-.WLP.C+O$$G=I[UJYBAAG0M MYV(TDI*ED2NR(T6X!%P[U5_:SE5`%CS2\@@9J83&B`F,^"+].\Y7BRI$TZ=& M)44PP3]P3!&*!$GTC>M.Z1C+,(!Z^#3L+?2M+UBI M3SAD5Z.Q-_;/_8OQX'0T'G0_G@WZ)_YPY/_^J3?^>P?@L+.SF2WU(7-B68S' M3?G7:@(;C.2,TRNM>LY5@<$I,)7]"F/*?P.ISK:SKLRTD7`4#LBQ?EZ?TIED MQE(FM3IEMI-9P[!`*'N5X_!,;$XP#R+*$X8&;`8)_J)-=V5KI1$.]<`CX:41 M_V!ZBHEH%.PL+@L M&UZ7@XF>%P0T(4+NV[K7D,P0EZCYC%'6I8RA0.^^BE#?2JX4W%81N$N5(-.I M,=5:@:&V!M`$XA1B]@>,$G2.H!HK();40NPVB93!=N"V"F!3VH!6!W)]&C=# M8XT8NWKO];V+KC\Z\_WQ:(G*ZNNJ[K>[WOTR49#*UCDV2]R_D9^7#T7%GU'* M,MTJ[#NI4)UBF4@:)*K^\O]JV9=KMGCHR<\Q-M>.&&G?AKNJZ%T-129M/NK. MH%4!0U>-4'&/OI3;I``7=X,"KM*^?;BA;^<::AS,#`\Q_ZQZ["<2R&\NB(DH M@:*8L12-MT7M6.O0TV-%2XW(2J*1-(O"2\C$PX;-4AEKZ29IOQ"55`O0:NJM M4>G!P>#2'WKCWN!B5'A@8)"KNL9^Y4'!4DF=?+/23]!$%,T`_;XLW?MOBEJ" M$JF3NU*Z76]T=MH?_%E7];5.]+<9#*UPB8V>V1@,[1&-X7MUB37);WMX5Y3R6!%JU3OG::<.D- MY""83+KR75%<5EJG;*F.+JJ.C/R)E(*!L(" M,'O*K:H0.M9VLEQV;4E,U-L/C"9Q[A*6SGRK\-8=7H0KM\Q;NY9%N2+R?=TU M>O83O2Z4_+[.EWS3/S&0C5J^[?S8<(NS:8IL+;[%+&D[Z=(C'_\%4$L!`AX# M%`````@`&S#K0)+CQ,PJ?0``Y(X*`!0`&````````0```*2!`````&%L>FTN M;V(M,C`Q,3$Q,S`N>&UL550%``/53OU/=7@+``$$)0X```0Y`0``4$L!`AX# M%`````@`&S#K0'KRT'@J`P``"Q<``!@`&````````0```*2!>'T``&%L>FTN M;V(M,C`Q,3$Q,S!?8V%L+GAM;%54!0`#U4[]3W5X"P`!!"4.```$.0$``%!+ M`0(>`Q0````(`!LPZT"G\,%X,`T``*;$```8`!@```````$```"D@?2```!A M;'IM+F]B+3(P,3$Q,3,P7V1E9BYX;6Q55`4``]5._4]U>`L``00E#@``!#D! M``!02P$"'@,4````"``;,.M`\D(NW;0;``"+:P$`&``8```````!````I(%V MC@``86QZ;2YO8BTR,#$Q,3$S,%]L86(N>&UL550%``/53OU/=7@+``$$)0X` M``0Y`0``4$L!`AX#%`````@`&S#K0,@>LX=E$0``%A(!`!@`&````````0`` M`*2!?*H``&%L>FTN;V(M,C`Q,3$Q,S!?<')E+GAM;%54!0`#U4[]3W5X"P`! M!"4.```$.0$``%!+`0(>`Q0````(`!LPZT`U4D):B04``!HF```4`!@````` M``$```"D@3.\``!A;'IM+F]B+3(P,3$Q,3,P+GAS9%54!0`#U4[]3W5X"P`! @!"4.```$.0$``%!+!08`````!@`&`"P"```*P@`````` ` end XML 18 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.1.0.1 * */ var moreDialog = null; var Show = { Default:'raw', more:function( obj ){ var bClosed = false; if( moreDialog != null ) { try { bClosed = moreDialog.closed; } catch(e) { //Per article at http://support.microsoft.com/kb/244375 there is a problem with the WebBrowser control // that somtimes causes it to throw when checking the closed property on a child window that has been //closed. So if the exception occurs we assume the window is closed and move on from there. bClosed = true; } if( !bClosed ){ moreDialog.close(); } } obj = obj.parentNode.getElementsByTagName( 'pre' )[0]; var hasHtmlTag = false; var objHtml = ''; var raw = ''; //Check for raw HTML var nodes = obj.getElementsByTagName( '*' ); if( nodes.length ){ objHtml = obj.innerHTML; }else{ if( obj.innerText ){ raw = obj.innerText; }else{ raw = obj.textContent; } var matches = raw.match( /<\/?[a-zA-Z]{1}\w*[^>]*>/g ); if( matches && matches.length ){ objHtml = raw; //If there is an html node it will be 1st or 2nd, // but we can check a little further. var n = Math.min( 5, matches.length ); for( var i = 0; i < n; i++ ){ var el = matches[ i ].toString().toLowerCase(); if( el.indexOf( '= 0 ){ hasHtmlTag = true; break; } } } } if( objHtml.length ){ var html = ''; if( hasHtmlTag ){ html = objHtml; }else{ html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ objHtml + "\n"+''+ "\n"+''; } moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write( html ); moreDialog.document.close(); if( !hasHtmlTag ){ moreDialog.document.body.style.margin = '0.5em'; } } else { //default view logic var lines = raw.split( "\n" ); var longest = 0; if( lines.length > 0 ){ for( var p = 0; p < lines.length; p++ ){ longest = Math.max( longest, lines[p].length ); } } //Decide on the default view this.Default = longest < 120 ? 'raw' : 'formatted'; //Build formatted view var text = raw.split( "\n\n" ) >= raw.split( "\r\n\r\n" ) ? raw.split( "\n\n" ) : raw.split( "\r\n\r\n" ) ; var formatted = ''; if( text.length > 0 ){ if( text.length == 1 ){ text = raw.split( "\n" ) >= raw.split( "\r\n" ) ? raw.split( "\n" ) : raw.split( "\r\n" ) ; formatted = "

"+ text.join( "

\n" ) +"

"; }else{ for( var p = 0; p < text.length; p++ ){ formatted += "

" + text[p] + "

\n"; } } }else{ formatted = '

' + raw + '

'; } html = ''+ "\n"+''+ "\n"+' Report Preview Details'+ "\n"+' '+ "\n"+''+ "\n"+''+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+' '+ "\n"+'
'+ "\n"+' formatted: '+ ( this.Default == 'raw' ? 'as Filed' : 'with Text Wrapped' ) +''+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+' '+ "\n"+'
'+ "\n"+''+ "\n"+''; moreDialog = window.open("","More","width=700,height=650,status=0,resizable=yes,menubar=no,toolbar=no,scrollbars=yes"); moreDialog.document.write(html); moreDialog.document.close(); this.toggle( moreDialog ); } moreDialog.document.title = 'Report Preview Details'; }, toggle:function( win, domLink ){ var domId = this.Default; var doc = win.document; var domEl = doc.getElementById( domId ); domEl.style.display = 'block'; this.Default = domId == 'raw' ? 'formatted' : 'raw'; if( domLink ){ domLink.innerHTML = this.Default == 'raw' ? 'with Text Wrapped' : 'as Filed'; } var domElOpposite = doc.getElementById( this.Default ); domElOpposite.style.display = 'none'; }, LastAR : null, showAR : function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }, toggleNext : function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }, hideAR : function(){ Show.LastAR.style.display = 'none'; } }
XML 19 R7.htm IDEA: XBRL DOCUMENT v2.4.0.6
Organization, Consolidation and Presentation of Financial Statements
3 Months Ended
Nov. 30, 2011
Organization, Consolidation and Presentation of Financial Statements  
Nature of Operations [Text Block]

Allezoe Medical Holdings, Inc., formerly Stanford Management, Ltd. (the “Company”), was incorporated under the laws of the State of Delaware on September 24, 1998 with the authorized common stock of 25,000,000 shares at $0.001 par value.  On March 9, 2007, at the Annual General Meeting of Stockholders a Resolution was approved increasing the authorized share capital to 500,000,000 common shares with a par value of $0.001 per share.

 

The Company was organized for the purpose of acquiring and developing mineral properties.  On February 18, 2011, all of the mineral properties and related development and exploration activities were disposed of as part of a series of transactions resulting in the Company moving into the medical technology industry.

 

On February 18, 2011, the Company acquired all of the outstanding shares of Organ Transport Systems, Inc. (“OTS”), a Nevada corporation, and simultaneously disposed of the assets relating to its former activities in mining exploration, along with all related liabilities. Consequently, OTS was considered to be the surviving entity, with the Company intending to include only the financial results of OTS in its financial statements. In March, 2012, however, the Company determined that the development costs and time to development for the OTS technology were significantly greater than originally expected and, as a result, determined to return OTS to Healthcare of Today, Inc., from which it had been originally acquired. As a result, the February 18, 2011 transaction with OTS was rescinded and OTS is no longer a part of the Company’s corporate group. The Company will focus on the HPV detection and treatment technology as well as on the technology currently being developed by BioCube, Inc. for the disinfection of healthcare facilities. The historical financial results presented in this Report have been restated to present those solely of the Company.

 

Nature of Operations

 

The Company has recently formed a wholly-owned subsidiary, SureScreen Medical, Inc., through which we have entered into a licensing agreement with AVM Corp. for the licensing of proprietary, patent pending technology that would enable healthcare providers to "see and treat" Human Papillomavirus (HPV), the most common sexually transmitted infection and a cause of cervical cancer, In addition to offering easy, affordable, and on-the-spot HPV diagnosis, the technology offers an important alternative to the HPV vaccine.

Use of Estimates, Policy [Policy Text Block]

Use of Estimates

 

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. A significant estimate as of November 30, 2011 and August 31, 2011, respectively included a 100% valuation allowance for deferred tax assets arising from net operating losses incurred since inception.

 

Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ materially from estimates.

Development Stage Enterprises

Development Stage

 

The Company's financial statements are presented as those of a development stage enterprise. Activities during the development stage include company formation, equity issued for patents and technology, and fixed assets and further implementation of the business plan. The Company has not generated any revenues since inception.

Going Concern Note

Going Concern

 

As reflected in the accompanying financial statements, the Company has not yet emerged from the development stage, has a net loss of $1,248,931 and net cash used in operations of $382,930 for the quarter ended November 30, 2011; and negative working capital of $297,424 and an accumulated deficit of $4,087,756 at November 30, 2011.

 

The accompanying financial statements of the Company have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business.  The Company is a development stage company and has suffered recurring losses and has no established source of revenue.  Its ability to continue as a going concern is dependent upon achieving profitable operations and generating positive cash flows.

 

There can be no assurances that the Company will be able to achieve profitable operations or obtain additional funding.  These factors create substantial doubt about the Company’s ability to continue as a going concern.  The financial statements do not include any adjustments that might result from the outcome of the uncertainty.

 

Management intends to raise financing through private or public equity financing or other means and interests that it deems necessary to provide the Company with the ability to continue in existence.

XML 20 R3.htm IDEA: XBRL DOCUMENT v2.4.0.6
BALANCE SHEETS (PARENTHETICAL) (USD $)
Nov. 30, 2011
Aug. 31, 2011
Common stock, par value $ 0.001 $ 0.001
Shares authorized 500,000,000 500,000,000
Shares issued 95,069,482 61,825,039
Shares outstanding 95,069,482 61,825,039
XML 21 R1.htm IDEA: XBRL DOCUMENT v2.4.0.6
Document and Entity Information
3 Months Ended
Nov. 30, 2011
Document and Entity Information  
Entity Registrant Name Allezoe Medical Holdings Inc
Document Type 10-Q
Document Period End Date Nov. 30, 2011
Amendment Flag false
Entity Central Index Key 0001080602
Current Fiscal Year End Date --08-31
Entity Common Stock, Shares Outstanding 95,069,482
Entity Filer Category Smaller Reporting Company
Entity Current Reporting Status No
Entity Voluntary Filers No
Entity Well-known Seasoned Issuer No
Document Fiscal Year Focus 2012
Document Fiscal Period Focus Q1
XML 22 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENT OF OPERATIONS (USD $)
3 Months Ended 158 Months Ended
Nov. 30, 2011
Nov. 30, 2010
Nov. 30, 2011
Net Income (Loss)      
Revenues $ 0 $ 0 $ 0
General & Administrative      
Payroll and payroll taxes 491,978 0 2,545,045
Professional fees 510,543 4,950 790,201
Travel and entertainment 925 0 4,035
Insurance 0 0 48,559
Office expense 0 268 1,209
Telephone and internet 0 0 6,353
General and administrative 492 75 281,357
Dues and subscriptions 0 0 55
Repairs and maintenance 0 0 4,202
Total Expenses 1,003,938 5,293 3,681,016
Loss from operations (1,003,938) (5,293) (3,681,016)
Other income (expense)      
Finance cost 0 0 (133,494)
Interest, net (244,993) 0 (273,246)
Income (loss) before income taxes (1,248,931) (5,293) (4,087,756)
Income taxes 0 0 0
Net income (loss) qualified $ (1,248,931)    
Earnings Per Share:      
Net loss per common share (basic and diluted) $ (0.02) $ 0.00  
Weighted average number of common shares outstanding      
Weighted average number of shares outstanding during the period - basic and diluted 67,112,080 52,170,000 67,112,080
XML 23 R12.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity
3 Months Ended
Nov. 30, 2011
Equity  
Stockholders' Equity Note Disclosure [Text Block]

The Company is authorized to issue 500,000,000 shares of common stock, par value $0.001 per share.

 

On September 2, 2011, the Company issued 391,304 shares of common stock for services rendered under consulting agreements.

 

On October 13, 2011, the Company issued 4,000,000, shares of common stock for services rendered under consulting agreements.

 

On November 8, 2011, the Company converted $50,000 of notes into 2,666,667 shares of common stock.

 

On November 17, 2011, the Company converted $50,000 of notes into 4,830,918 shares of common stock.

 

On November 29, 2011, the Company converted $60,000 of notes into 8,888,888 shares of common stock.

 

The Company issued an additional 12,466,666 shares to Healthcare of Today, Inc., pursuant to the original OTS acquisition agreement and closing whereby in the event that additional common shares were issued to other parties, then additional common shares would also be issued to Healthcare of Today, Inc. so that its resulting ownership percentage of the then outstanding common shares would remain at 60 percent. Though the Company agreed to return its stock in OTS to Healthcare of Today, Inc. in exchange for the return of the 78,255,000 shares of stock previously issued to Healthcare of Today, Inc., pursuant to the agreement to rescind the acquisition of OTS, the additional 12,466,666 shares that were issued were not returned and are considered to be issued and outstanding as of November 30, 2011. These shares have been recorded at fair market value and are included in payroll related expenses on the statement of operations and stock based compensation on the statement of cash flows for the three months ended November 30, 2011.

 

As a result of these transactions, there were 95,069,482 common shares outstanding at November 30, 2011.

XML 24 R11.htm IDEA: XBRL DOCUMENT v2.4.0.6
Debt
3 Months Ended
Nov. 30, 2011
Debt  
Debt Disclosure [Text Block]

The following is a summary of notes payable at November 30, 2011 and August 31, 2011:

Description

November 30, 2011

August 31, 2011

Asher Enterprises, Inc.

Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature April 11, 2012 and is convertible 180 days after issuance into shares of the Company’s common stock at a price discounted from average trading price. $53,000 Note less discount of $21,326 for conversion.

            31,674

            17,083

Asher Enterprises, Inc.

Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature May 18, 2012 and is convertible 180 days after issuance into shares of the Company’s common stock at a price discounted from average trading price. $40,000 Note less discount of $21,703 for conversion.

            18,297

            6,680

Asher Enterprises, Inc.

Note payable to Asher Enterprises, Inc. The note accrues interest at 8% per annum and mature July 5, 2012 and is convertible 180 days after issuance into shares of the Company’s common stock at a price discounted from average trading price.

          32,500

-

Magna Group

Convertible notes payable to The Magna Group. The notes accrue interest at 12% per annum and mature November 4, 2012 and are convertible into shares of Allezoe common stock at a price discounted from the average trading price. $150,000 in Notes less discount of $57,122 for conversion.

92,878

-

 

Convertible debentures

Convertible notes payable to related parties – officers by OTS. The notes accrue interest at 12% per annum, mature December 15, 2012, and are convertible one year after issuance into shares of Company common stock at a price discounted from average trading price. No beneficial conversion recorded as note transferred back to OTS. See Note 8.

       1,447,126

       -

Crystal Falls Investments, LLC.

Convertible notes payable to Crystal Falls. The notes accrue interest at 9% per annum and mature January 31, 2012 and are convertible into shares of Allezoe common stock at a price discounted from the average trading price. $100,000 Note less discount of $42,765 for conversion.

          57,235

          40,815

Total

       1,679,710

       64,578

Less: current portion

232,584

64,578

Long-term debt

 $       1,447,126

 $                 -

 

Notes payable consist of borrowings under convertible debenture arrangements. In July 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $53,000 with interest payable at 8% per annum with a maturity date of January 31, 2012. The indebtedness including interest is convertible into common stock at 58% of the average lowest three (3) trading prices during the ten (10) trading day period ending on the latest complete trading day prior to conversion. In August 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $40,000 with interest payable at 8% per annum with a maturity date of January 31, 2012. The indebtedness including interest is convertible into common stock at 58% of the average lowest three (3) trading prices during the ten (10) trading day period ending on the latest complete trading day prior to conversion. In July 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $100,000 with interest payable at 9% per annum with a maturity date of January 31, 2012. The indebtedness including interest is convertible into common stock at $.29 per share. In October 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $32,500 with interest payable at 8% per annum with a maturity date of July 4, 2012. The indebtedness including interest is convertible into common stock at 58% of the average lowest three (3) trading prices during the ten (10) trading day period ending on the latest complete trading day prior to conversion. In November 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $50,000 with interest payable at 12% per annum with a maturity date of November 4, 2012. The indebtedness including interest is convertible into common stock at 50% of the average lowest price during the ten (10) trading day period ending on the latest complete trading day prior to conversion.

 

In November 2011, the Company entered into an arrangement with a creditor in which the Company borrowed $260,000 with interest payable at 12% per annum with a maturity date of November 4, 2012. The indebtedness including interest is convertible into common stock at 75% of the average lowest price during the three (3) trading day period ending on the latest complete trading day prior to conversion. This was an assignment of part of the convertible notes payable to related parties – officers by OTS where $261,453 was assigned to a creditor for $260,000. In November 2011, the Company converted $160,000 of the note into 16,386,473 shares of common stock. The Company accounted for the borrowings under these arrangements in accordance with ASC 470-20 Debt with Conversions and Other Options. The fair value of the beneficial conversion feature is calculated using the intrinsic value method at the time of issuance or commitment date. The company records a debt discount for the calculated value, which is amortized over the debt term.

XML 25 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Related Party Disclosures
3 Months Ended
Nov. 30, 2011
Related Party Disclosures  
Related Party Transactions Disclosure [Text Block]

Healthcare of Today, Inc. (HOTI) provides financial, accounting, legal, administrative and similar services to the Company at a monthly fixed fee of $10,000, commencing March 1, 2011.

 

XML 26 R13.htm IDEA: XBRL DOCUMENT v2.4.0.6
Income Taxes
3 Months Ended
Nov. 30, 2011
Income Taxes  
Income Tax Disclosure [Text Block]

The Company accounts for income taxes in accordance with accounting standards for Accounting for Income Taxes which require the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statements and tax basis of assets and liabilities, and for the expected future tax benefit to be derived from tax loss and tax credit carry-forwards. Additionally, the standards require the establishment of a valuation allowance to reflect the likelihood of realization of deferred tax assets.

 

The following is a schedule of deferred tax assets as of November 30, 2011, and August 31, 2011:

 

 

 

November 30, 2011

 

August 31, 2011

Net operating loss

 

 $             4,087,756

 

 $                  2,475,744

Future tax benefit at 34%                     

 

1,389,837

 

841,753

Less: Valuation allowance

 

   (1,389,837)

 

(841,753)

Net deferred tax asset

 

 $                           --

 

 $                               --

 

The valuation allowance changed by approximately $548,084 during the three months ended November 30, 2011.

 

Under Sections 382 and 269 (the ‘shell corporation’ rule) of the Internal Revenue Code, following an “ownership change,” special limitations (“Section 382 Limitations”) apply to the use by a corporation of its net operating loss, or NOL, carry-forwards arising before the ownership change and various other carry-forwards of tax attributes (referred to collectively as the ‘Applicable Tax Attributes’). The Company had NOL carry-forwards due to historical losses of Stanford of approximately $368,374 at November 30, 2011.

 

The Company has adopted the provisions of FASB ASC 740-10-25. As a result of its implementation, the Company performed a comprehensive review of its uncertain tax positions in accordance with recognition and measurement standards established by FASB ASC 740-10-25. In this regard, an uncertain tax position represents the Company’s expected treatment of a tax position taken in a prepared and filed tax return, or expected to be taken in a tax return, that has not been reflected in measuring income tax expense for financial reporting purposes. The Company does not expect any reasonably possible material changes to the estimated amount of liability associated with uncertain tax positions through November 30, 2011. The Company’s continuing policy is to recognize accrued interest and penalties related to income tax matters in income tax expense.

 

XML 27 R14.htm IDEA: XBRL DOCUMENT v2.4.0.6
Fair Value Measures and Disclosures
3 Months Ended
Nov. 30, 2011
Fair Value Measures and Disclosures  
Fair Value Disclosures [Text Block]

Fair Value of Financial Instruments

 

The carrying amounts of the Company’s short-term financial instruments, including accounts payable and accrued liabilities, approximate fair value due to the relatively short period to maturity for these instruments.

 

Fair Value of Measurements

 

The Company follows accounting guidance relating to fair value measurements. This guidance establishes a fair value hierarchy that prioritizes the inputs to valuation techniques used to measure fair value into three levels as follows:

 

Level 1 – quoted prices (unadjusted) in active markets for identical assets or liabilities that the Company has the ability to access as of the measurement date.

 

Level 2 – inputs other than quoted prices included within Level 1 that are directly observable for the asset or liability or indirectly observable through corroboration with observable market data.

 

Level 3 – unobservable inputs for the asset or liability only used when there is little, if any, market activity for the asset or liability at the measurement date.

 

At November 30, 2011, the Company has no instruments that require additional disclosure.

 

The asset or liability’s fair value measurement level within the fair value hierarchy is based on the lowest level of any input that is significant to the fair measurement. Valuation techniques used need to maximize the use of observable inputs and minimize the unobservable inputs.

 

Recurring Fair Value Measurements

 

In accordance with accounting principles generally accepted in the United States of America, certain assets and liabilities are required to be recorded at fair value on a recurring basis.

XML 28 R16.htm IDEA: XBRL DOCUMENT v2.4.0.6
Subsequent Events
3 Months Ended
Nov. 30, 2011
Subsequent Events  
Subsequent Events [Text Block]

In December, 2011, the Company issued 18,247,619 common shares on conversion of $101,000 in loan principal (see Note 7) and 36,231,884 common shares for $250,000 in consulting fees. HOTI was issued 32,687,701, common shares for stock based compensation.

 

In December, 2011, the Company entered into an Acquisition Agreement (the "Acquisition Agreement") with Élan Health Services, Inc. (the "Seller"), pursuant to which it will acquire BioCube, Inc., a Nevada corporation (“BioCube”), which will then become our wholly-owned subsidiary as filed in “ITEM 1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT” of the 8-K dated January 5, 2012.

 

Effective March 19, 2012, the Company, Healthcare of Today, Inc. and Élan Health Services, Inc. agreed to rescind the acquisition of Organ Transport Systems, Inc. (“OTS”) from Healthcare of Today, Inc. by the Company, which closed in February, 2011.  Under the terms of the rescission, the Company agreed to return its stock in OTS to Healthcare of Today, Inc. in exchange for the return of the 78,255,000 shares of stock issued to Healthcare of Today.  However, since Healthcare of Today, Inc. had previously transferred all of the shares of the Company received in the earlier transaction to third parties, of which 48,037,610 were transferred to Élan Health Services, Inc. for the assumption of debt, it was agreed that Élan Health Services would return the 48,037,610 shares held by it immediately, and then would credit the balance of 30,217,390 common shares against the planned acquisition of BioCube, Inc. by the Company from Élan Health. The market value of the shares to be received as a credit at March 19, 2012 was $0.0155 per share, or a total of $468,370, which has been recorded as “Loan Receivable” on the balance sheet in March 2012.  The net effect of the rescission transaction has been to return OTS as a subsidiary of Healthcare of Today, Inc., to remove OTS as a subsidiary of the Company.  The table below summarizes the effect of the rescission transaction in March 2012:

 

Shares

Price

Value

Acquisition of OTS-February 18, 2011

78,255,000

 $ 0.5500

N/A

Allezoe Shares Returned by Élan in March 2012

(48,037,610)

 $ 0.0155

$ (744,583)

Stock still due to Allezoe on BioCube closing

(30,217,390)

 $ 0.0155

 $ (468,370)

 

XML 29 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
STATEMENT OF STOCKHOLDERS' EQUITY (USD $)
Total
Common Stock
Additional Paid-in Capital
Deferred Equity
Accumulated Other Comprehensive Income (Loss)
Stockholders' Equity at Sep. 23, 1998          
Stock issued during period, Value, founder shares $ 47,170 $ 47,170 $ 0 $ 0 $ 0
Stock issued during period, Shares, founder shares 47,128,280 47,170,000 (41,720) 0 0
Stock issued during period, Value 50,000 5,000 45,000 0 0
Stock issued during period, Shares 5,000,000 5,000,000 0 0 0
Stock issued during period, Value, services 12,600 0 12,600 0 0
Stock issued during period, Shares, services 0 0 0 0 0
Adjustments to paid in capital 138,600 [1] 0 138,600 0 0
Net income (loss) qualified (363,081) 0 0 0 (363,081)
Stockholders' Equity at Aug. 31, 2010 (156,431) 52,170 154,480 0 (363,081)
Shares issued, at Aug. 31, 2010 52,170,000 52,170,000 0 0 0
Stock issued during period, Value, services 1,803,637 8,170 3,475,467 (1,680,000) 0
Stock issued during period, Shares, services 8,170,773 8,170,773 0 0 0
Adjustments to paid in capital 302,265 [2] 0 302,265 0 0
Net income (loss) qualified (2,475,744) 0 0 0 (2,475,744)
Stockholders' Equity at Aug. 31, 2011 208,738 61,825 4,665,738 (1,680,000) (2,838,825)
Shares issued, at Aug. 31, 2011 61,825,039 61,825,039 0 0 0
Stock issued during period, Value, services 451,043 4,391 446,652 0 0
Stock issued during period, Shares, services 4,391,304 4,391,304 0 0 0
Adjustments to paid in capital 211,196 [2] 0 211,196 0 0
Net income (loss) qualified (1,248,931) 0 0 0 (1,248,931)
Stockholders' Equity at Nov. 30, 2011 $ 149,025 $ 95,070 $ 5,821,711 $ (1,680,000) $ (4,087,756)
Shares issued, at Nov. 30, 2011 95,069,482 95,069,482 0 0 0
[1] Expenses paid by shareholder
[2] Discount on notes payable
XML 30 R10.htm IDEA: XBRL DOCUMENT v2.4.0.6
Accounting Policies
3 Months Ended
Nov. 30, 2011
Accounting Policies  
Cash and Cash Equivalents, Policy [Policy Text Block]

Cash and Equivalents

 

The Company considers all highly liquid instruments purchased with a maturity of three months or less to be cash equivalents.  The Company had no cash equivalents at November 30, 2011 and August 31, 2011, respectively.

 

The Company minimizes its credit risk associated with cash by periodically evaluating the credit quality of its primary financial institution. The balance at times may exceed federally insured limits.  There were no balances that exceeded the federally insured limit at November 30, 2011 and August 31, 2011, respectively.

Earnings Per Share, Policy [Policy Text Block]

Earnings per Share

 

In accordance with Financial Accounting Standards Board “FASB” Accounting Standards Codification “ASC” Topic 260, “Earnings per Share,”  basic earnings (loss) per share (“EPS”) is computed by dividing net income (loss) available to common stockholders by the weighted average number of common shares outstanding during the period, excluding the effects of any potentially dilutive securities. Diluted EPS gives effect to all dilutive potential of shares of common stock outstanding during the period including stock options or warrants, using the treasury stock method (by using the average stock price for the period to determine the number of shares assumed to be purchased from the exercise of stock options or warrants), and convertible debt or convertible preferred stock, using the if-converted method. Diluted EPS excludes all dilutive potential of shares of common stock if their effect is anti-dilutive. The computation of basic and diluted loss per share for the period from September 24, 1998 (inception) to November 30, 2011, is equivalent since the Company has had continuing losses. The Company also has no common stock equivalents.

Significant Accounting Policies [Text Block]

Basis of Presentation of Interim Period Financial Statements

 

The accompanying unaudited financial statements of the Company at November 30, 2011 and 2010 have been prepared on the accrual basis of accounting in accordance with generally accepted accounting principles (‘GAAP’) for interim financial statements, instructions to Form 10-Q, and Regulation S-X.

 

In management’s opinion, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation to make the Company’s financial statements not misleading have been included. The results of operations for the periods ended November 30, 2011 and 2010 presented are not necessarily indicative of the results to be expected for the full year.

Share-based Compensation, Option and Incentive Plans Policy [Policy Text Block]

Accounting for Stock-Based Compensation

 

The Company adopted the provisions of FASB ASC 718-20, Stock Compensation – Awards Classified as Equity, which require companies to expense the estimated fair value of employee stock options and similar awards based on the fair value of the award on the date of grant. The cost is recognized over the period during which an employee is required to provide service in exchange for the award, usually the vesting period. The Company’s stock-based compensation plans and assumptions used in determining stock-based compensation expense common stock are computed using the treasury stock method which assumes that the increase in the number of shares is reduced by the number of shares which could have been repurchased by the Company with the proceeds from the exercise of the options and warrants (which were assumed to have been made at the average market price of the common shares during the reporting period). Diluted loss per common share is the same as basic loss per share as the effect of potentially dilutive securities are anti-dilutive.

 

Non-Employee Stock Based Compensation

 

Share-based payment awards issued to non-employees for services rendered are recorded at either the fair value of the services rendered or the fair value of the share-based payment, whichever is more readily determinable.

Stockholders' Equity, Policy [Policy Text Block]

The Company is authorized to issue 500,000,000 shares of common stock, par value $0.001 per share.

 

On September 2, 2011, the Company issued 391,304 shares of common stock for services rendered under consulting agreements.

 

On October 13, 2011, the Company issued 4,000,000, shares of common stock for services rendered under consulting agreements.

 

On November 8, 2011, the Company converted $50,000 of notes into 2,666,667 shares of common stock.

 

On November 17, 2011, the Company converted $50,000 of notes into 4,830,918 shares of common stock.

 

On November 29, 2011, the Company converted $60,000 of notes into 8,888,888 shares of common stock.

 

The Company issued an additional 12,466,666 shares to Healthcare of Today, Inc., pursuant to the original OTS acquisition agreement and closing whereby in the event that additional common shares were issued to other parties, then additional common shares would also be issued to Healthcare of Today, Inc. so that its resulting ownership percentage of the then outstanding common shares would remain at 60 percent. Though the Company agreed to return its stock in OTS to Healthcare of Today, Inc. in exchange for the return of the 78,255,000 shares of stock previously issued to Healthcare of Today, Inc., pursuant to the agreement to rescind the acquisition of OTS, the additional 12,466,666 shares that were issued were not returned and are considered to be issued and outstanding as of November 30, 2011. These shares have been recorded at fair market value and are included in payroll related expenses on the statement of operations and stock based compensation on the statement of cash flows for the three months ended November 30, 2011.

 

As a result of these transactions, there were 95,069,482 common shares outstanding at November 30, 2011.

 

XML 31 FilingSummary.xml IDEA: XBRL DOCUMENT 2.4.0.6 Html 34 100 1 true 4 0 false 3 false false R1.htm 000010 - Document - Document and Entity Information Sheet http://ALZM.OB/20111130/role/idr_DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 000020 - Statement - BALANCE SHEETS Sheet http://ALZM.OB/20111130/role/idr_BALANCESHEETS BALANCE SHEETS false false R3.htm 000030 - Statement - BALANCE SHEETS (PARENTHETICAL) Sheet http://ALZM.OB/20111130/role/idr_BALANCESHEETSPARENTHETICAL BALANCE SHEETS (PARENTHETICAL) false false R4.htm 000040 - Statement - STATEMENT OF OPERATIONS Sheet http://ALZM.OB/20111130/role/idr_STATEMENTOFOPERATIONS STATEMENT OF OPERATIONS false false R5.htm 000050 - Statement - STATEMENT OF STOCKHOLDERS' EQUITY Sheet http://ALZM.OB/20111130/role/idr_STATEMENTOFSTOCKHOLDERSEQUITY STATEMENT OF STOCKHOLDERS' EQUITY false false R6.htm 000060 - Statement - STATEMENT OF CASH FLOWS Sheet http://ALZM.OB/20111130/role/idr_STATEMENTOFCASHFLOWS STATEMENT OF CASH FLOWS false false R7.htm 200000 - Disclosure - Organization, Consolidation and Presentation of Financial Statements Sheet http://ALZM.OB/20111130/role/idr_DisclosureOrganizationConsolidationAndPresentationOfFinancialStatements Organization, Consolidation and Presentation of Financial Statements false false R8.htm 250000 - Disclosure - Accounting Changes and Error Corrections Sheet http://ALZM.OB/20111130/role/idr_DisclosureAccountingChangesAndErrorCorrections Accounting Changes and Error Corrections false false R9.htm 275000 - Disclosure - Risks and Uncertainties Sheet http://ALZM.OB/20111130/role/idr_DisclosureRisksAndUncertainties Risks and Uncertainties false false R10.htm 290000 - Disclosure - Accounting Policies Sheet http://ALZM.OB/20111130/role/idr_DisclosureAccountingPolicies Accounting Policies false false R11.htm 460000 - Disclosure - Debt Sheet http://ALZM.OB/20111130/role/idr_DisclosureDebt Debt false false R12.htm 500000 - Disclosure - Equity Sheet http://ALZM.OB/20111130/role/idr_DisclosureEquity Equity false false R13.htm 770000 - Disclosure - Income Taxes Sheet http://ALZM.OB/20111130/role/idr_DisclosureIncomeTaxes Income Taxes false false R14.htm 815000 - Disclosure - Fair Value Measures and Disclosures Sheet http://ALZM.OB/20111130/role/idr_DisclosureFairValueMeasuresAndDisclosures Fair Value Measures and Disclosures false false R15.htm 845000 - Disclosure - Related Party Disclosures Sheet http://ALZM.OB/20111130/role/idr_DisclosureRelatedPartyDisclosures Related Party Disclosures false false R16.htm 870000 - Disclosure - Subsequent Events Sheet http://ALZM.OB/20111130/role/idr_DisclosureSubsequentEvents Subsequent Events false false All Reports Book All Reports Process Flow-Through: 000020 - Statement - BALANCE SHEETS Process Flow-Through: Removing column 'Aug. 31, 2010' Process Flow-Through: 000030 - Statement - BALANCE SHEETS (PARENTHETICAL) Process Flow-Through: Removing column 'Aug. 31, 2010' Process Flow-Through: 000040 - Statement - STATEMENT OF OPERATIONS Process Flow-Through: Removing column '12 Months Ended Aug. 31, 2011' Process Flow-Through: Removing column '143 Months Ended Aug. 31, 2010' Process Flow-Through: 000060 - Statement - STATEMENT OF CASH FLOWS alzm.ob-20111130.xml alzm.ob-20111130.xsd alzm.ob-20111130_cal.xml alzm.ob-20111130_def.xml alzm.ob-20111130_lab.xml alzm.ob-20111130_pre.xml true true